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Abstract 
An investigation into novel protecting group strategies for the prevention of imide 
formation at the Asp-X segment of a peptide sequence was undertaken. Research 
centred around the esterification of the aspartyl side chain with an acid labile protecting 
group which exerted an extreme steric influence on the system. 
Three protecting group strategies were extensively studied with respect to the aspartyl 
residue; namely derivatised trityl systems, the 2,2,4,4-tetramethylpent-3-yl (Tmp) system 
and the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl (Dmbp) system. 
The characteristics of the trityl 3-aspartates indicated that they possessed the 
requirements sought in a successful protecting group, but orthogonal synthesis of such 
derivatives applicable to automated SPPS proved elusive. 
The 9-fluorenyhnethyloxycarbonyl (Fmoc) amine n-protected aspartyl residue was 
successfully synthesised with the side chain protected with the Tmp and Dmbp groups. 
The respective -derivatised aspartyl residues were incorporated into peptide sequences 
which were known to be susceptible to aspartiniide formation, namely the partial 
sequence of coat protein phage MS2 and fërrodoxin, and tested for their efficacy in 
preventing rearrangement during Fmoc-based SPPS. 
The f3-aspartyl-protected peptides were subjected to a variety of acidic deprotection 
protocols and the merits of each were assessed with respect to aspartiniide formation. 
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Dmbp 2,4-dimethyl-2,4-bis(4 '-methoxyphenyl)pent-3-yl 
DMF N,N-dimethylformamide 
Dmp 2,4-diniethylpent-3-yl 
EDT ethane- 1,2-dithiol 
EDTA ethylenedianiinetetraacetic acid 




HOCt 1-hydroxy-4-ethoxycarbonyl- 1 ,2,3-triazole 
HPLC high performance liquid chromatography 
fIRMS high resolution mass spectrometry 
1K 	 infrared 
m 	 multip let 
MBH 	 4,4'-dimethoxybenzhydryi 
Mel 	 methyl iodide 
Mpe 	 3-methylpent-3-yl 
NMR 	 nuclear magnetic resonance 
PAM 	 phenylacetamidomethyl 
Pfp 	 pentafluorophenyl 
Phe 	 phenacyl 
Pmc 	 2,2,5,7, 8-pentamethylchroman-6-sulphonyl 
RP-HPLC 	 reverse phase HPLC 
Rt 	 retention time 
s 	 singlet 
SPPS 	 solid phase peptide synthesis 
t 	 triplet 
TFA 	 trifluoroacetic acid 
tic 	 thin layer chromatography 
THF tetrahydrofuran 
Tmp 2,2,4,4-tetramethyipent-3-yl 





20 Natural Occurring Amino Acids 
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Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic Acid Asp D 
Cysteine Cys C 
Glutamic Acid Glu E 
Glutamine Gin Q 
Glycine Gly G 
Histidine His H 
Isoleucine lie I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro p 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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CHAPTER ONE : 114TRODUCTION 
1.1 Introduction 
The synthesis of peptides (small proteins) has gone through a chemical, as well as a 
technological, metamorphosis since Hofmeister and Emil Fischer (2)  first proposed 
that the structure of proteins is best represented by chains of amino acids linked to 
each other through amide bonds. 
The use of conventional organic synthesis allowed the preparation of peptides; 
classical solution phase methodology being employed by the half century. The total 
number of steps involved in peptide synthesis of even moderately sized peptides is 
substantial, and as a result the synthesis of such peptides was labour intensive. As the 
peptide chain was extended, the synthesis was fraught with solubility problems, and in 
addition the isolation and purification of all intermediates required great skill to 
establish even moderate yields. However, the isolation, structure determination and 
moreover, the synthesis of the nonapeptide amide hormone, oxytocin, by du 
Vigneaud 3 was a remarkable achievement and demonstrated the huge potential to 
synthesise biologically active peptides. 
The step-wise synthesis that du Vigneaud and Bodanszky 4 employed in the oxytocin 
project incorporated a repetitive cycle of steps with the end result of elongating the 
peptide chain. This repetition of the cycle was conducive to automation, and this was 
realised by KB. Merrifield (5) in 1963 in the synthesis of a tetrapeptide. The 
attachment of an amine protected amino acid, to an insoluble polymeric support 
(resin), followed by amine deprotection and consequent acylation of the exposed 
amino group with the penultimate residue, resulted in the elongation of the peptide 
chain as this cycle process was repeated. This novel concept heralded a new era in 
both biology and chemistry, and thus 'solid phase peptide synthesis' was born. 
1 
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The advantages of incorporating an insoluble solid support are four fold: 
The use of a large excess of starting materials and reagents can be employed to 
drive reactions to completion. 
The need for traditional isolation and purification techniques were made 
redundant as all soluble by-products can be removed by filtration. 
The resin-bound peptide is synthesised in the one reaction vessel throughout the 
process therefore minimising physical loss of material. 
The process can be automated reducing labour time. 
In spite of these advantages there was resistance to the general acceptance of the 
technique due to concerns from many chemists with respect to the non-isolation of 
intermediates and the apparent 'blind' synthesis of peptides through a lack of real time 
monitoring techniques. The technological advances in peptide automation and 
chromatographic purification methods have circumvented such fears to such an extent 
that the solid phase principle has been incorporated in peptide sequence analysis and 
oligonucleotide synthesis. 
1.2 The Merrifield arrnroach - Boc strate 
The principle of solid phase peptide synthesis being demonstrated with the synthesis 
of a tetramer incorporating the benzyloxycarbonyl (Z) N'protection 5 , Merrifield 
then synthesised the nonapeptide bradykinin utilising the tert-butyloxycarbonyl 
(Boc) moiety for the amine protection. The overall yield of the chromatographically 
pure peptide was 68%, and illustrated a turning point in peptide synthesis with the 
procedure serving as the prototype for the standard approach associated with his 
name. The basic principles of the synthesis are outlined in Scheme 1. 
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Scheme 1. Merr/Ield's Boc SPPS Strategy. 
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The insoluble support developed was a polystyrene cross-linked with 2% 
divinylbeiizene. This in turn is chloromethylated to facilitate the attachment of the 
first Na Boc protected amino acid by nucleophilic displacement. The Boc group is 
then cleaved by treatment with mild acid (TFA/dichloromethane) and neutralised to 
yield the free amino group which can couple to the penultimate Na protected amino 
acid via classical dicyclohexylcarbodiimide (DCC) methodology. The deprotection, 
neutralisation and coupling cycles are repeated with the appropriate Boc protected 
amino acids until the target sequence is filly assembled. The side chains of particular 
amino acids are blocked with semi-permanent protecting groups which are stable to 
the mild acidic conditions which induce Boc deprotection. The peptide-resin is finally 
treated with a strong acid, anhydrous hydrogen fluoride, which not only deprotects 
the acid labile side chains but also cleaves the peptide from the polymer support to 
yield the fully deprotected crude peptide. 
The Boc methodology in peptide synthesis has been utilised to synthesise many 
important compounds, but has inherent problems associated with it: 
A graded acidolysis deprotection profile is utilised to cleave the Boc group, side 
chain protecting groups and the peptide resin linkage. However, the peptide-resin 
benzyl ester linkage is partially cleaved with TFA, ca. 1-2% per cycle, inducing 
serious loss of peptide as the synthesis proceeds. 
The use of strong acids in the final deprotection stage can be detrimental to 
sensitive sequences, inducing rearrangements and side reactions. 
The use of the highly corrosive anhydrous hydrogen fluoride facilitates the need 
for specialised glassware and great vigilance is of paramount importance. 
Refinements to the Merrifield methodology have confronted some of the problems. 
The development of the PAM resin 7 (1), which is more acid stable due to the 
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electron withdrawing effect of the amide function, reduces the concern of peptide loss 
during synthesis. 
HO _Hr_ Ki_ 
(1) 
Alternatives to hydrogen fluoride have been sought with the introduction of a 
TFMSA 8 deprotection strategy which facilitates the use of standard apparatus, 
however the use of this strong acid can still induce unwanted side reactions. The 
generation of t-butyl cations from the deprotection can induce side reactions 
concerning nucleophilic side chains such as unprotected tryptophan, tyrosine, 
methionine and histidine 9 , although a scavenger cocktail in the deprotection solution 
minimises such effects. Several other acid labile Na protecting groups have been 
developed illustrated in table 1, which involve a graded acidolysis deprotection 
profile. These have not found general use however due to expense of synthesis. 
Moreover, a protection scheme which depends on differing kinetic stability of 
protecting groups cannot be totally efficient due to the impurities which accumulate 
throughout any synthesis. 
Table 1. Acid labile amine protecting groups. 
2-Phenylpropyl-2-oxycarbonyl 	 Poc 	 700 
2-(4-Biphenyl)propyl-2-oxycarbonyl 	Bpoc 	 3000 
2-(3,5-Dimethoxyphenyl)propyl-2-oxy 	Ddz 	 1400 
carbonyl 
2-(4-Methylphenyl)propyl-2-oxycarbonyl 	Mpc 	 11000 
Triphenylinethyl 	 Tit 	 21000 
* Relative cleavage rate in 80% acetic acid at room temp. (Boc=1) 
5 
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1.3 Fmoc Solid Phase Peptide Synthesis 
The aforementioned disadvantages of a graded acidolysis deprotection profile 
concerning the Boc methodology initiated an investigation into a truly orthogonal 
strategy for the synthesis of peptides. Therefore, a number of base labile N 
protecting groups were considered' ° of which the 9-fluorenylmethoxycarbonyl 
(Fmoc) (2) derivatives of Carpino and Han 01 proved to be most suitable. The Fmoc 







The Fmoc group is extremely stable to acidic conditions, but can be cleaved in a 
matter of seconds at room temperature (12)  when secondary amines are employed. A 
solution of 20% piperidine in DMF is the reagent of choice. 
This deprotection strategy neither affects the acid labile Z, Boc or any t-butyl based 
side chain protecting groups, thus complete orthogonality can be achieved when an 
acid labile linker-resin is incorporated. 





4, Fnoc deprotection 
F12N A CO2—Rlnkerl~—[Polystyrenej 
Repetitive DCC nediated 
coupling of Frmc amino 
acid 
0 
0)~ .J}{(JHç() - - pjc Unker1— Po1ystyrene] 
Cleavage & total 
depmtection with TFA 
I!'  
H2NcHRQ - - .NH c02H 
Scheme 2. Fmoc-based strategy to SPPS. 
The solid support used in standard Fmoc SPPS is essentially the same as with the Boc 
methodology in that it is cross-linked polystyrene based. However it incorporates an 
acid sensitive linker to which the first Fmoc amino acid is attached via an ester 
linkage. The first amino acid is preactivated and coupled to such a resin in the 
presence of a catalytic amount of DMAP before amine deprotection with 20% 
piperidine in DMF. The resulting carbamate salt spontaneously decarboxylates to free 
7 
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the amine, which is ready for coupling after a copious wash cycle. The deprotection of 
the Fmoc moiety via an Elcb mechanism results in a dibenzocyclopentadienide anion, 
which in turn produces the dibenzofulvene (or the corresponding piperidide adduct) as 






 02 H 
H2NACO2 H 	1 
Co2 gt-~- —o NH CO2 H 
Scheme 3. The deprotection mechanism of Na-Fmoc  amino acids. 
The second N  Fmoc protected amino acid is then coupled (Section 1.5.2) and the 
cycle of deprotection and coupling is repeated until the desired peptide has been 
synthesised, whereupon the peptide is cleaved from the resin support with 95% TFA. 
This final cleavage protocol also induces deprotection of the acid labile side chain 
protecting groups. 
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1.4 Boc vs. Fmoc methodologies 
Historically, the bulk of peptides synthesised has been achieved utilising the Boc 
methodology. However, several publications which compare the pure peptide yields 
of the two contrasting methods have shown that the Fmoc methodology has 
comparable results. Moreover, it is when 'difficult' sequences are sought, which are 
very hydrophobic or incorporate residues susceptible to rearrangement, that the Fmoc 
protocol is indeed superior(13) . 
A survey throughout 40 laboratories, which had to synthesise a standard peptide 
sequence of 16 residues' 14 , incorporating both Boc and Fmoc moieties, was 
undertaken and a sample of the crude peptide from each laboratory was analysed for 
purity and yield. The test peptide incorporated potential sites for post-modification 
and multiple sites for problematic or slow couplings. The results overwhelmingly 
supported the Fmoc strategy. Over 33% of the crude cleavage products which 
incorporated the Boc methodology did not contain any of the desired peptide and 
over 44% of the Boc derived products were unable to attain greater than 25% purity. 
In contrast, 31% of the samples prepared via the Fmoc strategy attained over 75% of 
the desired peptide. 
In addition, the Fmoc strategy in peptide synthesis introduced the possibility of direct 
spectrometric monitoring of the deprotection proflle' 5 . The dibenzofulvene-
piperidine adduct released after deprotection has a strong absorbance at ca.300 nm in 
the ultra-violet region, and its uptake from solution during acylation and the 
consequent release from the solid support into solution during deprotection provides 
the opportunity for real time monitoring and quantitation. The wavelength selected, 
302nm, is the isosbestic point relating the dibenzofulvene and its piperidine adduct. 
This monitoring can be utilised in a continuous flow method which also incorporates a 
fast solvent exchange which reduces wash times and solvent consumption resulting in 
improved efficiency and economic viability. 
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Therefore, the use of the Fmoc strategy has been employed by the author and the 
following sections are in reference to the Fmoc strategy, although there are many 
overlaps in the protocol of both methods. 
1.5 The Solid Support 
The 'solid' support is in fact a gel polymer matrix, in which reactions can occur not 
only on the surface but inside matrix particles or beads. Therefore, particular 
characteristics must be incorporated into the matrix system to facilitate such reactions. 
The following characteristics must apply: 
The matrix must contain reactive flinctionalities at which a linker and subsequent 
amino acids can be attached. 
Stability to reaction conditions and mechanical procedures is of paramount 
importance in the structure of the matrix. 
The matrix must possess the ability to swell in organic solvents during synthesis, 
hence enabling the rate-limiting effect of diffusion of reactants throughout the matrix, 
resulting in rapid reactions. 
The original Merrified resin, a chioromethylated styrene-divinylbenzene co-polymer, 
confronted such requirements and proved itself in numerous syntheses. However 
refinements were incorporated by reducing the divinylbenzene content from 2 to 1%, 
resulting in better swelling characteristics, although at a cost of reduced mechanical 
stability. In addition the chloromethylated moiety was exchanged for a 
hydroxymethyl function which resulted in the reduction of unwanted reactions with 
susceptible side chains. 
10 
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The polyamide resin developed by Atherton and Sheppard (9) has receieved wide 
popularity due to the possibilty of increased solvation of the peptide chain. It has 
been argued that the polystyrene based resins are too hydrophobic, and that if a more 
hydrophilic resin was in place, this would result in faster and more efficient reaction 
rates due to increased solvation. This methodology is incorporated in a continuous 
flow system, where the peptide resin is continually solvated during synthesis. The 
polyamide polymers are chemically bonded to kieselguhr to attain mechanical rigidity, 
and this provides the aforementioned characteristics needed, resulting in many 
successful syntheses'. 
1.5.1 The resin linker 
The 'linker' between the first amino acid and the polymeric support has three features 
which can be exploited: 
A handle is provided to which an amino acid can be attached. 
A 'spacer' is introduced which induces a certain distance between the growing 
peptide chain and the polymeric matrix therefore minimising unfavourable steric 
crowding and promoting fast reactions. 
Orthogonality can be incorporated into the system. 
Depending on the structure of the linker, final cleavage protocols can produce 
carboxylic acid, amide or hydrazide 18 functionality at the C-terminus. 
In Boc methodology the vast majority of peptides are synthesised utilising the PAM 
linker-resin('), however the Fmoc protocol enables the use of more acid labile linkers. 
The most common of these is the p-benzyloxybenzylalcohol resin (3) developed by 
Wang(") which was successfully utilised in the first synthesis of a peptide 
11 
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incorporating the Fmoc protocol 20 . Its popularity is due to the facile cleavage with 
50% TFA in aprotic solvents. The desire to use the mildest possible conditions and 
possess differing strategies of orthogonality have driven this area and produced linkers 
such as the 2-chlorotntyl resin 21 (4) which can be cleaved in 1% TFA solution or 
acetic acid and fluoride cleavable 1inkers 22 such as the one illustrated below (5). 
[Polymer] 
HO" 	 - 
(3) 
olynier] 
- 	 Si(CH3)3 
(4) 
1.5.2 Coupling 
The success in the synthesis of peptides is obviously dependant on the efficiency of 
the peptide bond forming reaction. The synthesis of the peptide bond is facilitated by 
activating the carbonyl of the carboxylic acid by replacement of the hydroxyl group 
with an electron withdrawing substituent, thus inducing nucleophilic attack by the 
amino component of the corresponding amino acid to be coupled. A multitude of 
amide forming methods (23)  have been devised but are outwith the scope of this report, 
therefore the methods with which the author was involved shall be described later. 
The problem with activation of the carboxyl function of an Naacylamino  acid is that it 
can result in racemisation due to the formation and enolisation of an oxazolone 24 , as 
12 
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illustrated in scheme 4. The intermediate enol can subsequently convert into either 
the D or L configurations. 
H 
Y 
0 x 0 
- HX 













Scheme 4. Base catalysed racemisation via an oxazolone mechanism. 
1.5.3 Carbodiiniides 
The introduction of dicyclohexylcarbodiiniide (DCC) as a reagent for the formation of 
peptide bonds was of paramount importance in peptide snthesis 25 . The novel 
feature introduced was that addition of the reagent could be initiated in the presence 
of the carboxyl component as well as the amino component, thus activation and 
coupling could proceed concurrently. 
13 
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Refinements to the DCC methodology have eliminated most of the initial 
disadvantages. The induction of racemisation and the irreversible formation of N-acyl 
ureas can be eliminated with the addition of auxiliary nucleophiles such as 1-
hydroxybenzotriazole (HOBt) 2 . The presence of a second nucleophile in the 
reaction mixture reduces the concentration of the 0-acylurea thereby reducing 
racemisation, and moreover the acidic nature of HOBt prevents proton extraction 
from the chiral carbon and hence contributes to the conservation of the chiral 
integrity. The use of diisopropylcarbodiimide (DIC) 27 has been introduced as it 
produces a more soluble urea during the reaction and hence, is more suitable to the 
automated protocol. 
1.5.4 Anhydrides 
The symmetrical anhydrides of Fmoc N protected amino acids have found favour in 
solid phase peptide synthesis for several reasons: 
The ease of preparation from two equivalents of amino acid and one equivalent of 
carbodiiniide. 
They are generally stable crystalline solids. 
Their high reactivity and unambiguous aminolysis of the carbonyl function. 
However, the concept forces one equivalent of amino acid to be discarded wastefully 
and the problems encountered with carbodunñdes (Section 1.5.3) are evident. In 
addition racemisation of histidine derivatives is of concern (28)  
14 
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1.5.5 Active Esters 
The aforementioned disadvantages of using carbodiimides and symmetrical anhydrides 
for amide formation have resulted in research centring around the utilisation of active 
esters. 
A series of active esters, which have found popularity due to excellent results, have 
been based on hydroxylamine functionality. The l-hydroxybenzotriazole (HOBt)' 2 , 
3-hydroxy-3,4-dihydro- 1,2,3 -benzotriazine-4- one  (Dhbt) 29 and 1-hydroxy-4-ethoxy 
carbonyl- 1 ,2,3-triazole (HOCt) 30 are all weakly acidic, thus proton abstraction from 
the chiral carbon is suppressed, defending its chiral integrity. 
0 qN 






However these compounds are not acidic enough to protonate the amine functionality 
of the amino acid and therefore do not interfere with the acylation process. They 
function as powerful auxiliary nucleophiles which react with the highly reactive 
intermediates induced in carbodiimide mediated reactions producing the active esters 
(6), (7) and (8), thus reducing the lifetime of these racemisation-prone species. 
1.5.6 Protection 
It is evident from the sections on Boc and Fmoc methodologies, that a protecting 
group strategy must be employed to prevent unwanted couplings. The unambiguous 
15 
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formation of a peptide bond between two structurally similar amino acids requires 
protection of the amino component of one amino acid and the carboxyl function of the 
other. The Fmoc Na protection (as with Boc) fulfils one criterion, and initial C-
terminal carboxyl protection in standard SPPS is usually incurred via coupling to the 
polymeric support. 
In addition, many of the proteinogernc amino acids have reactive side chain 
fbnctionalities which can interfere with the coupling process, and cause side reactions 
independently. Hence an orthogonal protecting group strategy must be employed 
which alleviates such by-product formation, not only during synthesis but also in the 
final deprotection protocols used within SPPS. Protecting groups which can be 
utilised must adhere to particular criteria: 
Facile introduction into synthesis of Na protected Boc or Fmoc a amino acids. 
Reduce or eliminate the reactivity of the protected functionality. 
Protect the chiral integrity of the protected species. 
Facile orthogonal removal, except in the special case when complete removal is 
required of all protecting groups concurrently at the end of a synthesis. 
The base labile Na protection by Fmoc has encouraged a great research effort into 
finding suitable protecting groups which can be cleaved in differing acidic strengths. 
In general, the standard protocol for deprotection of acid labile side chain protecting 
groups is addition of a TM/scavenger mix at room temperature for 3-4 hours. 
Commonly used acid labile protecting groups are illustrated in table 2 below: 
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Arg'3 Pmc 
Asn, GIn 32 Mbh / Trt 
Asp, Glu 33 t-Bu ester 
Cys Acm / S-t-Bu / Trt 
iIis 3 Trt / Bum 
Lys Boc 
Trp 3 Boc 
Ser, Thr, Tyr t-Bu ether 
Table 2. Common acid labile protecting groups for amino acid residues. 
Every amino acid has unique problems and points of interest, and detailed analysis of 
each is outwith the scope of this report. However, it cannot be over emphasised that 
the development of a protecting group strategy for a particular synthesis is frequently 
the most important and difficult aspects in SPPS. The choice of side chain protection 
is not only dependant on the chemistry used, but also on the coupling and cleavage 
methods employed, the resin type, solubility of the derivative in question, and the 
sequence of the particular peptide being synthesised. 
There are limitations to some of the protecting group strategies available, and 
concentration in the forthcoming chapters will be centred around the most common 
problems encountered in peptide synthesis. 
1.6 The Aspartic Acid Residue 
The side chain carboxyl fimction of the aspartic acid residue must have semi-
permanent protection during SPPS if the following undesirable side reactions are to be 
avoided: 
17 
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Interaction of the carboxylate ions with counter ions such as trialkylammoniuni 
ions or cationic species produced during SPPS and deprotection protocols. 
Reaction of the free carboxyls with an activated amino acid to form mixed 
anhydrides or active esters, which in turn can result in intramolecular, as well 
intermolecular, reactions inducing the formation of branched peptides. 
However, the most serious malfunction in peptide synthesis when synthesising 
aspartyl containing peptides is the intramolecular cycisation of the residue, resulting 
in the irreversible formation of 'aspartimide' or 'succinimide' peptides 37 . The 
cycised peptide can be ring opened to form the desired cx-peptide, the concomitant 
formation of significant amounts of 3-peptide and a derivative induced by nucleophilic 
displacement (eg. piperidine in Fmoc synthesis) as illustrated in scheme 5. All of 
which can render the separation and characterisation of the desired peptide very 
difficult. 
0 












Scheme 5. Aspartimide formation and ring opening by piperidine or hydroxyl 
anion. 
The cycisation can be induced in acidic or basic conditions, and is therefore inherent 
in Boc and Fmoc SPPS methodologies. The acidic protonation of the carboxyl 
M. 
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induces an electrophilic centre at the ester carbon inviting nucleophilc attack from the 



















Scheme 6. Acid catalysed apartimide formation. 
The deprotonation of the amide nitrogen in basic conditions creates a nucleophilic 
species which in turn attacks the aforementioned carbon, once again inducing 














NH 	 R 
0 
Scheme 7. Base catalysed aspartimide formation. 
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The incidence of aspartmide is therefore dependant on the strength and chemical 
properties of the acids I bases used in the deprotection protocol of SPPS, but is also 
sequence dependant with respect to the n+1 residue (Section 1.6.1) and invariably 
relies on the protecting group (Section 1.7) which esterifies the side chain. 
1.6.1 The SeQuence Dependability in Aspartimide Formation 
The n+1 amino acid residue, with respect to the aspartic acid residue in SPPS, has a 
significant and crucial effect on the susceptibility of a peptide to aspartmiide 
formation. 
The use of the acid labile t-butyl ester function as the protecting group for the aspartyl 
side chain has found widespread popularity due to the ease of synthesis, and the 
stability of the group towards basic and nucleophilic attack. The function can be 
readily cleaved by TFA and is therefore compatible with Fmoc-based SPPS and is the 
function used in the forthcoming sections unless otherwise stated. 
The following examples demonstrate the extent of the problems encountered in 
sensitive sequences: 
(a). Asp-Gly 
The induction of aspartiniide in peptides is most severe when the adjacent C-terminus 
amino acid is glycine, presumably due to the lack of steric hindrance in the side chain. 
The formation of the aspartimide in Asp-Gly sequences is abundant in both Boc and 
Fmoc methodologies. 
In Boc based chemistry, the graded acidolysis technique of deprotection incurs the 
side reaction. The main factor being the harsh final stage deprotection with BE 
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The extent of the problem was exemplified by Merrifield et aP8 when the synthesis of 
the active fragment 125-133 of bovine pituitary growth hormone (bGH) was 
attempted utilising Boc chemistry. The synthesis of the nonapeptide, H-Arg-Leu-Glu-
Asp-Gly-Thr-Pro-Arg-OH, incorporated the potentially troublesome Asp(OtBu)-Gly 
sequence and therefore some evidence of aspartiniide and -peptide was expected. 
However, when the crude peptide was analysed after BF deprotection, almost 
quantitative formation of the imide had resulted. Consequent ring opening by dilute 
aqueous alkali resulted in the formation of a and -peptides which were inseparable, 
and hence the synthesis was a complete failure. 
The rearrangement was again exemplified by Giralt et al(39) when synthesising the 
hexamer, H-Val-Lys-Asp-Gly-Tyr-Ile-OH, from a Pam resin incorporating Boc 
methodology. The aspartic acid side chain was protected as the t-butyl and benzyl 
esters. In both cases, the syntheses resulted in 5-6% aspartiniide formation when a 
deprotection protocol incorporating BF for 1 hour at 0°C. The purified peptide was 
then once again treated with HF, replicating the initial cleavage procedure, and 
resulted in 5-6% aspartimide indicating the side reaction was induced by the HF 
cleavage conditions rather than the SPPS conditions involved during synthesis. When 
a low-high HF cleavage protocol was utilised, as much as 12% aspartmñde was 
observed. 
The synthesis was then undertaken incorporating the Fmoc methodology with 
Asp(OtBu) protection. The main factor which induces rearrangement in this protocol 
is not the mild acidic cleavage used for final deprotection, but the repeated Fmoc 
deprotection during synthesis with piperidine. As with the Boc chemistry, 5-6% 
aspartimide was detected. 
The above examples indicate the immense problem facing peptide chemists, in that 
predicting the outcome of a specific synthesis containing Asp-Gly sequences is well 
nigh impossible. 
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(b). Asp-Asn 
The severity of rearrangement to form aspartimides in sequences containing the Asp-
Asn functionality is now being realised. The synthesis of peptides with such a 
sequence being incorporated can be just as problematic as the aforementioned Asp-
Gly sequences. 
Demonstration of such profound instability of the sequence was illustrated by Doling 
et at") in the synthesis of the partial sequence of coat protein phage MS2. The Fmoc 
strategy was employed in the synthesis of the 25-mer which incorporated 
Asp(OtBu) 11-Asn(Trt) 12, which utilised Fmoc deprotection with 50% piperidine-DMF 
for 20 minutes/step, and a standard trifluoroacetic acid resin cleavage protocol. The 
synthesis was a complete failure with no evidence of the desired peptide being formed. 
The resultant peptide obtained had a mass difference of +67 (ES-MS) with respect to 
the desired peptide. The peptide sequence was resynthesised as two separate 
peptides, namely the N-terminal 12-mer and the C-terminal 14-mer (ie. the peptide 
was split between the Asp-Asn in the sequence). In contrast, both syntheses 
illustrated no detrimental effects, which indicated that the Asp-Asn moiety was the 
problematic area. The mass difference of +67 was accounted to the formation of the 
aspartimide, and subsequent ring opening by base to form the piperidide adduct in 
quantitative yield. 
This profound instability in Asp-Asn containing sequences to piperidine is now 
arguably the most destructive factor in peptide synthesis. The aforementioned 
example of rearrangement in such sequences was confirmed by Sweeney et al". The 
attempted synthesis of the EGF-like domain from human blood coagulation factor X 
failed completely, with quantitative formation of the piperidide adduct. The 48-mer 
incorporated an Asp-Asn function at residue 10, therefore it is believed that 
rearrangement at this site to the aspartimide, and subsequent pipenthde formation 
resulted in failure of the synthesis of the desired peptide. 
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In addition a model peptide, H-Lys-Ala-Asp(OtBu)-Asn(Trt)-Ala-OH, was 
synthesised within the same group utilising standard Fmoc methodology, but 
incorporating a 10% piperidine-DMF deprotection protocol to reduce possible side 
reactions. Upon cleavage with TFA, analysis indicated up to 25% pipendide 
formation. 
The above studies indicate that susceptible sites close to the N-terminus of a peptide 
will therefore give rise to a crude product containing a minimal percentage of 
rearranged product, whereas a similar site close to the C-terminus may be more 
problematic as the percentage abundance of cycised product accumulates 
progressively from the larger number of deprotection cycles. 
(c). Asp-Ser 
The formation of aspartimides in sequences incorporating an Asp-Ser functionality is 
a considerable problem in Boc based chemistry. 
The harsh deprotection strategies involved in Boc based protocol, such as BF or 
MSA, have resulted in profound rearrangement even in the simplest of sequences. A 
model study by Yajima et af42 on the rearrangement of H-Asp-Ser-OH when 
subjected to BF or MSA, resulted in 20% production of the aminosuccinimide. 
This instability was further illustrated by the research of Okada et al 43 . The Boc 
based SPPS of the pentapeptide, Boc-Asp-Ser-Ser-Thr-Ser-OMe, resulted in 60% of 
the aspartimide adduct being isolated in a crystalline form when the benzyl ester was 
utilised as the aspartic acid side chain protecting agent. Minimal quantities of the 
desired peptide were recovered. The harsh acidolytic cleavage conditions obviously 
promote the rearrangement, however it is thought a base catalysed rearrangement may 
also be in force according to the scheme 8 below (proposed mechanism is not 
concerted). 
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Scheme 8 Base catalysed aspartimide formation in Asp-Ser residues. 
The protection of the serine residue, as the t-butyl ether, in conjunction with an Fmoc-
N° protection strategy involving mild acid and base deprotection protocols, results in 
negligible rearrangement. Therefore, the problems previously encountered in Boc 
based SPPS can now be evaded by utilising the correct procedure. 
(d). Asp-His 
Histidine is one of the most problematic amino acids in SPPS, by both Boc and Fmoc 
strategies. The main problems associated with the use of histidine are acylation, 
racemisation and aspartimide formation. 
The Boc-based synthesis of peptides containing the Asp-His segment has proven 
problematic due to rearrangement at this site to the corresponding aspartimide 43 . 
Model studies on the dipeptide, ZAsp-FlisOMe, demonstrated that a standard 
hydrogen fluoride cleavage protocol at room temperature resulted in 61% formation 
of the f3-peptide. Repetition of the cleavage procedure at 0 and -25 °C respectively, 
induced 74% rearrangement indicating a catalytic effect from the midazole ring. 
However the protection of the 'r-nitrogen of the miidazole ring by the trityl group 
reduces the basicity of the ring and the steric bulk helps to prevent base-catalysed 
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rearrangement. Therefore the aforementioned protection utilised in conjunction with 
Fmoc-based SPPS suppresses the formation of aspartunide and related products. 
(e). Asp-Phe 
The utilisation of ammonia in the neutralisation step in Boc SPPS protocol has been 
shown to produce succinimide formation, ammonolysis, transpeptidation and 
epimerised products when Asp-Phe has been incorporated into the sequence. The 
synthesis of a pentagastrin analogue resulted in a heterogeneous reaction mixture, 
completely lacking the expected product, when a Boc protocol was used in 
conjunction with the t-butyl protection of the aspartyl side chain. Therefore, Schon et 
af44 completed studies on a model peptide, Z-Asp(OtBu)-Phe-NH 2, on the effect of 
ammonia on such a sequence. Ammonia was bubbled through a methanolic solution 
of the peptide and the resulting products analysed. The formation of the aspartimide 
and subsequent ring opening to the -peptide was considerable (55%), and 35% of 
the epimerised adducts were also identified. 
The emergence of more unorthodox approaches to cleavage protocols in SPPS, to 
alleviate the problems encountered with standard protocols, has resulted in some 
novel applications of reagents. The provision of further orthogonality in the synthesis 
of peptides retaining their side chain protecting groups, was sought by Ramage et 
a/ 22 and latterly by Ueki et al 4 . The principal was the utilisation of a linker which 
allowed rapid release of the final peptide under mild conditions, namely nucleophilic 
cleavage by TBAF. 
However, in the studies initiated by Ueki et a!, it was found that 100% formation of 
the f3-peptide resulted on treatment of the Asp-Phe peptide with TBAF / DMF within 
10 minutes. The protection of the aspartyl side chain with cyclohexyl or t-butyl gave 
comparable results. 
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Therefore the susceptibility of the Asp-Phe moiety to rearrangement has been 
demonstrated, however the use of standard Fmoc protocol and reagents renders the 
problem inconsequential. 
(1). Asp-Ma 
The cyclisation to form aspartiniides has been realised in both Boc and Fmoc 
methodologies, when Asp-Ma has been incorporated into the sequence of the peptide. 
The rearrangement seems to result from acidic catalysis, therefore has a more 
profound effect in Boc SPPS protocols. 
The treatment of the dimer, Z-Asp(OBzl)-Ala-OBzl, with BF or MSA, resulted in up 
to 15% aspartimide formation according to Yajima et al' 42 . 
The synthesis of glycopeptides for biological studies has recently gained popularity. 
The activation and subsequent glycosylation of the aspartyl 3-carboxyl group required 
in such syntheses, requires an orthogonal aspartyl side chain protecting group 
compatible with Fmoc/t-butyl methodology. Therefore Johnson et al 47 utilised the 
0-allyl group which has been widely applied in peptide synthesis, which is stable to 
standard Fmoc protocol conditions but can be removed specifically with palladium-
based reagents. However, the synthesis of the six-mer Ac-Glu-Asp(O-allyi)-Ala-Ser-
Lys-Ala-NH2, via standard Fmoc methodology resulted in 60% aspartiniide 
formation. The formation ofpiperidide adducts was not detected. 
The synthesis was repeated using standard Fmoc methodology, but the t-butyl group 
was utilised for the protection of the aspartyl side chain. The synthesis was a success 
with minimal aspartimide production, thus indicating that the rearrangement of 
peptides due to the Asp-Ma sequence is not a major problem if the correct synthesis 
protocol and protecting strategies are employed. 
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1.6.2 Conformational Influence on Aspartimide Formation 
The synthesis of the partial sequence of coat protein phage MS2, 
DNGGTGDVTVAPSNF, by means of the Fmoc strategy by Dolling et aI40 , resulted 
in approximately 40% piperidide formation at the Asp 1-Asn2 segment. 
The synthesis of the aforementioned parent peptide with stepwise elongation at the N-
terminaI, resulted in an increase in pip eridide formation. Lengthening of the peptide 
chain with a Val-Lys-Val segment induced up to 70% of the piperidide derivative. 
This surprising result indicates that the tendency of side product formation depends 
not only on the nature of the amino acid at the carboxylic site of the aspartyl residue, 
but also on N-terminal elongation. This may be rationalised by the formation of a 
supporting conformation of the growing peptide chain. 
The evidence for such a conformational influence was realised by the synthesis of 
certain analogues of the corticotropin-releasing hormone, CRH. The peptide 
(consisting of an Asp 25-G1n26-Leu27 -Ala 28 segment in the forty-one amino acid chain) 
was synthesised in good yield with no evidence of aspartiniide or related by-products. 
However when the Leu 27-A1a28 segment of the peptide was substituted with the 
corresponding D-amino acids, the main product was found to be the aspartmiide, with 
the corresponding pipendide in evidence as the side product. 
Therefore it can be concluded that a conformational influence on aspartimide 
formation exists and is dependent on the position of replacement of certain amino 
acids. 
1.7 13-Aspartyl Protecting Group Strategies Developed 
The research into minimising the formation of aspartiniide and imide related by- 
products during SPPS has centred around protecting the 0-carboxyl of the aspartyl 
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residue as an ester function. The following sections demonstrate the success of such 
an approach. 




The cyclohexyl moiety was developed as a protecting agent for the J3-aspartyl side 
chain by Tam et a1 48 . The utilisation of the group within Boc based SPPS seemed 
desirable due to the following favourable characteristics: 
Incorporation of steric hindrance into the side chain to prevent intramolecular 
aminolysis resulting in rearrangement. 
Stable to TFA treatment but cleavable in strong acid. 
The carbonium ion produced on cleavage of the protecting group would 
rearrange irreversibly to the more stable tertiary methylcyclopentyl cation, thus being 
self- deactivating. 
+ 
The cyclohexyl protected fragment of the four-mer, Boc-Glu-Asp-Gly-Thr-OH, was 
synthesised utilising standard Boc methodology. The resultant deprotection with BF 
produced as little as 5% aspartimide, in a sequence susceptible to rearrangement. 
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However, prolonged exposure to base such as triethylamine, resulted in quantitative 
conversion of the peptide to the aspartimide. Thus indicating the protecting group 
strategy as inappropriate for the synthesis of large peptides using Fmoc-based 
methodology. In addition, studies initiated by Giralt et aP9 , on the synthesis of the 
hexapeptide, H-Val-Lys-Asp-Gly-Thr-lle-OH, which utilised the cyclohexyl group for 
aspartyl side chain protection, have shown that up to 70% pipendide results when an 
Fmoc protocol is used. 
Therefore, although the cyclohexyl group can be utilised with success for small 
peptides in Boc-based protocols, it has severe short-comings for the synthesis of 
problematic sequences. 
1.7.2 The 13-Phenacyl Group (Phe) 
—NH CO— 0 
The phenacyl group was introduced, with some success, by Merrifield et 	to 
protect the side chain of aspartic acid in Boc based SPPS. The protecting group can 
be cleaved by sodium thiophenoxide prior to global deprotection by BF, therefore 
leaving the J3-carboxyl free which had been shown to be less susceptible to 
rearrangement in cleavage protocols 50 . 
The Merrifield group synthesised tetramers incorporating an Asp-Gly function which 
had been shown to give quantitative formation of aspartimide during standard HF 
cleavage protocols when 3-benzyl protection was employed. The aspartmiide 
formation was reduced to 2.5% when the phenacyl protecting strategy was employed, 
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deprotection being effected by sodium thiophenoxide treatment followed by a 
standard BF cleavage protocol. 
However, prolonged exposure to triethylamine induced severe formation of the 
corresponding -peptide, indicating that the protecting strategy was poor for large 
peptides and incompatible with Fmoc-based SPPS. Therefore the prolonged 
treatment by sodium thiophenoxide needed (8 hours) for phenacyl deprotection 
coupled with the instability to base has limited the use of this strategy. 
1.7.3 The 0-1(2)-Adamantyl Groups (1-Ada / 2-Ada) 
'NH CO#w. 






The introduction of the [- 1-adamantyl (9) and f3-2-adamantyl (10) groups by Okada 
et af51  proposed the most promising results to date at that time, in the suppression of 
aspartmnde in SPPS. 
Incorporation of the 13-  1-adamantyl and 13-2-adamantyl groups as ester functions to 
protect the side chain of aspartic acid during the synthesis of the five-mer, H-Asp-Ser-
Ser-Thr-Ser-OMe, improved the synthesis considerably due to aspartimide 
prevention. The results are outlined in tables 3 and 4 below: 
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Table 3. Products of SPPS of DSSTS-OMe following HF cleavage. 
Table 4. Products of SPPS of DSSTS-OMe following TFMSA cleavage. 
Initially it was thought that these impressive results in Boc-based SPPS could be 
transferred to Fmoc-based SPPS, as both the adamantyl esters are stable to the 
exposure of 55% piperidine. However Karistrom et aP2 proved that sustained 
exposure to 20% pipendine could induce up to 80% of imide related by-products in 
susceptible peptides incorporating the Asp-Gly moiety, even with the adamantyl 
protecting strategy. 
1.7.4 The 6-24-Dimethyl-3-pentyl Group (Dmp) 
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The stability to bases, such as piperidine, used in SPPS is of paramount importance to 
the success of a protecting group. This was realised by Karistrom et on 
development of their protecting group, the 2,4-dimethyl-3-pentyl function. 
The protecting group was incorporated as an ester function of the aspartic acid side 
chain in the synthesis of a model peptide, Boc-Lys(CIZ)-Tyr(BrZ)-Asp(ODmp)-Gly-
Phe-MBHAresin. Standard Boc-based SPPS protocol was utilised in the synthesis, 
and a standard BF cleavage procedure produced the desired peptide in 95% of the 
total product. Approximately 3% aspartimide was detected and negligible 3-peptide 
was identified. Prolonged exposure (4 hours) to 20% piperidine did not facilitate 
rearrangement in the fully protected peptide-resin. 
Therefore the Dmp has been shown to suppress aspartiniide formation in model 
peptides, and has a stability to piperidine which promotes orthogonality towards 
Fmoc-based chemistry. However large and extremely sensitive peptides have not 
been synthesised, and the groups stability to acid (TFA t112 40 hours at 43°C) requires 
harsh and inconvenient cleavage protocols, therefore resigning the strategy to Boc 
SPPS. 
1.7.5 The 13-3-Methylpent-3-yl Group (Mpe) 
CO- 
The search for a more acid labile protecting ester function to be used in Fmoc-based 
SPPS was initiated by Karistrom et aP2 with the synthesis of the tertiary alkyl 
moiety, 3-methylpent-3-yl. 
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The esterification of the asp arty! side chain to form the corresponding 
FmocAsp(OMpe)OH amino acid was synthesised and the 13-protecting group was 
found to be cleaved by 95%TFA / 5% .H20 within 30 minutes. A model peptide, H-
Val-Lys-Asp-Gly-Tyr-lle-NH2, was synthesised incorporating the protecting strategy 
via standard Fmoc-based SPPS protocol. 
The resin bound peptide was treated with 20% piperidinefDMF after termination of 
the synthesis, to establish base stability and the resultant product was cleaved from the 
resin with TFA. The amount of the corresponding miide-related products is outlined 
in the table below: 
Table 5. Fmoc SPPS of VKDGTI-NH 2 followed by treatment with 20% 
piperidine/DMFfor 20 hours. 
Therefore it has beeen shown that the Mpe group can suppress aspartimde formation, 
but may be susceptible to pipendine induced rearrangement in long and sensitive 
syntheses. 
1.8 The N42-hydroxy-4-methoxybenzvl) (Limb) Backbone Protection 
The base removal of the amidic proton of the n+l amino acid with respect to the 
aspartic acid residue in SPPS has been shown to promote intramolecular nucleophilic 
attack on the 13-carboxyl of the aspartyl side chain, thus forming unwanted cycisation 
and iniide formation. Therefore protection of the amide backbone renders the 
particular nitrogen non-nucleophilic, hence no cydisation to form aspartiniide 
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derivatives can ensue. Johnson et af54 demonstrated the success of such an approach 





113CO 	 OH 
(11) 
The troublesome synthesis of the 1-6 fragment from scorpion Androctonus australis 
Hector (toxin II), incorporating an Asp-Gly function which is susceptible to 
aspartimide formation, was successfully completed when the Asp(OtBu)-Gly amide 
bond was protected during Fmoc-based synthesis by the N-(2-hydroxy-4-
methoxybenzyl) moiety. Cleavage and deprotection of the peptide with a TFA I 
scavenger cocktail (90 nuns.) resulted in exclusively unmodified peptide (cf. 71% 
modification using standard Asp(OtBu)/Fmoc SPPS) even after prolonged exposure 
(24 hrs.) to piperidinefDMF. 
Equally impressive results were observed using this protocol in the synthesis of a 
segment of coat protein phage MS 2. The heptadecapeptide, which incorporated a 
rearrangement susceptible Asp-Asn function, was successfully synthesised using 
standard Fmoc-based SPPS, while utilising the N-(2-hydroxy-4-methoxybenzyl) 
protection of the Asp-(Hmb)Asn amide bond. 
The potential problem with such an approach is the pseudo Asp-Pro nature of the 
protected aspartyl bond, as this has been shown to be susceptible to acid catalysed 
chain cleavage 55 . However no evidence of TFA lability of the peptide bond was 
observed. 
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The aforementioned Hmb protocol of protection is therefore arguably the best 
strategy to date in SPPS to eliminate the formation of unwanted aspartiniides and 
related by-products. However, the formation of the aspartyl-(Hmb)-X protected 
amide bond has to be coupled off machine in a flask, with coupling times of up to 24 
hours. Therefore this method needs longer synthesis time and precludes standard 
protocol procedures. In addition the N-protected amino acids are very expensive (56)  
and may not be economically viable for large syntheses. 
1.9 Non-Synthetic Protection Protocols 
Martinez and Bodanszky 57 efficiently suppressed aspartiniide formation during 
synthesis by the use of additives such as l-hydroxybenzotriazole or 2,4-dinitrophenol 
to the Fmoc deprotecting agent. 
The additives serve as a buffer in the deprotection solution, therefore reducing the 
potential of intramolecular nucleophilic attack from the nitrogen in the amide 
backbone to the -carboxyl of the aspartyl side chain. However, while this can 
sometimes be effective in suppressing undesired rearrangements, it inhibits monitoring 
the progression of the synthesis in Fmoc SPPS, as Fmoc deprotection data is more 
difficult to obtain using ultraviolet measurements. 
However this disadvantage may be overcome if more than one deprotection cycle is 
introduced. Moreover utilisation of the HOCt reagent in the coupling solution, 
instead of the HOBt derivative, does not interfere with the monitoring process as the 
absorbance at 302nm is not affected. 
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CHAPTER 2: RESULTS & DISCUSSION 
2.1 Requirements for a Protectin2 Groun Strate 
The most profound and detrimental side reaction in peptide synthesis is the formation of 
cyclic aspartinildes and related by-products. The formation of these unwanted products 
in Asp-X (X is a susceptible amino acid, Section 1.6.1) sequenced peptides can be 
catalysed by acid or base, and is therefore observed in both Boc and Fmoc synthetic 
strategies. 
The susceptibility to rearrangement in aspartyl containing peptides is dependent on the 
n+ 1 amino acid (with respect to the C-terminus of asp artic acid), the side chain protecting 
group, the conformational influence of the peptide chain and the conditions of 
deprotection and cleavage of the peptide. Thus a protecting group strategy must be 
designed to combat the influence of the aforementioned parameters, however at present 
no protecting strategy has been totally successful. 
The majority of research in this area has centred around the design of -aspartyl esters 
(Section 1.7), and from this work it is evident that the success of a protecting group is 
dependent on the following criteria: 
(1). Steric Hindrance 
The formation of aspartiniide and related by-products has been shown to be most prolific 
in cases where minimal steric bulk in the adjacent amino acid (eg. glycine), or in the side 
chain ester moiety (eg. benzyl compared to adamantyl), is present. 
That steric hindrance is a factor in aspartiniide suppression suggested it would prove 
expedient to quantify the steric nature of substrates by consideration of their degree of 
36 
Chapter 2 : Results & Discussion 
substitution. The aspartiniide suppression can therefore be related to the classical work 
of Newman (58) . The investigation into the rates of esterification of a series of carboxylic 
acids incorporating differing degrees of steric hindrance produced the 'Newman rule of 
six' which states: 
'In reactions involving addition to an unsaturated function containing a double bond, the 
greater the number of atoms in the six position, the greater the effect.' 
The original numbering scheme incorporated for the carboxylic acids (12) has been 
modified to begin from the carbonyl of the ester (13), the position of nucleophilic attack 










Therefore in designing a protecting group ester function, one must have constituents at 
the six position to promote maximum steric interaction. According to Newman, a 'six 
number' of 9 or over introduced considerable steric interactions (eg. ester (13) has three 
protons at each six position relating to a 'six number' of 9, cf tert-butyl moiety which has 
a 'six number' of zero). 
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Orthogonal Deprotection 
An orthogonal deprotection strategy is defined (59) as being one in which a set of 
independent classes of protecting group exist, where any one class of protecting group 
may be removed in any order in the presence of all the others without affecting them. 
Thus a novel side chain protecting group for use in Fmoc-based SPPS must be 
completely stable to attack by bases such as pipendine which are used throughout the 
synthetic deprotection cycles. 
In addition, if a one step total deprotection and resin cleavage procedure is the objective, 
the protecting group must be sufficiently acid labile to be cleaved rapidly by TFA with 
existing compatible side chain protection. A more acid stable protecting group may be 
sought for a two stage deprotection strategy, depending on the protection of other amino 
acids in the sequence. 
Monitoring 
Ideally, in the design of an improved protecting group strategy it would be expedient to 
incorporate a label in such a group to enable monitoring of the synthetic cycle. A 
chemical tag that could easily be detected by physical or spectroscopic means would be 
desirable in order to monitor side reactions and possible deprotection profiles. The 
simplest design of such a label, to be compatible with Fmoc-based SPPS, would be one 
amenable to UN analysis, therefore a derivative absorbing at a wavelength outwith the 
300nm range of Fmoc would be desirable. This would allow in situ monitoring of chain 
assembly and deprotection cycles during SPPS. 
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(4). Unreactive Derivatives Upon Acidic Cleavage 
The cleavage of protecting group residues by acid consequently results in the production 
of activated cationic species, which are susceptible to nucleophilic attack from amino acid 
side chains incorporated in the peptide sequence. Therefore acidolysis can result in 
unwanted alkylation of amino acid residues such as tryptophan 60 , tyrosine 61 and 
methionine' 62 . The alkylation of tryptophan has been observed to produce the N-tert-







The introduction of a scavenger cocktail into the deprotecting solution can alleviate this 
problem but is not always a reliable protocol. Therefore the design of a new protecting 
group should incorporate a self-quenching, or deactivating mechanism, which eliminates, 
or reduces, the potential of the cationic species to react. 
Such a deactivating mechanism has been addressed by Merrifield in the design of the 
cyclohexyl protecting strategy (Section 1.7.1), the irreversible rearrangement of the 
cyclohexyl cation to the less reactive methyl-cyclopentyl cation proving successful. 
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Stability to Nucleophilic Attack 
The formation of aspartmiide is dependent on nucleophilic attack from the amide nitrogen 
to the carbonyl of the aspartyl side chain. Therefore it follows that a successful 
protecting group will be one that on esterification with the aspartyl side chain will 
promote resistance in the carbonyl to nucleophilic attack. This may be possible by 
designing a sterically hindered ester function to act as a poor leaving group. 
Solubility 
The solubility of the novel derivative must be compatible with synthetic protocols 
utilised in SPPS in order to promote optimum yields and ease of automation. A solubility 
in DMF of 0.25 mo!' is required for compatibility with the automated peptide 
synthesiser. 
Economic Viability 
The synthesis of a novel protecting group must be facile, utilising readily available 
materials which are inexpensive. The amount of synthetic steps must be kept to a 
minimum, with each step high yielding. The protecting group should be attached easily 
to the 3-carboxylic acid of the aspartyl residue and must be cleaved quantitatively upon 
completion of the peptide chain assembly to maximise recovery of the product. The 
protected amino acid should couple to the polypeptide in high yield, on the synthesiser in 
standard coupling times. 
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2.2 The 3-Ethylpent-3-y] Group 
Research into the suppression of aspartimide formation was initiated within this 
laboratory by Longstaff who proposed the t-butyl based derivative 3-ethylpent-3-yl' 63 
(15). 
(15) 
The group was proposed as it fulfilled a number of the aforementioned characteristics 
required for a successful protecting group (section 2.1). 
Firstly, the group should possess considerable steric hindrance to intramolecular attack 
according to Newman's 'rule of six.' The 3-ethylpent-3-yl function has a 'six number' of 9, 
compared to zero for the corresponding tert-butyl moiety, therefore exhibits a more 
profound steric influence on the system. 
In addition, the steric influence due to such a tertiary alkyl system, would promote 
stability of the system to base hydrolysis, therefore application to Fmoc-based SPPS 
could be utilised. An increased positive inductive effect (cf t-butyl group) would also be 
observed resulting in increased stabilisation of the carbocation (16) formed on cleavage. 
This combined with the carbocation's ability to deprotonate to the more stable tn-
substituted olefin (17), would result in a greater lability to acid. 
41 
Chapter 2 : Results & Discussion 
R 	
H - R 	H 
(16) 	 (17) 
Scheme 9. Proposed acidolysis of the 3-ethylpent-3-yl ester. 
It was expected that the formation of the olefin would occur rapidly within the solvent 
cage, thereby avoiding the possibility of carbocation induced side reactions. Therefore an 
orthogonal deprotection profile would be obtained in conjunction with Fmoc-based 
SPPs. 
The 3-ethylpent-3-yl hydrocnmamate ester was synthesised for model hydrolysis studies. 
The base hydrolysis studies were initiated in 1:1 dioxan / sodium hydroxide (2 molar 
equivalents) solution and the results analysed by HPLC. 
The design of the sterically hindered tertiary alkyl system was successful in that the ester 
was stable to base hydrolysis for in excess of four days. However treatment with 20% 
TFAJDCM resulted in instantaneous acidolysis, conditions considered too labile for use in 
standard SPPS. 
Although the 3-ethylpent-3-yl moiety could not be used as an aspartyl protecting group, 
the hydrolysis studies were an important milestone in confirming the characteristics 
needed in the design of a novel protecting strategy. 
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2.3 Anthracenyl & Ortho Esters 
Research within the Ramage group continued in the search for a novel protecting group 
strategy for the asp arty! residue (64) . 
The synthesis of the hexamer, H-Val-Lys-Asp-Gly-Tyr-lle-OH, was undertaken utilising 
standard Fmoc-based SPPS incorporating a range J3-aspartyl protecting groups. The 
peptide was deprotected and cleaved from the resin with 95% TFA/ 5% scavenger mix, 
the results for the syntheses corresponding to the different protecting groups involved are 
summarised in table 6. 
tert-Butyl N/A 13 
1-(4'-Fluorophenyl)-2-methylprop-2-yl  15 
9-Anthracenylmethyl  100 
1-(9'-Anthracenyl)-3-methylbut-3-yl  38 
4-Methyl-2,6,7-frioxabicyclo [2.2.2] octyl  100 
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The conversion of the carboxylic acid to the ortho ester, the 4-methyl-2,6,7-
trioxabicyclo[2.2.2]octyl derivative (21), would reduce the electrophilic nature of the 
carbon (initially of the carbonyl) therefore suppressing aspartimide formation. In 
addition, such systems had proven stable to nucleophiles such as (3rignard reagents, 
therefore indicating possible protection against intramolecular attack. 
The acid lability appeared to be within the requirements for utilisation within Fmoc-based 
SPPS, and stability towards base afforded the orthogonality required. 
mNH CO 
(21) 
Synthesis of the hexamer, Val-Lys-Asp-Gly-Tyr-lle, incorporating the ortho esterified 
Asp residue, by standard Fmoc-based SPPS proceeded well with no evidence of 
rearrangement during synthesis. However upon total deprotection and cleavage with 
TFA, 100% aspartmiide was detected by FABMS (table 6). 
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This disappointing result can be explained if the mechanism into acid catalysed hydrolysis 




R O OH 
R  
OH 
Scheme 10. Acid catalysed hydrolysis of ortho esters. 
The acid catalysed hydrolysis results in an electrophilic centre, therefore promoting 
nucleophilic attack and subsequent cyclisation. 
The failure of the anthracenyl derivatives to suppress aspartimide formation ((19) & (20), 
table 6), suggested that although steric bulk was evident, the planarity of the system was 
ineffective in the context of inhibiting intramolecular nucleophilic attack in asp artyl 
residues. Therefore it was apparent that a new approach towards aspartic acid protection 
was of paramount importance. 
2.4 The Triphenylinethyl Analogues 
The tntyl (triphenylmethyl) group has been of considerable interest historically as a 
protecting group in peptide chemistry. Although it has found limited use as protection 
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for the Namoiety  in amino acids(65) , tntyl derivatives are commonly utilised in protecting 
strategies within nucleoside chemistry 6 . 
The investigation into carboxylic acid protection with respect to the trityl group was 
undertaken by Zervas et aE67 whose research highlighted the following characteristics of 
such systems: 
Severe acid lability of the trityl ester. 
Hydrolysis of the ester can be achieved by treatment with methanol or water-dioxan. 
Polyaryl systems can be susceptible to hydrogenolysis. 
The profound instability of the tntyl esters proved troublesome in the synthesis of the 
corresponding (free amine) carboxyl protected amino acids by Zervas et al, with only 
glycine being derivatised. 
The stability of the triphenyhnethyl cation, attributed to a strong resonance effect 
between the aryl rings, promotes cleavage of the ester fhnction as formation of the 
carbocation is always favoured. The stability of carbocations can be measured from the 
ionisation of the corresponding alcohols in acidic solutions, represented as: 
R+2H 2 O 	 ROIl + 11 3 0 
Indication of the carbocation stability can be numerically represented via the pKR+ value 
according to the equation: 
pKR+  = HR + log CR+/CROH 
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where HR is the Hammett acidity fimction, CR+ and CROH  the concentrations of the cation 
and alcohol respectively. The table below illustrates some pKR+ values calculated for 
derivatised trityl compounds 68 . 
4, 4', 4"-Triamino +7.57 
4, 4', 4"-Triniethoxy +0.82 
4, 4', 4"-Trimethyl -3.56 
Unsubstituted -6.63 
4, 4', 4 11-Trichloro -7.74 
4-Nitro -9.15 
3,3', 3"-Trichloro -11.03 
4,4'-Dinitro -12.90 
Table 7. PKR + of substituted trilyl derivatives. 
As can be seen from the table above, the stability of the trityl carbocations can be 
diminished by substituting electron withdrawing groups onto the aryl rings. Thus suitable 
substitution could bring the desired stability to carboxylic ester functions. 
The stability of the carbocation could be further reduced if the resonance effect of the 
trityl group could be disturbed. Although initial theories on the structure of the trityl 
system suggested resonance stabilised planarity, it is now believed that the aryl rings are 
in a twisted conformation according to the crystal structure (22) and the computational 
representation (23) below. 
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The stenc interaction of the ortho hydrogens necessitates such a conformational 
constraint, therefore it was proposed that substitution of the protons with a bulkier atom 
would result in a reduction in the planarity and hence the resonance stabilisation. 
Thus synthesis of ortho and para halogenated trityl derivatives was undertaken as it was 
proposed that such esters would have the desired acid lability, as well as steric bulk, to 
provide adequate protection for the aspartyl residue. 
2.4.1 Synthesis of Triphenylniethyl Analogues 
A literature search into the synthesis of the halogenated trityl derivatives was investigated 
and revealed that classical Grignard methodology could be employed, although yields 
were very poor (— 20%)(6971). 







X1 = X2 =Cl/F,) 
X1=X =X3 = Cl/F 
CH3COBr 
r 









Scheme 11. Synthetic route to halogenated trityl bromides. 
The corresponding substituted trityl alcohols were obtained in a pure form by 
recrystallisation, and treatment with acetyl bromide produced the corresponding bromide. 
The trityl analogues synthesised are outlined in table 8. 
(24) 4-Chioro 25 
(25) 4,4'-Dichloro 26 
(26) 4,4',4"-Trichloro 23 
(27) 4-Fluoro 32 
(28) 4,4'-Difluoro 39 
(29) 4,4',4"-Trifluoro 28 
(30) 2-Chloro 32 
Table 8. Substituted trityl analogues synthesised 
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The bromide was immediately used in the next step without purification in order to 
minimise any hydrolysis. 
The 2,2'-dichlorotriphenylmethyl alcohol was successfully synthesised in good yield 
(70%) utilising classical alkyl lithium chemistry as outlined in scheme 12. 
Br I 
Li 	
Cl 	 -.-...- 	Cl 
i THF/Reflux a 0 10 	 H iL Aqueous wAip 	 CI 
U 
(31) 
Scheme 12. Synthetic pathway of 2,2 '-dichiorotrityl alcohol. 
Halide substitution on the ortho or para carbons of the remaining unsubstituted phenyl 
ring of the 2,2-thchloro analogue could not be achieved utilising (irignard or alkyl lithium 
chemistry. 
The esterification of the aspartyl side chain with the trityl analogues could be achieved by 
a variety of methods: 
The free carboxylic acid treated with the trityl halide in the presence of a weak 
hindered base 72 . 
The metal salt of the carboxylic acid treated with the trityl halide (73)  
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Method 1 was initially investigated. The synthetic route to synthesise the -carboxyl 
protected free aspartic acid is outlined in scheme 13. 
The readily available ZAspOBzl derivative was chosen as the starting material due to the 
provision of excellent protection for the N and a-carboxyl moieties. On esterification of 
the aspartyl side chain, it was considered that the Z and benzyl groups could be cleaved 
concomitantly using hydrogenation to reveal the free amino 3-trityl protected asp artic 
acid. The free amine could then be protected by the Fmoc function to provide a 
derivatised amino acid applicable to automated SPPS. 
Scheme 13. Proposed synthesis of trityl analogue protected aspartic acid. 
The esterification of the 3-carboxyl of the ZAspOBzl was successful for the trityl system 
with yields ranging from 60-70% (32-34). The esterifled derivatives could not be purified 
or analysed by chromatographic methods, as decomposition on such systems prevailed. 
However, purification was achieved by recrystallisation and analysis completed by 
spectroscopic means. 
The esterification of the asp artyl side chain complete, orthogonal deprotection of the Z 
and benzyl moieties was undertaken. Research centred around the hydrogenation of the 
derivatives at atmospheric pressure, using the following conditions: 
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• Differing quantities of palladium supported on charcoal. 
S The use of palladium supported on barium sulphate. 
e The length of reaction. 
However attempts at selective cleavage of the Z and benzyl groups proved futile. 
Analysis by NPvIR indicated that the minimum quantity of palladium needed to cleave the 
benzyl group resulted in the deprotection of the trityl analogues. 
In addition the profound instability of the trityl analogue esters to chromatography 
suggested severe acid lability, and demanded that all ester derivatives synthesised must be 
purified by crystallisation. . The mixture of products obtained on hydrogenation of (32-
34) proved isolation of the desired product to be impossible. 
This approach failed due to the instability of the trityl esters to hydrogenation. Thus a 
new strategy in orthogonal deprotection was required. 
2.4.2 Ortho2onal Deprotection Strategies to 13-Trityl Asp Protection 
(A). Esterification of FmocAspOPfp: 
The orthogonal protection of the aspartic acid functionalities could be achieved utilising 
activated esters at the cc-carboxyl, in conjunction with NaFmoc  protection. 
The pentafluorophenyl (Pf) moiety for cc-carboxyl protection was selected since the 
corresponding derivatised amino acid (35) could be coupled directly in SPPS. This 
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would alleviate the need for a deprotection step which had proved problematic in the 








R = Trityl Analog 
OH 	 0 
FF 	
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OR 	RCI 	 OH 
JFmocNH CO2P1i 	 FmocNBCO2PJj 
I 	(35) 
Scheme 14. Proposed synthesis of FmocAsp(OTrityl analogue) -peptide fragment. 
The commercially available FmocAsp(OtBu)OH was esterifed with the pentafluorophenyl 
alcohol utilising classical dicyclohexylcarbodiinnde methodology. Recrystallisation 
providing the Pip ester in 84% yield. Subsequent treatment with TFA selectively cleaved 
the tert-butyl function, setting up the system for esterification with the trityl analogues. 
It was hoped that the esterification of the aspartyl side chain with the trityl analogues 
would be achieved with the methodology utilised with the ZAspOBzl system. However 
the esteriflcation mediated with the trityl bromides and DIEA was unsuccessful. 
The variation of solvents (DMF or DCM), an increased temperature range (25-60 °C) 
and prolonged reaction times proved fruitless as starting materials or complex mixtures of 
were isolated in each case. 
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The following esterification procedures were then investigated with respect to the trityl 
derivatisation of the FmocAspOPfj residue: 
(1). Esterification with the corresponding trityl bromide in the presence of imidazole. 
(2). Conversion of the aspartyl 0-carboxyl to the acid fluoride and subsequent treatment 





(3). Conversion of the aspartyl 3-carboxyl to the acid chloride and subsequent treatment 





However, in each of the experiments, only the starting materials or complex mixtures 
were observed. 
(B). Esterification of FmocAspOMe: 
The failure to esterif' the aspartyl side chain in the presence of the a-pentafluorophenyl 
ester indicates that the steric bulk of a system incorporating the tntyl derivatives in 
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conjunction with the Pf'p moiety is not viable. Hence the a-carboxyl protection is crucial 
to the success of developing a trityl ester moiety, therefore an orthogonal group 
constituting negligible steric interaction was required. Therefore a-methyl protection 
was investigated. The side chain of FmocAspOMe was successfully esterified with the 
2,2'-dichloro (38) and 4,4'-dithioro (39) tntyl bromides respectively in 60% yield 
(utilising the esterification methodology from the ZAspOBzl system). The two esters 
were used in model studies for selective hydrolysis of the a-methyl ester. 
The literature revealed that selective hydrolysis of methyl esters could be achieved 
utilising protease enzymes 7782 . It was hoped that extremely efficient cleavage would 
ensue to enable minimal reaction times in the aqueous conditions, thus preventing the [3-
trityl ester hydrolysis. Table 9 illustrates the conditions employed. 
Subtilisin Carlsberg 25 / 6.5 or 8.1 Ammonium acetate / H20 
Subtilisin Carlsberg 37 / 6.5 or 8.1 Ammonium acetate / H20 
Subtilisin Carlsberg 25 / 6.5 or 8.1 Ammonium acetate / 10% DMF 
Subtilisin Carlsberg 37 / 6.5 or 8.1 TRIS buffer / 10% DMF 
Subtilisin Carlsberg 37 / 6.5 or 8.1 Ammonium acetate / 90% tBuOH 
Porcine liver esterase 25 or 37 / 7.0 Ammonium acetate / 10% DMF 
Candida cylindracea 25 or 37 / 7.0 Ammonium acetate / 10% DMF 
Carboxypeptidase Y 25 or 37 / 7.0 70% Acetone / H20 
Table 9. Protease enzymes used in attempted methyl ester hydrolysis. 
In all of the above enzymatic reactions, no hydrolysis of the methyl ester was achieved, 
presumably due to the severe steric implications of the tntyl analogues preventing methyl 
ester hydrolysis at the active site of the enzyme. 
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The use of metal hydroxides (83)  and carbonates 84 have been shown to hydrolyse methyl 
esters in alcoholic solutions. The instability of trityl systems to alcohols has been proven, 
therefore a solvent mix of dioxan / water was utilised in the hydrolysis studies of the 2,2'-
dichiorotrityl J3-ester of FmocAspOMe. 
Selective hydrolysis of the methyl ester in respect to the tntyl ester was achieved using 
lithium hydroxide or sodium carbonate. However, Fmoc deprotection was also evident 
resulting in horrendous isolation problems. The instability of the tntyl systems to 
chromatography coupled with the inability to initiate crystallisation, resulted in the a-
methyl ester protecting strategy being abandoned. 
(C). Esterification of Copper Complexes: 
The alkylation of alkali metal salts of respective amino acid copper (II) complexes has 
proven an efficient method in the synthesis of J3-esterified aspartyl residues 85 . Therefore 
the attempted trityl esterification of the aspartyl side chain was undertaken according to 
scheme 15. 












H3 N 	CO2 
R = Trityl analogue 
Scheme 15. Aspartyl side chain protection via a copper complex. 
The formation of the N,N,N',N'-tetramethylguanidinium salt of the copper complex 
enabled the reduction of water in the system to 10%, and subsequent addition of the 
bromide of the 2,2'-dichlorotrityl analogue followed. Release of the derivatised amino 
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acid from the copper complex could be achieved by treatment with EDTA. However 
once again only starting materials could be identified, possibly due to the aqueous 
conditions necessitated in the reaction solution which would hydrolyse the tntyl 
analogues. 
2.4.3 Successful Inhibition of Nucleophilic Attack by Trityl Systems 
The hypothesis that trityl systems would provide the necessary characteristics for side 
chain protection of the aspartyl residue were confirmed by the studies on the 2- 
chiorotrityl resin 8 . 
Synthesis of peptides with C-terminal proline or Pro-X (X being a hindered residue) can 
be very problematic, with loss of the peptide from the resin due to diketopiperazine (40) 




0 ' --'r 0 N)  
OT 
(40) 
Scheme 16. Diketopiperazine formation in the dipeptide Val-Pro-Resin. 
However use of the 2-chiorotrityl resin completely suppresses the intramolecular 
nucleophilic attack, which induces the rearrangement, due to the steric influence exerted 
on the system. 
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Moreover, attachment of the C-terminal of glycine, in an Asp(OtBu)-Gly segment, to the 
2.-chiorotrityl resin resulted in complete inhibition of aspartimide formation during Fmoc-
based SppS,871.  Thus trityl systems have been shown to possess the characteristics of 
which were sought: 
Severe steric influence which suppresses aspartmilde formation. 
Orthogonal acid lability, cleavage facilitated by acetic acid / TFE / DCM or 0.1% v/v 
TFA. 
The very stable and sterically hindered trityl-cations formed during cleavage are not 
attacked by nucleophilic side chains. 
However orthogonal protection of the asp artyl side chain by trityl systems has proven 
elusive. 
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CHAPTER 3 
3.0 The 2.2.4.4-Tetramethvinent-3-vi (Tmn) Grou 
The results obtained from the investigation into the 3-ethylpent-3-yl moiety (section 
2.2) and the trityl systems (section 2.4) suggested that such sterically hindered esters, 
which resulted in tertiary carbocations upon cleavage, were of extreme acid lability. 
Therefore a protecting group which results in the formation of a secondary alkyl 
carbocation on acidic cleavage may be more suitable, with respect to the aspartic acid 
residue, as the profound acid lability would be reduced. 
Karlstrom et a103 had shown that their secondary alkyl system, the 2,4-dimethyl-3-
pentyl ester (Dmp) (section 1.7.4), was stable to TFA (t 1 12 38.5 hrs at 43 0C). 
Therefore a harsh BF cleavage procedure was required for complete deprotection of 
the ester function limiting the protocol to Boc-based SPPS. 
In view of these results and the conclusions from our own research, it was proposed 
that a secondary ester function could be utilised in Fmoc-based SPPS if it possessed an 
increased lability to acid with respect to the Dmp moiety. 
The 2,2,4,4-tetramethylpent-3-yl (Tmp) derivative (41) was a plausible candidate, the 
criteria required for a 3-aspartyl protecting group seemingly evident: 
(1). A greater steric influence on the system would incur with a 'Newman number' of 
18 compared to 12 for the Dmp system. 
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The addition of the two extra methyl groups would increase the stabilisation of 
the resultant cation on deprotection, which would favour an increased acid lability in 
the system - 
A methyl migration on acidic deprotection would be expected, inducing olefin 
formation (42) and thus self-quenching its reactivity. Thus limiting the possibility of 
interference with nucleophilic side chains within the peptide structure (scheme 17). 
RCOH 	+ 	..,.... 	 +
. (42) 
Scheme 17. Acidolysis of the 2,2,4, 4-tetramethylpent-3-yl (Tmp) ester. 
3.1 Synthesis of FmocAsp(OTmp)OH (46) 
The synthesis of the side chain protected aspartyl residue, FmocAsp(OTmp)OH (46), 
is outlined in scheme 18. 
The commercially available 2,2,4,4-tetramethylpentan-3-one was reduced to the 
corresponding alcohol, a colourless low melting crystalline solid, in> 90% yield with 
lithium aluminium hydride. The aspartyl side chain was then esterifled by classical DIC 
methodology, resulting in the fully protected ZAsp(OTmp)OBzl (44) derivative as an 
oil. The esterification was an extremely clean reaction, however the oil could be 
further purified to >99% by flash chromatography to give an unoptimised yield of 
60%, however it was preferable for routine syntheses to proceed with the unpurified 
product to the hydrogenation step. 
The deprotection of the amino and cc-carboxyl moieties could be achieved in 90% 
yield. Treatment with 10% palladium supported on charcoal and subsequent 
hydrogenation at atmospheric pressure yielded the HAsp(OTmp)OH (45) as a white 
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solid. Orthogonal protection of the amino function was achieved by incorporating the 
Fmoc moiety via an FmocOSu / potassium hydrogen carbonate protocol. Tituration 
with diethyl ether afforded the FmocAsp(OTmp)OH (46) derivative as a white solid in 
70% yield. 







Lithium aluminium hydride \ THF 






FmocOSu \ Base 
Scheme 18. Synthesis ofFmocAsp(OTmp)OH. 
Therefore the desired protected aspartyl residue can be obtained in 4 steps, without 
chromatographic purification, with an overall yield of 51%. 
3.2 Stability Studies on the 2.2,4,4-Tetramethylpent-3-VI Ester 
Stability studies on the FmocAsp(OTmp)OH (46) derivative were undertaken with 
respect to the lability of the side chain ester to acidic hydrolysis. 
The protected aspartyl residue (0. immol) was subjected to acids commonly used in 
SPPS and analysis by HPLC at 302nm assured an accurate deprotection profile as 
scavengers incorporated in the cleavage mix were not detected. 
61 
Chapter 3 : Results & Discussion 









95% TFAI5% H20 (lOml)/ 37°C 10 
95% TFAI5% H20 (lOml)/ 25°C 40 
1. 1M TFMSA / scavenger mix' 0.5 
1.4M HB174 / scav. mix2 <0.5 
1M TMSBr / scavenger mix' 1.5 
95% TFA/5% H20 I 43°C 40 
95%TFAI5%H 201430C 6 
95% TFA/5% H20 / 43°C 489 
'm-cresol, thioanisole, EDT, TFA (200 4, 500 p1, 200 p1, 1 ml) 
211BF4, m-cresol, thioanisole, EDT, TFA (250 p1, 150 t1, 800 p1, 200 p1, 2.4 ml) 
3Afler 3 hours no peak corresponding to FmocAsp(OTmp)OH or FmocAspOH could 
be detected, instead a peak corresponding to a more hydrophobic species was evident. 
Table 10. Stability studies on FmocAsp(OTmp)OH (46). 
As can be seen from the results outlined above, the 2,2,4,4-tetramethylpent-3-yl ester 
has considerable more acid lability than the corresponding Dmp system. The Tmp 
derivative can be cleaved rapidly with a TFMSA or tetrafluoroboric acid deprotection 
protocols. 
The provision of orthogonality of the Tmp system to Fmoc-based SPPS had to be 
assessed, therefore the stability of that system to base hydrolysis was investigated. The 
results would also indicate the susceptibility of the system to nucleophilic attack, and 
hence to aspartimide formation. 
A model ester, 2,2,4,4-tetramethylpent-3-yl hydrocinnamate (47), was synthesised and 
treated with an aqueous sodium hydroxide / dioxan solution. 
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(47) 
The reaction was quenched with pH 7 phosphate buffer and analysed by HPLC. The 
results of the Tmp system in comparison to the model esters previously tested within 
this laboratory, are tabulated below: 
2,2,4,4-Tetramethylpent-3-yl 6 days 0% 
tertiary Butyl 1 day 25% 
3-Ethylpent-3-yl 4 days 0% 
Benzyl 1 hour 100% 
1-(4'-fluorophenyl)-2-methylprop-2-yl 5 days 25% 
Dibenzosuberyl 3 hours 50% 
9-Anthracenylniethyl 3 hours 55% 
1-(9'-Anthracenyl)-3-methylbut-3-yl 6 days 10% 
Table 11. Alkaline hydrolysis studies of some model hydrocinnamate esters. 
As can be seen from the table above, the stability to base hydrolysis has been 
successfully incorporated into the design of the Tmp system. Therefore the lability to 
acid, coupled with the profound stability to alkaline hydrolysis provides the 
orthogonality required for a protecting group strategy for use in Fmoc-based SPPS. 
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3.3 Synthesis of VLVDNGGTGDVTVAPSNF (48) 
Beyermann et aI40 demonstrated that the synthesis of the title peptide, the partial 
sequence of coat protein phage MS2, was extremely problematic due to the 
susceptibility for aspartiniide formation at the Asp 4-Asn5 site. 
A standard Fmoc-based SPPS was employed with t-butyl protection of the aspartyl 
side chain. Prolonged treatment with 50% piperidine / D1'vlF after the automated 
synthesis followed by total deprotection and cleavage with TFA resulted in 70% 
piperidide formation, with less than 20% of the desired product being isolated. 
The profound propensity of the title peptide towards aspartiniide formation provided 
an excellent model to test the efficacy of the 2,2,4,4-tetramethylpent-3-yl system to 
suppress the induced cycisation. 
Therefore the title peptide (48) was synthesised using a standard Fmoc-based protocol. 
An initial substitution of 0.25 mmol of FmocPheOH on a p-benzyloxybenzylalcohol 
fimctionalised (Wang) resin was utilised, with single couplings employed with four 
equivalents of preformed HOCt esters. All side chains were protected as described in 
the experimental notes with the exception of Asp 4 which incorporated the Tmp 
function as the side chain ester. 
The coupling efficiencies for each amino acid residue were estimated from the 
integration of the peak obtained from the uptake of the dibenzofulvene-piperidine 
adduct produced from the deprotection cycle during synthesis. The coupling efficiency 
profile is demonstrated in figure 1, and clearly indicates that the steric bulk of the 
Asp(OTmp) side chain has no detrimental effect on the ability to form amide bonds 
during automated stepwise synthesis. 
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peptide sequence 
Figure 1. Estimated coupling efficiency for title peptide (48). 
3.3.1 Stability of Asp(OTmp)-Protected Peptide (48) to Piperidme 
The synthesised peptide (48), VLVDNGGTGDVTVAPSNF, incorporating the 
Asp(OTmp) residue was tested for susceptibility to piperidine mediated rearrangement. 
The resin bound peptide was stirred in 50% piperidine / DMF for 5 hours at room 
temperature, before being cleaved with 95% TFA I scavenger cocktail within 3 hours. 
Evaporation of the solution and subsequent precipitation of the peptide by diethyl 
ether, afforded a white solid which was dissolved in 20% acetic acid / 80% water and 
eluted through a G25 Sephadex column. The peptide containing fractions were pooled 
and lyophilised yielding a white solid. 
Analysis by HPLC indicated one main product as demonstrated in figure 2. The peaks 
were isolated by preparative HPLC, analysed by laser desorption mass spectrometry 
and FABMS. The results indicated that the minor constituents were truncated 
peptides and the main product, R 19 minutes, had a mass corresponding to 127 Da 
larger than the desired peptide. Thus indicating the main product to be the 
Asp(OTmp)-protected peptide. The products obtained were completely free of 
aspartimide or related products. 
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Figure 2. HPLC profile ofpiperidine treated crude products & the MALDI-ToFMS 
ofpur/iedpeptide (48). 
3.3.2 TFMSA treatment of Asp(OTmp)-Protected Peptide (48) 
The stability studies initiated on the parent amino acid, FmocAsp(OTmp)OH (46), 
suggested a facile cleavage of the aspartyl side chain could be achieved utilising a 
standard TFMSA protocol. Therefore aliquots of resin bound peptide were subjected 
to differing cleavage conditions incorporating 100 ptl TFMSA in a TFA / scavenger 
cocktail. The peptides were analysed by HPLC and mass spectrometry, the results are 
outlined in table 12: 
TFMSA/scav.mix' 0 to 25 60 40/60 
TFMSA/scav.mix 1 0 60 70/30 
TFMSA/scav.mix' -10 60 80/20 
TFMSA/scav.mix 1 -15 60 70 /02 
TFMSA/scav.mix' -15 90 95/ 0 
TFMSAJscav.mix 1 -20 to -25 60 40 /02 
'TFMSA, TFA, thioanisole, EDT, m-cresol (100 tl, lml, 100 p1, 50 pi, 200 tl) 
2 	% of a—peptide attributed to insufficient cleavage ofAsp(OTmp)-peptide. 
Table 12. TFMSA mediated cleavage of VL VDNGGTGD VT VAPSNF (48). 
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The results demonstrate that the profound acidic strength of the TFMSA does indeed 
induce aspartimide formation. However a reduction in the temperature decreases the 
rate of cycisation to such an extent, that at -15°C no aspartimide or related products 
were detected. 
The cleavage rate of the Asp(OTmp) ester, although facile above 0°C, is considerably 
slower at reduced temperatures. The decrease in the aforementioned cleavage rate 
corresponds to -25% of the Asp(OTmp) protected peptide being evident at -15 °C 
within the hour. However prolonged exposure to the cleavage mix provides efficient 
deprotection of the aspartyl residue. 
An illustration of the susceptibility of the Asp-Asn segment of the peptide (48) to 
rearrangement was demonstrated when the desired product was submitted for laser 
desorption mass spectrometry. The desired compound was collected after elution from 
the HPLC, in a 0.1% v/v  TFA / aqueous acetomtrile solution and left standing for 5 
days before analysis. Complete cydisation to the aspartiniide was evident, 1744 Da, 
expressing the extreme sensitivity of the system to acid catalysed rearrangement. 
A comparison of the Asp(OTmp) protected system was undertaken with respect to the 
Fmoc-based synthesis of the corresponding Asp(OtBu) protecting strategy. The resin 
bound Asp(OtBu)-peptide was treated with the standard TFMSA / scavenger mix 
previously utilised and stirred at 0°C for one hour. The standard work-up and analysis 
protocols previously described for the Asp(OTmp) system were repeated. The peptide 
was shown to form the corresponding aspartmiide in 70% yield, compared to 30% for 
the aforementioned system within the same environment. 
Therefore the Asp(OTmp) protecting strategy has been shown to completely suppress 
piperidine mediated rearrangement during SPPS. In addition it can be efficiently 
cleaved utilising a TFMSA protocol with negligible cydisation to the aspartiniide or 
related compounds. 
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3.3.3 Alternative Deprotection Strategy to Asp(OTmp) 
Although the TFMSA cleavage protocol bore excellent results in conjunction with the 
Asp(OTmp) protecting strategy, the utilisation of such a strong acid had a number of 
ff'I.JPiJ1 
Low temperatures were necessary to prevent rearrangement and therefore the 
cleavage procedure was not applicable to standard protocols. 
The use of TFMSA cannot be used in an orthogonal deprotection strategy which 
incorporates Cys(t-Bu) or Arg(Pmc) as substantially inferior products are obtained due 
to partial deprotection of the residues and the consequent side reactions induced. 
Therefore an investigation into alternative cleavage protocols was sought. 
Tetrafluoroboric acid (HBF 4) in TFA, in the presence of thioanisole, had been found to 
cleave various protecting groups currently employed in Fmoc-based SPPS without 
significant side reactions according to Kiso et a/ 88 . 
Tetrafluoroboric acid in TFA is a weaker acid than HBr in TFA 89 . Despite this a mild 
deprotection protocol (4°C for 1 hour) utilising HBF 4 can quantitatively cleave: 
• t-Butyl groups from the side chains of Ser, Thr, Tyr, Asp and Glu. 
• The Boc group at Lys, Bum group at His, Mbh at AsnJG1n and the Mtr group of 
Arg. 
• Bulky amino acids from Wang or MBHA resins. 
In addition orthogonality in conjunction with protected cysteine residues can be 
achieved using Acm protection, as the Cys(Acm) is completely stable to HBF 4 
treatment even in the presence of thioanisole. 
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The effectiveness of an HBF 4-thioanisole cleavage protocol was demonstrated in the 
synthesis of the rat brain natriuretic peptide 45 (rBNP45) by Fmoc-based pp(90) 
The peptide contained six problematic Arg residues, two sites susceptible to 
aspartimide formation (Asp 3-Ser4 & Asp 40-G1y41 ) and a Met residue which was known 
to be easily oxidised within the 45 amino acid chain. 
Despite the potential set-backs, the peptide was isolated in 92% yield utilising a HBF 4 
cleavage (4°C for 90 mins.) protocol, compared to 84% with TFA. Moreover the 
crude peptide from the HBF 4 cleavage contained fewer impurity peaks on HPLC 
analysis with respect to TFA, TFMSA and BF cleavage protocols respectively. Acid 
hydrolysis and leucine aminopeptidase (LAP) digestion indicated no aspartimide 
formation. Therefore the utilisation of a tetrafluoroboric acid cleavage protocol was 
investigated with respect to the Asp(OTmp)-protected peptide (48). Aliquots of the 
resin bound peptide (48) were treated with differing concentrations of tetrafluorobonc 
acid-diethyl ether complex in a TFA / scavenger cocktail to assess the optimum 
conditions for total deprotection and resin cleavage. 
The reaction for each corresponding aliquot was undertaken at 4°C for one hour under 
a nitrogen atmosphere. Subsequent precipitation by diethyl ether and elution through a 
G25 Sephadex column afforded the purified peptide fractions which were pooled and 
lyophilised to yield a white solid. The peptide was analysed by HPLC and FABMS, 
the results outlined in table 13. 
. 	 . . 	
.... 
	




0.7 M <2 30 60 18 
1.4M <2 <5 90 85 
1.7M <2 0 90 88 
2.0M <2 0 90 88 
'with resnect to the volume of TFA. 2No ninendide detected. 3lnsufficient cleavaae 
from resin. 
Table 13. HBF4 mediated cleavage profile of VL VDNGGTGDVTVAPSNF(48). 
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The excellent results outlined above prove that a tetrafluoroboric acid cleavage 
protocol is a viable alternative to TFA or TFMSA procedures in that it is fast , efficient 
and does not induce rearrangement in sensitive sequences. 
The analysis of the crude peptide products upon cleavage with l.4M HBF 4 is shown in 
figure 3. 
.------ 	 . . 
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â*IflUtCN 
2 15.6 1762.9149 1762.9900 a-peptide 
4 19.2 1889.1579 1889.2213 Asp(OTmp)-peptide 
Figure 3. The HPLC &FABMS profiles of]. 4M HBF 4 cleavage of (48). 
The analytical data in figure 3 corresponds to the crude cleaved peptide after elution 
from a G25 Sephadex column and resultant lyophilisation. The minor substituents, 
peaks 1 and 3, correspond to truncated peptides produced during synthesis and 
deprotection, while peak 4 represents the Asp(OTmp)-protected derivative. 
Therefore it can be seen from figure 3 that the cleavage procedure involving the 
tetrafluoroboric acid results in a very clean product profile with few truncated peptides 
and negligible rearranged products. 
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The desired peptide (peak 2, figure 3) was isolated by preparative HPLC and the 
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Figure 4. HPLC trace of the pur/iedpeptide & the correspondingMALDl-ToFMS. 
The desired peptide was subjected to classical Edman degradation and analysed by an 
Applied Biosystems 477A protein sequencer. The full eighteen amino acids were 
sequenced indicating that the isolated peptide was the desired a-isomer rather than the 
rearranged 3-adduct resulting from ring opening of the aspartiniide. The amino acid 
analysis is shown below: 
N 
Asp /Asn 4 3.81 
Thr 2 2.06 
Ser 1 1.04 
Pro 1 1.21 
Gly 3 2.94 
Ala 1 1.08 
Vat 4 3.94 
Leu 1 1.06 
Phe 1 0.88 
Table 14. Amino acid analysis of VLVDNGGTGDAPSNF (48). 
71 
Chapter 3: Results & Discussion 
3.4 Synthesis of ASYKVTLKTPDGDNVITYPD-Nfl2 (49) 
The title peptide (49) represents the N-terminal segment of ferrodoxin, which contains 
two adjacent sites (..Asp"-Gly-Asp 13-Asn..) susceptible to aspartiniide formation. 
Packmann demonstrated that standard Fmoc-based SPPS of the title peptide 
incorporating the Asp(OtBu) residue at sites 11 and 13, resulted in two main products 
upon TFA mediated total deprotection and cleavage 91 . The major constituent was a 
peptide of mass 2096.0 Da, some 36 Da lighter than expected (2132.2 Da), suggesting 
the presence of two aspartimide residues. Amino acid sequence analysis of the peptide 
gave the correct sequence up to Asp" at which point the yield of phenylthiohydantoin 
amino acid dropped by 95%. At Asp 13  the yield dropped to <<1% and the sequence 
analysis effectively terminated. The data therefore confirmed the presence of 
approximately 95% -peptide formation at Asp" and 95-100% f-peptide formation at 
Asp'3, consistent with the formation of aspartiinide at each Asp residue which 
subsequently ring opened to the predominant 13-peptide form. 
The minor constituent corresponded to a peptide of mass 2180.0, a mass indicative of 
only one of the aspartimide residues ring opening to form the piperidide adduct. No 
peptide was detected which possessed the required mass of the desired peptide, 
indicating that under the conditions of synthesis conversion to the aspartiniide at Asp" 
and Asp" is quantitative. 
Thus the synthesis of the title peptide (49) would provide a stem test of the efficacy of 
the Asp(OTmp) to suppress aspartimide formation. 
The peptide (49) was synthesised on a 0.25 mmol scale using the dibenzosuberyl linked 
resin (introduced by Ramage) 92 . Single coupling utilising 4 equivalents of preformed 
HOCt esters were performed. All side chains were protected as described in the 
experimental notes with the exception of Asp 1 ' and Asp 13 which incorporated the Tmp 
function as the side chain esters. The coupling profiles were obtained as described 
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Figure 5. Estimated coupling efficiency for title peptide (49). 
Once again it can be seen that the steric influence of the protected asp artyl side chain 
does not interfere with the amide bond forming reactions during automated peptide 
synthesis. 
3.4.1 BIBF4 Mediated Deprotection of Peptide (49) 
Aliquots of the resin bound peptide (49) were treated with differing concentrations of 
tetrafluoroboric acid-diethyl ether complex in a TFA / scavenger cocktail to assess the 
optimum conditions for total deprotection and resin cleavage. 
The reactions were undertaken at 4°C for one hour under a nitrogen atmosphere. 
Subsequent precipitation by diethyl ether and elution of the solid through a G25 
Sephadex column afforded the scavenger free peptide fractions which were pooled and 
lyophilised to yield a white solid. 
The peptides were analysed by HPLC and FABMS, the results are outlined in table 15. 
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............. -01 ........... 	 ..... 	 ........... 
0.7M <2 50 45 
1.4M <2 30 60 
1.7M <5 5-10 85 
2.0M <5 0 90 
Table 15. Cleavage ofpeptide (49) with differing concentrations of HBF4. 
The peptides, corresponding to the particular cleavage conditions, were analysed by 
HPLC and FABMS. Figure 6 illustrates the HPLC trace of the crude peptidic 
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Figure 6. The HPLC profile of the peptide (49) after treatment with 0. 7MHBF 4. 
The treatment of the resin bound peptide with 0.7M HBF 4 / TFA resulted in three main 
products. The respective peaks outlined in figure 6 were separated by preparative 
HPLC and analysed by FABMS, the results tabulated below: 
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..... 
... 	 . 	 .................. ........... 
1 15.2 2133.4094 2133.1217 13-peptide 
2 15.3 2133.4094 2115.1176 aspartimide 
3 15.4 2133.4094 2133.1215 cx-peptide 
4 19.1 2133.4094 2259.2760 Asp(OTmp)peptide 
5 20.2 2133.4094 23 84.8500 bis-Asp(OTnip) peptide 
Table 16. FABMS of the isolated peaks corresponding to figure 6 
Although the aspartyl protecting group strategy was extremely successful with respect 
to aspartimide suppression, the results indicated that the aforementioned cleavage did 
not efficiently deprotect the two Asp(OTmp) moieties, with considerable quantities of 
the mono and di-aspartyl protected species in evidence. 
However an increase in concentration of the tetrafluoroboric acid induces complete 
deprotection of the Asp(OTmp) residues, but at the expense of formation of the 
aspartimide and related products (peaks 1 & 2 as illustrated figure 7). No evidence for 
the formation of the corresponding piperidide was observed. 
21 	
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Figure 7. HPLC profiles of]. 7M & 2.0 M HBF 4 cleavage protocols ofpeptide (49) 
respectively. 
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The desired peptide, peak 3 (figure 7, table 15), was isolated by preparative HPLC and 
sequenced by the Edman degradation technique. All twenty-two amino acids were 
identified correctly, thus proving the product was indeed the cc-peptide. 
Amino acid analysis confirmed the product to be the desired peptide, the results 
tabulated below: 
Asp/Asn 4 4.16 
Thr 3 3.20 
Ser 1 1.03 
Pro 2 2.31 
Gly 1 1.14 
Ala 1 1.16 
Val 3 3.17 
Ile 1 0.77 
Leu 1 1.10 
Tyr 1 0.99 
Lys 2 2.22 
Table 17. Amino acid analysis of ASYKVTLKTPDGDNVITVPD-NH 2 (49). 
3.5 Conclusion : The Asp(OTmp) Protecting Strategy 
The side chain of the aspartic acid residue can be conveniently protected as the 
2,2,4,4-tetramethylpent-3-yl (Tmp) ester in good yield. 
The Tmp ester is relatively stable to TFA (ti/2 40 hours at room temperature), but can 
be efficiently cleaved within 90 minutes by TFMSA or HBF 4 cleavage protocols. The 
ester has profound stability towards base hydrolysis, thus providing complete 
orthogonality in conjunction with Fmoc-based SPPS. 
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The Tmp moiety completely suppresses aspartiniide, and hence piperidide, formation 
during automated Fmoc-based SPPS, even in the most sensitive of sequences. Upon 
total deprotection and cleavage by the aforementioned acidic protocols, the crude 
product consists of negligible quantities of the aspartimide or related by-products and a 
high percentage yield of the desired cc-peptide. 
The Asp(OTmp) system can be utilised in a one or two step deprotection strategy 
providing alternative deprotection profiles depending on the requirements of synthesis. 
Therefore the 2,2,4,4-tetramethylpent-3-yl group provides excellent protection against 
aspartimide formation throughout SPPS and purification protocols. 
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CHAPTER 4 
4.0 The 24-Dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl Group (Dmbp) 
The success of the 2,2,4,4-tetramethylpent-3-yl (Tmp) protecting group strategy in the 
suppression of aspartimide formation prompted an investigation into alternative 
strategies which would provide a fhrther option in orthogonal deprotection. An 
increase in the acid lability of the ester with respect to the Tmp system would provide 
the possibility of deprotection by a standard TFA cleavage protocol. 
The modification of the Tmp system to induce rapid olefin formation was investigated 
and it was proposed that if a group (R) with a greater migratory aptitude, with respect 
to the methyl group, was incorporated into the system then a more rapid cleavage rate 
would be observed. Scheme 19 outlines the hypothesis: 
o ArR 	 R 	Y R 
R' R 	 R'CO11 fast 
Scheme 19. Proposed olefin formation when R has a greater migratory aptitude than 
the methyl group. 
The idea of 'migratory aptitude' evolved from competition experiments in which one of 
two groups on the same atom could migrate to the migration terminus (a carbocation), 
leaving the other behind. If R' migrated in preference to R 2 , it was said to have a 
higher migratory aptitude and the ratio of products formed by R' and R 2 migration was 
used to set up a quantitative scale of migratory aptitudes". 
This classical work on carbocation rearrangements relating to the pinacol-pinacolone 
rearrangement suggested that the aryl derivatives were of greater migratory 
aptitude(94) . 
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The main principle of this early work is that the group which constitutes a greater 
electron donation, therefore possessing a greater positive resonance and to a lesser 
extent inductive effects, will migrate to the carbocation. Thus the migrating group 
effectively attacks the vacant orbital of the carbocation by nucleophilic donation. This 
concept was proven experimentally and a migratory aptitude scale was derived: 
p-anisyl> p-tolyl > phenyl > alkyl > hydrogen 
The relative rates of migration concerning each group are ambiguous, depending on 
the method of interpretation of results and the system under investigation. Bachmann 
et al initially prescribed the p-anisyl (4-methoxyphenyl) group as migrating 70 times' 93 
more rapid than the phenyl group, and later revised the value to 500 (941)) 
The classical work on the driving forces in the Wagner-Meerwein rearrangement by 
Winstein et al reiterated such findings 95 . Investigation into the relative rates of 
migration in the acetolysis of p-toluenesulphonates found the aforementioned 
migratory aptitude scale to hold true. However the calculations into providing the 
relative rates were once again ambiguous depending on the type of compound tested 
and on the interpretation of the results. 
Winstein et al concluded that the relative rate of migration of the phenyl group was 21 
times more rapid than that of the methyl group. Moreover, in a different system the 4-
methoxyphenyl group was approximated to migrate between 6 and 37 times more 
quickly than the corresponding phenyl derivative depending on conditions 
employed 9 . 
The long realisation that the anisyl group has a greater driving force for migration, 
with respect to the methyl and phenyl groups, is explicable due to anchimeric 
assistance from the aryl participant. The 4-methoxyphenyl (anisyl) group participates 
in such a nucleophilic displacement due to the resonance stabilisation of the transition 
state, as outlined in scheme 20. 
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Scheme 20. Resonance stablisation of aryl carbocations. 
The three membered ring is highly strained and therefore susceptible to rapid ring 
opening at the Ca or the Cp by attack from a nucleophile. Therefore it is clearly 
evident that the substitution of a methyl group by the 4-methoxyphenyl group in the 
Trap system should result in a more rapid hydrolysis of the initial ester due to the 
formation of an 'anisomum-ion' (50). The rapid ring opening of the 'anisonium bridge' 
could be achieved by the nucleophilic scavengers utilised in the cleavage protocols, or 
by rapid olefin formation as outlined below: 
H,CC) 






Scheme 21. Proposed mechanism for anchimerically assisted ester hydrolysis. 
Therefore it was proposed to synthesise the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl) 
pentan-3-ol for subsequent esterification with the aspartyl side chain. The protected 
aspartyl residue (51) would possess severe steric hindrance, thus suppressing 
aspartiniiide formation during SPPS, in accordance with the requirements set out for 
protecting group criteria (section 2.1). 




H N  
(51) 
In addition, the stability of the Tmp system to base hydrolysis suggests that the diaryl 
derivative should possess similar qualities. 
4.1 The 2,4-Diinethyl-2g4-diphenylpentan-3-ol Group 
The synthesis of the title compound was investigated to provide a model system for the 
desired diaryl system (section 4.0). The permethylation of dibenzyl ketone derivatives 
and subsequent reduction seemed to be the most direct synthetic route to such 
derivatised alcohols according to scheme 22. 
x 	
x 
NN 	 NN' 
x x 






I NNI yO H 	I N-I 
Permethylation 	 X = H or OMe 
Lithium aluminium hydride 
Scheme 22. Proposed route to permethylated diary! ketones. 
There are several methods for permethylation of ketones, the success of which is 
heavily dependant on the particular characteristics of the ketone, especially with 
respect to the steric interactions within the system. 
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Table 18 below outlines the synthetic methods attempted and the ratio of products 
produced. In each case, the commercially available 1,3-diphenylpropan-3-one was 
utilised as the starting material. 
Mel THF KU 40 30 / 70 / 01 
2' Mel THF KH 70 
0/90/102  
3(98) Mel THF KOBut/BuLi -78 to RT 0/90/0 2  
4 Mel Benzene KOBu t 80 0/90/8.5' 
5(99) Mel DMSO KOH 50-60 0 / 88 / 0' 
70 1UUULS W141ySU uy Jivi 
2%yield of isolated product 
Table 18. A ttemptedperrnethylation of dibenzylketone. 
The table above illustrates the difficulties encountered in the substitution of such a 
constrained system. The facile production of the tnmethylated derivative and 
subsequent failure in the synthesis of the tetramethyl derivative was obviously due to 
the severe steric interactions encountered within the system. 
The only reaction that produced the desired permethylated ketone (53) as a crystalline 
solid utilised potassium or sodium hydride as the base, and methyl iodide at elevated 
temperatures. Refluxing the THF mediated reaction for ten hours resulted in a mixture 
of the trimethylated (52) and tetramethylated (53) ketone derivatives respectively, the 
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Repetition of the aforementioned protocol with the corresponding trimethylated 
derivative as the starting material again proceeded with as little as 10% conversion to 
the desired compound. 
The utilisation of a 'superbase', a potassium tert-butoxide / butyllithium cocktail, 
resulted in a very clean, high yielding reaction with respect to the production of the 
trimethylated derivative (52). The trimethylated derivative (52) could be attained as a 
pure crystalline compound in 90% yield after recrystaffisation from absolute ethanol. 
The facile and high yielding synthesis of the trimethylated ketone (52) derivative 
prompted an investigation into the conversion of the aforementioned compound to the 
corresponding permethylated ketone (53). The potassium hydride mediated protocol 
which induced 10% permethylation was repeated in the presence of'18-crown-6 ether'. 
The enhancement in the yield of permethylated product was staggering, 90% after 
recrystallisation absolute ethanol. 
The methodology outlined above was translated to the synthesis of the 2,4-dimethyl-






OCH3 	 (54) 
Fl3CO. 1 DCH3 




(57) 	 (56) 
(i). MnCl2, 200-250°C /0.1 Torr(60%) (iii). KH, Mel, 18-crown-6 (90%) 
(u). BuLi, KOBut, Mel (90%) 	 (iv). LAH, THF, reflux (92%) 
Scheme 23. Synthetic pathway to 2, 4-dimethyl-2, 4-bis(4'-methoxyphenyl)pentan-3-ol 
(57). 
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The 1, 3-bis(4'-methoxyphenyl)prop an-3 -one (54) was synthesised according to 
Diederich et aP001 from the pyrolysis of the corresponding acid (via the manganese 
salt) resulting in a yellow solid. Subsequent recrystaffisation from absolute ethanol 
afforded the desired ketone as a white crystalline solid in 60% yield. 
4.2 Characteristics of TrilTetra-Methylated Diaryl Ketones 
19 Steric Crowding : The severe steric crowding in the aforementioned systems 
(sections 4.0 & 4.1) is exemplified by the X-ray crystal structure of the tnmethylated 
derivative (55) (figure 8). In the corresponding NMR, the two geminal cc-methyl 
substituents, as well as the two methoxy substituents, are represented as separate 
singlets indicating the presence of diastereoisomers as a result of the chiral centre at 
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Figure 8. The 200MHz 'H AMR & X-ray crystal structure of 2-methyl-2,4-bis(4'- 
methoxyphenyl) pentan-3 -one. 
The difference in the NMIR chemical shift of the methyl and methoxy substituents in 
the aforementioned compound was not evident in the analysis of the tetramethylated 
ketone as outlined below in figure 9. The absence of a chiral centre in the 
tetramethylated system (56) supports the conclusion that diastereoisomers were in 
evidence in the corresponding trimethylated NMR plot. 
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4 	 3 	 3 	 S 	 pfl 
rigure 7. zuvivirib ii ivivnt (X JtFUy C!)6)1U1 .)iUL- tUF V (Jf ,tatFttfyi,t(/I.) 
(4 '-methoxyphenyl)pentan-3-one. 
Carbonyl Frequency: An interesting feature in the series of substituted ketones is 
the differing frequencies of the carbonyl stretch in the infra-red spectra for each of the 
respective compounds. 
The carbonyl stretching frequencies for the ketones are listed in table 19. 
1 ,3-Diphenylpropan-3-one 	 1720 
2-Methyl-2,4-diphenylpentan-3-one (52) 	 1705 
2,4-Dimethyl-2,4-diphenylpentan-3-one (53) 	1680 
Table 19. Carbonyl stretchingfrequencies of respective ketones. 
The decreasing trend of the carbonyl frequency is also mimicked in the 4-
methoxyphenyl series, and provides a qualitative method for the identification of each 
of the respective compounds. 
It would be expected that the increase in a positive inductive effect from the extra a—
methyl groups would result in an increased polarity between the carbon and oxygen in 
the system,, inducing a greater repulsion and hence a bond lengthening of the carbonyl. 
This would ultimately result in a depression of the carbonyl frequency" °°, however the 
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disproportionate decrease relating to the conversion of the trimethylated to the 
tetramethylated derivatives suggests that additional parameters are in play. In addition, 
analysis of the respective X-ray crystal structures suggest that a significant increase in 
CO bond length does not occur as outlined in table 20. 
2-Methyl-2,4-diphenylpentan-3-one (52) 	 1.218 (5) 
2,4-Dimethyl-2,4-diphenylpentan-3-one (53) 	1.209(2) 
Table 20. CO bond lengths for ketones (52) & (53). 
Many parameters determine the precise frequency of a given carbonyl group, these 
include inductive, resonance and field effects which alter the force constant of the CO 
bond. However physical factors such as mass and angle effects and vibrational 
coupling also play a significant role and it is the combination of all the aforementioned 
parameters which result in the a particular frequency being observed. 
The general value of the carbonyl frequency in simple alkyl compounds is Ca. 1720 cm 1 
with few deviations. Only in special circumstances, such as when the bond angle is 
opened beyond 120° by steric effects, is any significant departure from this value 
observed(102)  . This sterically mediated phenomenon is illustrated in the alkyl series 
outlined in table 21. 
Methyl tert-butyl ketone 	1723 
Pentamethylacetone 	 1716 
Hexamethylacetone 	 1697 
Table 21. Carbonylfrequencies for methylated ketones. 
Therefore the depression in the uCO by the addition of an extra methyl group in the 
series outlined in table 21 suggests that such a steric interaction plays a significant role 
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in the depression of carbonyl frequency in the ketones (52, 53, 55, 56). Substantiation 
of such a view is provided by reference to the bond angle (a) of the respective ketones 
(52 & 53) as outlined in figure 10. However there is not an extremely large difference 
in the bond angle therefore it must be stressed that a combination of all the 
aforementioned parameters effect the observed frequency. 
a C=O 
2-Methyl-2,4-diphenylpentan-3-one (52) 	118.2(4) 
2,4-Dimethyl-2,4-diphenylpentan-3-one (53) 	122.6 (15) 
Figure 10. Respective bond angles of aryl ketones. 
Migratory Aptitude: During the investigation into the permethylation of ketones 
(section 4. 1), an alternative route was considered in view of the readily accessible 
trimethylated derivative (55). The research centred around the Lewis acid mediated 
ring opening of the epoxide (58) to form the desired alcohol according to scheme 24. 
0 	 OH 
A\/yAr W Ary,~,YAr Ar 	Ar 	Ar 	Ar 
(55) 	 (58) 
Reduce & Dehydrate (iii). MeLi, Lewis Acid 
Epoxidation 
Scheme 24. Proposed synthetic route to permethylated alcohol. 
A literature search revealed that the dehydration of secondary alcohols in 
hexamethylphosphorictriamide (HIVIPT) at elevated temperatures had been shown to 
be an efficient method with negligible by-products 103 . 
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Therefore the trmiethylated ketone (55) was reduced by a standard lithium aluminium 
hydride protocol to yield the subsequent alcohol. The alcohol was dissolved in HMPT 
and heated to 220°C, an aqueous work-up and recrystaffisation from absolute ethanol 
afforded a crystalline solid. However, although analysis by NMIR indicated that 
dehydration of the system did indeed occur, the desired olefin was not produced. The 
rearranged structure (59) was obtained. 
It was postulated that the mechanism of dehydration involved a carbocation species, 
contrary to initial theory 103 , which invoked an aryl migration and subsequent olefin 
formation to quench the cation according to scheme 25. The ring opening of the 
cyclopropyl ring favouring the formation of the more stable tertiary carbocation, thus 











Scheme 25. Proposed mechanism of olefin formation. 
The proposed mechanism outlined above which postulated an 1,2-aryl shift was 
supported by analysis of the X-ray structure, which clearly indicates olefin formation 
via aryl migration (figure 11). 
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Figure 11. X-ray crystal structure of the HMPT induced olefin. 
The crystal structure of the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl)pentan-3-ol (57) 
outlines the orientation of the methoxy function with respect to the phenyl ring (figure 
12). The planarity of that function further explains the susceptibility of the 4-
methoxyphenyl moiety to migrate as maximum resonance contribution from the 
methoxy moiety can be exploited. 
it igure 12. A-ray crystal structure oj DmDp-alcohol. 
Figure 12 (right) demonstrates the view through the plain of the methoxy bond, C61-
061, indicating the planarity of the bond with respect to the adjoining phenyl ring. 
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4.3 Synthesis of FmocAsp(ODmbp)OH (62) 
The synthesis of the title compound (62) was accomplished by repeating the 
methodology utilised in the synthesis of the FmocAsp(OTmp)OH residue (section 3.1) 
according to scheme 26. 
H300 	 OH 	OCH3 
ZHN cO2Bz1 
(60) 









ZAspOBzl, DIC, DMAP (c). FmocOSu, KHCO3 
Pd/C, H2, EtOH 	An = 4-methoxyphenyl 
Scheme 26. Synthetic pathway to FmocAsp(ODmbp)OH. 
The ZAspOBzl residue was esterified with the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl) 
pentan-3-ol (57) via classical DIC / DMAP methodology, providing the fully protected 
derivative as a colourless oil in 85-90%. 
The deprotection of the amino and cc-carboxyl moieties could be achieved in 90% yield 
by treatment with 10% palladium supported on charcoal under a hydrogen atmosphere 
which yielded the HAsp(ODmbp)OH residue (61) as a white solid. Orthogonal 
protection of the amino function was successful by incorporating the Fmoc moiety via 
FmocOSu / potassium hydrogen carbonate methodology. Trituration with diethyl 
ether afforded the FmocAsp(ODmbp)OH (62) derivative as a white solid in 70% yield. 
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4.4 Stability Studies on FmocAsp(ODmbp)OB (62) 
Stability studies on 0. immol of the title compound were undertaken to assess the 
susceptibility to acid hydrolysis. Analysis by HPLC at 302nm afforded an accurate 
deprotection profile as scavengers in the cleave mix were not detected. The results are 
tabulated below: 
95% TFA / Scav. mix' 	 25 	 5 hours 
1.1M TFMSA in TFAI Scav. mix' 	-15 	 9 mins. 
1.4M LEBF4 in TFA/ Scav. mix' 	 4 	 <15 mins. 
1M TMSBr in TFA/ Scav. mix' 	 0 	 40 mins. 
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Table 22. Deprotection profile of FmocAsp(ODmbp) OH (62). 
As outlined above, the Dmbp ester is considerably more acid labile than the Tmp 
moiety previously described (section 3.2). However the Dmbp system was not as acid 
labile as was first proposed (section 4.0), with a relative increase in lability 8 times that 
of the Trap system. 
Although an increase in the rate of acidic deprotection was observed in the Dmbp 
system with respect to the Tmp protecting group, it was lower than the calculations of 
Winstein and Bachmann would suggest. This could be explained if either the relative 
rates of migratory aptitudes are not entirely self-consistent due to parameters which 
were not taken into account at the time, or because the relative rates of migration 
which were calculated may be specific to the systems investigated. 
In addition the early work did not take into account stereochemistry, conformation, 
equilibration of cations etc. ( 104)  therefore the relative rates of migration are somewhat 
ambiguous. 
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One such parameter which was not considered in the early investigations corresponds 
to carbocation stabilisation. The migration of a group results in a subsequent 
carbocation being formed at the original site at which the migrating group was 
situated. The stability of that carbocation is obviously dependent on the ability of the 
adjoining substituents to stabilise the species. As a result the transition state stability is 
dependent not only on the ability of the group to migrate but also depends on the 
substituents on the original carbon. 
In the Dmbp system, the 4'-methoxyphenyl function can stabilise the carbocation 
induced by the migration of the subsequent methyl group as demonstrated in scheme 
27. Therefore competitive migration between the aryl and methyl groups exists. The 
migration of the methyl group may be a favourable pathway due to a relief in strain 








H3C 	 OCH3 
Scheme 27. Proposed carbocation stabilisation. 
The conformation of the Asp(ODmbp) system may also have a profound effect on 
deprotection profile. It has been suggested that effective anchimeric assistance 
requires a transition state in which the Ca, the leaving group and the 'assisting atom' lie 
in or near a common plane. In the Dmbp system, it follows that the it-orbitals of the 
anisyl ring should be in the plane of the sp 3 Ca orbital (and indeed the anti-bonding 
orbital) according to figure 13. 
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Figure 13. Proposed orbital interaction for maximum anchimeric assistance and 
Newman projection. 
However, if steric interactions within the system prevent the orientation of the aryl ring 
to coincide with maximum it-orbital interaction, then anchimeric assistance is less 
pronounced and a reduced rate of ester hydrolysis would be observed. The Newman 
projection in figure 13 demonstrates the steric crowding of the system,, indicating the 
difficulty encountered by the anisyl ring in achieving the planar orientation sought for 
maximum resonance contribution. 
The increase in the rate of ester hydrolysis, with respect to the Tmp system, does 
however provide an alternative orthogonal deprotection strategy utilising a TMSBr 
protocol. 
The provision of orthogonality of the Dmbp system to Fmoc-based SPPS had to be 
assessed, therefore the stability of that system to base hydrolysis was investigated. The 
results would also indicate the susceptibility of the system to nucleophilic attack, and 
hence to aspartimide formation. 
A model ester, the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl hydrocinnamate 
(63), was synthesised and treated with an aqueous sodium hydroxide / dioxan solution. 
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H 3 CO  
(63) 
The reaction was quenched with pH 7 acetate buffer and analysed by HPLC. Upon 
stirring the reaction for 6 days no evidence of ester hydrolysis was observed, indicating 
profound stability to nucleophilic attack. 
4.5 Synthesis of VLVDNGGTGDVTVAPSNF (64) 
As previously described, the synthesis of the title peptide (64), the partial sequence of 
coat protein phage MS2, has been shown to be extremely problematic due to the 
rearrangement at the Asp 4-Asn5 site (section 3.3). The great instability of the title 
peptide (64) to aspartimide formation provided an excellent model to test the efficacy 
of the 2,4-dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl system to suppress the 
cycisation. 
Therefore the title peptide (64) was synthesised using a standard Fmoc-based protocol. 
An initial substitution of 0.25 mmol of FmocPheOH on a 4-benzyloxybenzylalcohol 
functionalised (Wang) resin was utilised, with single couplings employed with four 
equivalents of preformed HOCt esters. All side chains were protected as described in 
the experimental notes with the exception of Asp 4 which incorporated the Dmbp 
function as the side chain ester. 
The coupling efficiencies for each amino acid residue were estimated from the 
integration of the peak obtained from the uptake of the dibenzofulvene-piperidine 
adduct produced from the deprotection cycle during synthesis. The coupling efficiency 
profile is demonstrated in figure 14, and clearly indicates that the steric bulk of the 
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Asp(ODmbp) side chain has no detrimental effect on the ability to form amide bonds 
within the system. 
Figure 14. Estimated coupling efficiencies in the synthesis of the peptide(64). 
4.5.1 Stability of Asp(ODmbp) Protected Peptide (64) to Piperidine 
The synthesised peptide (64), VLVDNGGTGDVTVAPSNF, incorporating the 
Asp(ODmbp) residue was tested for susceptibility to piperidine mediated 
rearrangement. The resin bound peptide was stirred in 50% piperidine I DMF for 5 
hours at room temperature, before being cleaved with 95% TEA / scavenger cocktail 
within 3 hours. Evaporation of the solution and subsequent precipitation of the 
peptide by diethyl ether, afforded a white solid which was dissolved in 20% acetic acid 
I 80% water and eluted through a G25 Sephadex column. The peptide containing 
fractions were pooled and lyophilised yielding a white solid, analysis by HPLC 
indicated one main product as demonstrated in figure 15. 
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Figure 15. HPLC profile & FABMS of main peak ofpiperidine treated peptide (64). 
The main peak was analysed by laser desorption mass spectrometry and FABMS and 
provided a mass of 2073 Da, 310 Da above the desired mass for the fully deprotected 
peptide, indicating the product as the Asp(ODmbp)-protected peptide. The minor 
peaks illustrated in figure 15 corresponded to truncated peptides, there was no 
evidence of aspartimide or related products. 
4.5.2 TFMSA treatment of Asp(ODmbp)-Protected Peptide (64) 
In view of the results on the Asp(OTmp) system, in which a low temperature cleavage 
protocol using TFMSA was established, an investigation into the optimum 
deprotection profile of Asp(ODmbp)-protected peptide (64) with the aforementioned 
acid was undertaken. 
The use of strong acids in the deprotection of peptides has been shown to catalyse the 
formation of asp arti.mides, but low temperatures can greatly reduce this. Therefore 
once again the cleavage protocols were performed at -15 T. The standard TFMSA 
cleavage procedure was used (100 41 of TFMSA in 1 ml of TFA in the presence of 
scavengers) to provide excellent results. The analysis by HPLC of a TFMSA mediated 
reaction is outlined in figure 16 below. 
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Figure 16. HPLC profile of a standard TFMSA cleavage ofpeptide (64) for 15 mins. 
The peaks were isolated by preparative HPLC and analysed by FABMS. The main 
peak, #3, R 12.6 mins.), had a mass corresponding to the desired peptide, 1763 Da. 
The minor constituents of the HPLC trace related to truncated peptides, with the 
exception of peak #4 (R 19.2 mins.) which had a mass corresponding to the 
Asp(ODmbp) protected peptide. Therefore the Dmbp ester moiety can be efficiently 
hydrolysed within 30 minutes, even at the extreme temperatures employed. 
The table below illustrates the lability of the Dmbp aspartyl side chain ester to 1. 1M 
TFMSA in TFA with the appropriate scavenger mixture. Moreover, at the sub-zero 
temperatures employed, the formation of aspartimide or related products was 
negligible. 
I TFMSA 1 5 mins. - 1 5 3 < 	1 22 
2 TFMSA 60 mins. -15 0 <1 86 
Table 23. TFMSA mediated cleavage ofpeptide (64). 
The culmination of the low temperature of the reaction and the short reaction time in 
expt. 1 / table 23, afforded a reduced yield of the peptide as it was not efficiently 
cleaved from the resin. 
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This suggests that a two stage deprotection strategy could ideally be utilised to provide 
rearrangement free products. The first stage of the strategy could be treatment of the 
resin bound peptide with TFA to efficiently cleave the peptide from the resin as well as 
deprotect the t-butyl based side chain protecting groups. The Asp(ODmbp)-protected 
peptide could then be treated with TFMSA for 15-20 minutes, to supply the fully 
deprotected peptide free of aspartimide or related products in good yield. 
The efficacy of such a two stage cleavage protocol was tested by treating the resin-
bound peptide for 3 hours with a standard TFA / scavenger cocktail solution at room 
temperature. Evaporation in vacuo, dissolution in 20% acetic acid / 80% water and 
elution through a G25 Sephadex column afforded a scavenger free product. The 
peptide containing fractions were pooled and lyophilised to yield a white solid, analysis 
by HPLC is demonstrated in figure 17. 
The Asp(ODmbp)-protected peptide was then subjected to a standard TFMSA / TFA / 
scavenger cocktail solution for 30 minutes at -15 0C. Precipitation of the peptide by 
diethyl ether addition, separation by centrifugation followed by elution through a G25 
Sephadex column afforded a scavenger free product. The fractions were pooled, 
lyophilised and analysed by HPLC, the profile is outlined in figure 17. 
I  
Figure 17. HPLC profile of (a). TFA treated (h). Post-TFA, TFMSA treated peptide 
(64). 
The HPLC profiles illustrated in figure 17 demonstrate the success of the two stage 
deprotection strategy. 
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The fractions relating to the desired peptide were purified by preparative HPLC and 
was subjected to classical Ednian degradation and analysed by an Applied Biosystems 
477A HPLC protein sequencer. The thU eighteen amino acids were sequenced 
indicating that the isolated peptide was the desired a-conformation rather than the 
rearranged 13-adduct resulting from ring opening of the aspartimide. 
4.5.3 HBF4 Mediated Cleavage of Peptide (64) 
The excellent results obtained utilising an HBF 4 mediated cleavage protocol with the 
Tmp system confirmed the methodology as exceptional. Therefore the efficacy of the 
cleavage protocol was tested in conjunction with the Asp(ODmbp)-protected peptide 
(64). 
The resin bound peptide (64) was treated with a standard 1.4M HBF 4IT17A/scavenger 
cocktail solution as previously utilised in aforementioned cleavage studies (section 
3.3.3). Under a nitrogen atmosphere, the solution was stirred at 4°C for one hour 
before precipitation of the peptide with diethyl ether. The peptide was isolated by 
centrifugation of the ethereal suspension, and the solid dissolved in 20% acetic acid / 
80% water and eluted through a G25 Sephadex column to provide a scavenger free 
product. The peptide containing fractions were pooled and lyophilised to yield a white 
solid, analysis of the crude product mixture by IHPLC is outlined in figure 18. 
Figure 18. HPLC profile of 1.4MHBF 4 mediated cleavage ofpeptide (64). 
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The constituents of the HPLC trace were isolated by preparative HPLC and analysed 
by FABMS. The main product, peak 3/K  14 minutes, had a mass corresponding to the 
fully deprotected desired peptide, 1763Da. The minor constituents corresponded to 
truncated products, with negligible formation of aspartimide or related products. 
However, the HPLC profile demonstrates a high percentage of truncated peptide 
products, peak 1 / figure 18, obtained upon cleavage with HBF 4 compared to the 
cleavage protocols previously outlined. 
4.5.4 TMSBr Mediated Cleavage of Peptide (64) 
Yajima et at 105)  reported that the cleavage and deprotection of peptides could be 
achieved utilising a 1M trimethylsilyibromide / TFA mediated protocol. 
This protocol involves a hard acid, the trimethyl silyl group in TFA, and a soft 
nucleophile, thioarnsole in the scavenger cocktail. This combination provided a 
method for deprotecting various protecting groups in SPPS. While the cleavage 
protocol deprotected the MBzI group from cysteine, other S-protecting groups such as 
t-Bu or Acm were unaffected. In addition, the quantitative reduction of the Met(0) 
residue provided an excellent alternative orthogonal deprotection strategy. The 
synthesis of Met(0) containing sequences was found to be superior utilising a TMSBr 
mediated deprotection with respect to a standard TEA procedure. 
The synthesis and deprotection of dynorphin, a heptadecapeptide containing an Asp-
Asn sequence which was known to be susceptible to aspartimide formation, was 
undertaken by the Yajima group. The desired peptide was isolated in good yield with 
negligible formation of the aspartimide or related products when a 1M TMSBr / TEA / 
thioanisole deprotection protocol was utilised. 
The efficiency of such a deprotection protocol was therefore tested with respect to the 
Asp(ODmbp) protected peptide (64). 
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The resin bound peptide was stirred in a 1M TMSBr / TFA / scavenger cocktail 
solution (lOmi) for 1 hour at 0°C under an inert atmosphere. The solution was filtered 
and evaporated in vacuo before precipitation by diethyl ether addition. The peptide 
was isolated from the ethereal solution by centrifugation, dissolved in 20% acetic acid / 
80% water and eluted through a G25 Sephadex column. The peptide containing 
fractions were pooled, lyophilised and analysed by HPLC. 
The analysis of the crude peptide products by HPLC and FABMS revealed the main 
product to be the desired filly deprotected peptide, mass 1763 Da. A secondary peak 
was in evidence, which related to 10% of the corresponding Asp(ODmbp) protected 
peptide. There was negligible formation of the aspartimide or related products. 
The incomplete cleavage of the Asp(ODmbp) residue after 1 hour (10% Asp(ODmbp)-
protected peptide) suggests an optimum cleavage time of 2-3 hours, as utilised in the 
aforementioned studies by Yajima 
The compound relating to the desired peptide was purified by preparative HPLC and 
was subjected to classical Edman degradation and analysed by an Applied Biosystems 
477A protein sequencer. The fill eighteen amino acids were sequenced indicating that 
the isolated peptide was the desired a-conformation rather than the rearranged 
adduct resulting from ring opening of the aspartimide. 
4.6 Conclusion 
The 2,4-dimethyl-2,4-bis(4 '-methoxyphenyl)pentan-3-ol can be successfully 
synthesised in 4 steps from the commercially available 4-methoxyphenylacetic acid. 
Esterification to the aspartic acid side chain was achieved by classical DIC 
methodology, and the subsequent formation of the FmocNa  amino acid can be 
achieved without chromatographic purification. 
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The Dmbp protection of the aspartyl side chain completely suppresses the formation of 
aspartimide or related products during Fmoc-based SPPS. 
The protecting ester group may be cleaved by a variety of acidic treatments. The 
utilisation of a low temperature TFMSA protocol or a tetrafluoroboric acid protocol 
provides the fully deprotected peptide in good yield with negligible rearranged by-
products. 
The acid lability of the protecting group in the aforemention cleavage protocols 
suggest a two stage cleavage and deprotection strategy would provide excellent 
results. The author suggests a standard TFA deprotection strategy for resin cleavage, 
followed by a HBF 4 cleavage protocol for 20-30 minutes for total deprotection. 
An alternative to the aforementioned strategy would be a single stage total 
deprotection with TMSBr, which has been shown to cleave the Dmbp group with 
negligible aspartirnide formation. 
The Dmbp group has therefore proven to be an excellent protecting group for the 
aspartyl residue, minimising aspartimide formation during SPPS and deprotection. 
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Chapter 5. Future Work & Recommendations 
5.0 TFA Deprotection Strategy: 
The merits of the 2,2,4,4-tetramethylpent-3-yl (Tmp) and the 2,4-dimethyl-2,4-bis(4'-
methoxyphenyl)pent-3-yl (Dmbp) derivatives have been demonstrated with respect to the 
protection of the side chain of the asp arty! residue. A range of orthogonal deprotection 
strategies have been developed, however to complete the series it would be desirable to 
synthesise a protecting group which possessed the qualities of the aforementioned 
derivatives but which could be cleaved by trifluoroacetic acid. 
This could be achieved by further derivatisation of the groups already synthesised, with 
consideration of the specific requirements needed with respect to the steric and electronic 
factors in the system. Substitution of the aromatic ring with electron donating substituents 
is an essential prerequisite for stabilisation of the carbocation formed by acido!ysis. 
Therefore further substitution of the aryl rings in the Asp(ODmbp) system should result in 
an increase in the acid lability which is sought, although the nature of the substituents must 
be carefully selected. 
The substitution of methyl groups onto the aryl ring would seem the obvious choice. The 
difficulties fronted in the synthesis of the Dmbp derivative suggest the addition of methyl 
groups at the ortho position of the rings would significantly increase the steric interactions 
within the system, proving the synthesis of (65) to be problematic if not impossible. 
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Methyl substitution at the meta positions (66) would not provide the extra cation 
stabilisation expected according to Ramage et a1 0 , the steric interactions between the 
respective methyl and methoxy groups in the system causing the oxygen lone pairs to lie in 
a position such that their availability for delocalisation with the phenyl ring it-system is 
reduced. 
The aforementioned limiting factors therefore suggest that the formation of a furyl ring 
system on the phenyl ring would provide the extra positive inductive effect sought, but 
would also orientate the oxygen lone pairs to provide the maximum delocalisation needed 
for resonance stabilisation and thus anchimeric assisstance. The structures (67) and (68) 
below demonstrate the possible derivatives which could provide a TFA labile deprotection 
strategy: 
It was suggested that the acidolysis of the Asp(ODmbp) ester was not as rapid as initially 
proposed due to steric interactions within the system which prevented maximum 
anchimeric assistance and resonance stabilisation. Therefore it would be interesting to 
synthesise a less sterically constrained system to compare the relative rates of acidolysis. 
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5.1 Histidine Protection 
Protection of the miidazole side chain of histidine during SPPS is a prerequisite, however 
current protocols have their disadvantages. During activation of Naprotected  histidine 
without side chain protection, the lt-nitrogen can serve as a base and abstract the C 
hydrogen, resulting in partial loss of chirality °°7 . 
The introduction of it-nitrogen protecting groups prevents such racemisation, but such 
derivatives are unpopular due to the difficulty in synthesis. The t-nitrogen is significantly 
more reactive as a nucleophile and therefore must be protected before the introduction of 
any it-protecting group 108 . The Bum°09 and Bom" ° groups are examples of it-
protecting groups that are currently used in SPPS, but these derivatives can induce 
methylated or formylated by-products upon acidic cleavage"' 1)• 
The urethane-type protecting groups on the 'v-nitrogen have demonstrated a reduction in 
racemisation, but are susceptible to nucleophilic displacement which can result in 
irreversible termination of synthesis" 12-114) Therefore if the problem of nucleophilic 
sensitivity could be solved, then a urethane-type protecting group would be ideal for 
histidine protection. The extreme stability of the Tmp and the Dmbp derivatives to 
nucleophiles as demonstrated in previous chapters suggest that a corresponding urethane 
derivative could be exploited to protect the histidine side chain. The stability to TFA of 
the Dmbp derivative would provide a convenient orthogonal deprotection strategy in 
conjunction with Fmoc-based SPPS. Structure (70) illustrates the corresponding His 
derivative: 
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CHAFFER 6: EXPERIMENTAL 
6.1 Notes 
All protected amino acids were purchased from Bachem Feinchemikalien AG or were 
synthesised as described in the text, and are of the L-configuration unless otherwise 
stated. All other chemicals used were purchased from Aldrich Chemical Co., Lancaster 
Chemicals or were synthesised as described in the text. All solvents,were distilled before 
use and the following were dried using the reagents given in parenthesis when required: 
tetrahydrofuran (sodium, benzophenone), dicliloromethane (calcium hydride), diethyl 
ether (sodium wire), benzene (sodium wire). Peptide synthesis grade dimethylformamide, 
1,4-dioxan and piperidine were obtained from Rathburn Chemicals, Walkerburn 
Scotland. Peptide synthesis grade trifluoroacetic acid was obtained from Applied 
Biosystems (ABI). High performance liquid chromatography (ITPLC) was carried out 
using either an ABI system, comprising of two 1406A solvent delivery systems, an 
1480A injector / mixer and a 1783A detector / controller, or alternatively a Gilson 
system comprising of two 306 solvent delivery systems, an 81 1C dynamic mixer, an 805 
manometric module, a 119 UV / VIS detector and a Gilson 715 software-driven gradient 
controller. The components were eluted from the following columns: 
: ABI Aquapore RP300 reverse phase silica (300A pore size, 7p1 spherical silica) 
220 x 4.6mm C 18) 
: ABI Aquapore RP300 reverse phase silica (300A pore size, 7il spherical silica) 
110 x 4.6mm C4) 
: Vydac reverse phase silica (5p.l particle size) 250 x 4.6mm C 18 . 
: Vydac reverse phase silica (10t1 particle size) 250 x 22mm C 18 . 
: Hychrom RPB reverse phase silica (300A pore size, 'lpi spherical silica). 
using a linear gradient of acetonitrile (far UV grade, Rathburn Chemicals) in Milli-Q 
grade water, where both solvents contained 0.1% v/v of HPLC grade trifluoroacetic acid 
(Fisons). 
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Melting points were determined using a Koffler hot stage melting point apparatus and are 
uncorrected. Optical rotations were measured on a AA1000 polarimeter (Optical 
Activity Ltd.) using a 10cm cell in the solvent indicated in the text. Ultra-violet spectra 
were recorded on a Varian Cary 210 spectrophotometer in the solvents indicated in the 
text. Infrared spectra were recorded on a Bio-RAD SPC 3200 (FT-IR) 
spectrophotometer. Analytical thin layer chromatography (t.l.c.) was carried out using a 
0.3mm layer of silica (Merck, kieselgel 609) on foil plates in the following solvent 
systems: 
98/8/2, chloroform / methanol / acetic acid 
50/50 ethyl acetate / hexane 
4/1 ethyl acetate / hexane 
4/1 diethyl ether / hexane 
9/1 petrol 40-60 / diethyl ether 
The components were observed with ultra-violet light at 254nni, by reaction with iodine, 
charring of the plate after spraying with ninhydrin for free amines, Mary's spray (4,4'-
bis[dimethylamino]benzhydrol) for carboxylic acids, or 20%sulphuric acid in methanol. 
High and low resolution fast atom bombardment (FAB) spectra were measured on a 
Kratos MS50TC instrument, using either thioglycerol, 3-mtrobenzyl alcohol or glycerol 
as a matrix. Electron impact mass spectra (El MS) were measured on a Kratos 902MS. 
Routine laser desorption time of flight mass spectra were measured on a PerSeptive 
Biosystems LaserTec Benchtop II system. All mass spectrometry were done by 
University of Edinburgh technical staff. Nuclear magnetic resonance (NIVIR) spectra 
were recorded on either a Jeol FX-60 (60MHz), a Bucker WP-200 (200mhz) or a 
Bucker AC-250 (250MiHz) spectrometer in the solvents stated in the text, utilising 
tetramethylsilane (I'MS) as the external standard (wc = 0.0). X-ray structure 
determination was performed by Dr S.Parsons on a Stoe Stadi-4, four circle 
diffractometer equipped with an Oxford Cryosystem variable temperature device, 
graphite monochronmted (Cu-Ku radiation, ?1.54184A). Elemental analyses were 
performed on a Perkin-Elmer 2400CHIN elemental analyser by L.Eades. Amino acid 
analyses were performed on a LKB 4150 alpha amino acid analyser on the hydrolysate 
obtained after heating samples at 110 °C for 24 hours in a sealed Carius tube, followed 
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by evaporation in vacuo to dryness. Peptide sequencing was carried out on an Applied 
Biosystems 477A sequencer at the Welmet sequencing facility, University of Edinburgh. 
6.2 Solid phase peptide synthesis 
The peptides described were synthesised on an Applied biosystenis 430A automated 
peptide synthesiser fitted with a UV monitoring system as described previously. All 
peptides were synthesised using the 9-fluorenylmethoxycarbonyl (Fmoc) strategy of Na 
protection. This incorporates the complementary use of orthogonal acid labile side chain 
protection and an acid labile peptide-resin linker. The following side chain protecting 
groups were used during synthesis : t-butyl esters for aspartic acid; t-butoxycarbonyl 
(Boc) for lysine; t-butyl ethers for tyrosine, threonine and serine; t-triphenylmethyl for 
histidine and acetamidomethyl (Acm) for cysteine. 
6.2.1 Preparation of Fmoc-Amino Acid Resins 
A solution of Fmoc amino acid (lmmol) and N,N'-diisopropylcarbodiiniide (DIC, 
0.5mmol) in DMF (20m1) was stirred for 15 minutes at room temperature, then 4-
alkoxybenzyl alcohol (Wang) resin, crosslinked with 1% divinylbenzene polystyrene 
(flmctionalised as 0.8 mmollg) was added as a pre-swollen suspension in DMF (5m1) 
together with a catalytic amount of 4-(N,N'-dimethylamino)-pyridine. The resultant 
suspension was sonicated for 2 hours. The suspension was filtered and the functionalised 
resin was sequentially washed with DMF, 1,4-dioxan, dichioromethane and diethyl ether 
before being dried in vacuo to yield the Fmoc-amino acid-resin. The loading of the 
functionalised resin was determined by treating 5mg of dried resin with 20% pipendine/ 
80% DMF in a 10 ml volumetric flask, and sonicating the solution for 20 minutes. The 
UV absorbance of the supernatant was then measured at 302nm and the loading 
calculated using the Beer-Lambert law (5302 = 15400 for fülvene-piperidine adduct). 
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6.2.2 Automated Solid Phase Peptide Synthesis 
Synthetic procedures were pre-programmed into an ABI 430A peptide synthesiser prior 
to commencement of the synthesis. The system included an Applied Biosystems 757 
absorbance detector linked to a Hewlett Packard HP3396A integrator for on line 
monitoring of the deprotection profile of the piperidine-dibenzoflilvene adduct which 
allowed monitoring of the synthesis using real-time assessment of the deprotected 
solution at 302mn in a continuous flow mode from the synthesiser to the detector. The 
syntheses were performed using 0.25 mmol of functionalised resin. Amino acids were 
coupled using a single or double couple cycle as described later in the text. 
The synthetic cycle for each amino acid involved three distinct steps incorporating a 
capping procedure to block any unreacted amino groups, a deprotection of the base 
labile Fmoc moiety and then the coupling of the next Na  protected amino acid. 
Therefore the desired sequence of amino acids was built in a stepwise manner from the 
C-terminus to the N-terminus. Each of these individual steps was followed by thorough 
washing of the resin with DIMF. The pre-programmed synthetic cycles are detailed 
below. 
Capping of unreacted N-termini : The resin was vortexed with a solution of acetic 
anhydride (0.5M), DIEA (0.125M) and HOBt (0.2% w/v) in DMF/1,4-dioxan (1:1, 
lOmi) for 10 minutes, before the solution was drained from the vessel and the resin 
washed with 6 portions of DMF: 1,4-dioxan. 
Deprotection of Fmoc : The resin was vortexed with a solution of 20% piperidine in 
DMF/1,4-dioxan (1:1, lOml) for 6 minutes before being drained. An aliquot of this 
deprotection solution was then sent to a UV detector in order to quantify the amount of 
dibenzofulvene-piperidine adduct present and therefore indicating the percentage of 
incorporation of each residue being coupled. This deprotection procedure was repeated 
twice more for 1.5 minute periods in order to establish if complete deprotection of the 
Fmoc had been successful The resin was then washed with 6 portions of DMF/1,4-
dioxan (1:1). 
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3. Coupling of Amino Acids: The coupling of residues on the automated synthesiser 
followed one of two possible methods: 
The HOBt Method : This method involves double couple cycles, the first cycle 
utilises a symmetrical anhydride with the second using a preformed HOBt ester. The 
formation of the symmetrical anhydride resulted from the Fmoc-amino acid (immol) 
reacting with DIC (0.5mmol) in DMF/1,4-dioxan (1:1, 8m1) for 10 minutes before the 
solution was transferred to the reaction vessel containing the resin. The mixture was 
then vortexed for 30 minutes, the resin drained and washed with 4 portions of DMF/1,4-
dioxan (1:1). 
The addition of the preformed Fmoc-amino acid HOBt active ester was initiated before 
the resultant solution was vortexed for a further 30 minutes. The HOBt active ester was 
formed by the reaction of the Fmoc-amino acid (0.5mmol), HOBt (0.5mmol) and DIC 
(0. 5mmol) in an activation vessel 
The resultant resin was drained and washed with 4 portions of DMF/1,4-dioxan (1:1). 
Asparagine, histidine and glutamine were coupled twice as their HOBt esters and glycine 
was coupled once as the symmetrical anhydride. 
The HOCt Method: A single coupling cycle was utilised incorporating the Fmoc-
amino acid HOCt active ester. The protocol used for the HOBt active esters was 
repeated with respect to the HOCt derivative on a immol scale. Histidine coupling was 
performed with the HOBt active ester. 
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4-Chlorotriphenylmethyl alcohol F C191115 CIO 294.78 1 (24) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry diethyl ether (5nil) was added. A solution of 4-
bromochlorobenzene (lOg, 0.05mol) in dry diethyl ether was added dropwise until 5 ml 
had eluted, whereupon rapid stirring induced reflux and the solution became colourless. 
The remainder of the 4- bromochlorobenzene solution was added. The resulting solution 
was stirred until no further exotherm was observed (1 hour). A solution of 
benzophenone (8.6g, 0.05mol) in dry diethyl ether was then added dropwise to the 
resultant solution inducing an exotherm and a red colouration. The solution was 
refluxed for 2 hours, cooled and added to an iced saturated ammonium chloride solution 
and stirred for 12 hours. The organic layer was separated and washed thoroughly with 
water and brine, then dried with anhydrous sodium sulphate. Evaporation in vacuo 
resulted in a yellow oil, crystallisation from diethyl ether / petroleum ether 40-60 yielded 
the title compound ( 3.7g, 25% ) as a white powder, nip. 73.5-75.5 °C ( Found: C, 
78.02; H,5.20. C 19H1500 requires C, 77.42; H, 5.13 ); t.l.c. Rf (D) 0.3; Umax 
(CHBr3)/cm' 3442(OH), 3050 (arom), 1600 (arom), 760 (Cl arom); X, (DCM)/nm 
229,260( E/dm3mor'cm' 13275, 983), H  (200MHz, CDC13) 6.52 (1H, OH), 7.19-7.32 
(1411, m, arom); Sc (200MHz, CDC13) 80.48 (R3cOH),  126.29, 126.67, 126.87 (arom. 
CH), 128.22 (arom CHCC1, 132.40 (quat. arom ); 145.26 (quat. arom CC1); m/z 
(FAB) 277 (M+, -OH), (El) 294 (M), HRMS (El) 294.09207, C 19111500 requires 
294.08114. 
44'-Dichlorotripheny1methyl alcohol I C19H14 0 329.23 1 (25) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry tetrahydrofuran (5ml) was added. A solution of bromobenzene 
(2.7m1, 0.03mol) in dry diethyl ether was added dropwise until 5 ml had eluted, 
whereupon rapid stirring induced reflux and the solution became colourless. The 
remainder of the bromobenzene solution was added. The resulting solution was stirred 
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until no further exotherm was observed (1 hour). A solution of 4,4'-
dichlorobenzophenone (5g,0.02mol) in dry tetrahydrofuran was then added dropwise to 
the resultant solution inducing an exotherm and a red colouration. The solution was 
refluxed for 2 hours, cooled and added to an iced saturated ammonium chloride solution 
and stirred for 12 hours. The organic layer was separated and washed thoroughly with 
water and brine, then dried with anhydrous sodium sulphate. Evaporation in vacuo 
resulted in a yellow oil, crystallisation from diethyl ether / hexane yielded the title 
compound ( 1.7g, 26%) as a white powder, nip. 87-88 °C (lit.87-88'71); ( Found: C, 
69.63; H, 4.56. C 19H14020 calculated is C, 69.32; H, 4.29); t.Lc. R f (D) 0.3; Umax 
(CHBr3)/cm 1 3531 (OH), 3055 (arom), 1600 (arom), 755 (Cl arom); ); A., (DCM)/nm 
230, 276 (c/dm3moF 1 cm' 22664, 1206), 8H (200MHz, CDC1 3) 2.90 (1H, s, OH), 7.20-
7.60 (13H, m, arom); 5 c (200MiHz, CDC13) 80.02 (R3cOH), 126.46, 126.92 (arom. 
cH), 127.99 (arom CHCC1), 132.15 (quat. arom ); 143.65 (quat. arom cCl); 144.79 
(quat. arom QC); m/z (El) 328 (M+), HRMS (El) 328.05438, C 19H14020 requires 
328.04217. 
4g4 ' ,4" - Trichiorotriphenylniethyl alcohol I C19I113C130 363.671 (26) 
A flask containing magnesium turnings (1.9g. 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry diethyl ether (5m1) was added. A solution of 4-
bromochiorobeuzene (lOg, 0.05mol) in dry diethyl ether was added dropwise until 5 ml 
had eluted, whereupon rapid stirring induced reflux and the solution became colourless. 
The remainder of the 4-bromochlorobenzene solution was added. The resulting solution 
was stirred until no further exotherm was observed ( 1 hour ). A solution of 4,4'-
dichlorobenzophenone (13. lg,0.05mol) in dry diethyl ether was then added dropwise to 
the resultant solution inducing an exotherm and a red colouration. The solution was 
refluxed for 2 hours, cooled and added to an iced saturated ammonium chloride solution 
and stirred for 12 hours. The organic layer was separated and washed thoroughly with 
water and brine, then dried with anhydrous sodium sulphate. Evaporation in vacuo 
resulted in a yellow oil, crystallisation from diethyl ether / hexane yielded the title 
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compound ( 4.4g, 23%) as a white powder, nip. 94-95 °C (lit.93.5-94°C45); ( Found: 
C, 62.62; H, 3.51, C 191413030 calculated for C, 62.75; H, 3.60 ); t.l.c. R1 (D) 0.3; Om 
(CHBr3)/cm' 3435 (OH), 3055 (arom), 1600 (arom), 749 (Cl arom); X (DCM)/nm 
230, 268 (c/dm3mor 1 cm 1 18807, 1062), 6H  (200MHz, CDC13) 2.69 (1H, OH), 7.18-7.37 
(1214, m, arom); 8c  (200MHz, CDC13) 79.64 (R3COH), 127.07 , 127.87 (arom. H), 
132.40 (quat.arom. C), 143.19 (quat.arom. CC1); nilz (FAB) 345 (M+, -OH), nilz (El) 
362 (M+), HRMS (El) 362.02095, C 19H13030 requires 362.00320. 
4-Fluorotriphenytmethyl alcohol I C191115F0 278.33 1 (27) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry diethyl ether (5m1) was added. A solution of 4-
bromofluorobenzene (5g, 0.03mol) in dry diethyl ether was added dropwise until 5 ml 
had eluted, whereupon rapid stirring induced reflux and the solution became colourless. 
The remainder of the 4-bromofluorobenzene solution was added. The resulting solution 
was stirred until no further exotherm was observed ( 1 hour ). A solution of 
benzophenone (4.73g,0.03mol) in dry diethyl ether was then added dropwise to the 
resultant solution inducing an exotherm and a red colouration. The solution was 
refluxed for 2 hours, cooled and added to an iced saturated ammonium chloride solution 
and stirred for 12 hours. The organic layer was separated and washed thoroughly with 
water and brine, then dried with anhydrous sodium sulphate. Evaporation in vacuo 
resulted in a yellow oil, crystallisation from diethyl ether I hexane yielded the title 
compound ( 2.3g, 32% ) as a white powder, nip. 115-118 °C (Found: C, 81.81; H, 
5.75. C 9H1 00 requires C, 81.99; H, 5.43 ); t.l.c. R (D) 0.3; Um (CHBr3)/cm' 3473 
(OH), 3050 (arom), 1600 (arom), 759 (CF); X m (DCM)/nm 228, 260 (/dm3mor'cm' 
8274, 903), oH (200MHz, CDC13) 2.9 (1H, s, OH), 6.95-7.85 (141-L m, arom); 0c 
(200Mhz, CDC13) 81.68 (R3çOH), 125.66-127.30 (arom. CH), 142.88 (quat. arom CF); 
m/z (El) 278, FIRMS (El) 278.11009, C 19H15170 requires 278.11069. 
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4,4'-Difluorofriphenylmethyl alcohol I C19R0 296.32 1 (28) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry tetrahydrofuran (5m1) was added. A solution of bromobenzene 
(20g, 0. 13mol) in dry tetrahydrofuran was added dropwise until 5 ml had eluted, 
whereupon rapid stirring induced reflux and the solution became colourless. The 
remainder of the bromobenzene solution was added. The resulting solution was stirred 
until no further exotherm was observed ( 1 hour ). A solution of 4,4'-
difluorobenzophenone (20g,0.08mol) in dry tetrahydrofuran was then added dropwise to 
the resultant solution inducing an exotherm and a red colouration. The solution was 
refluxed for 2 hours, cooled and added to an iced saturated ammonium chloride solution 
and stirred for 12 hours. The organic layer was separated and washed thoroughly with 
water and brine, then dried with anhydrous sodium sulphate. Evaporation in vacuo 
resulted in a yellow oil, crystallisation from diethyl ether / hexane yielded the title 
compound( 9.7g, 39% ) as a white powder, nip. 99-101 °C (lit. 1000C(71)); ( Found: C, 
77.49; H, 4.97. C 19H141720 calculated is C, 77.20; H, 4.76 ); t.l.c. Rç (D) 0.3; Umax 
(CHBr3)/cm 1 3471 (OH), 3050 (arom), 1600 (arom), 757 (F arom); X,, (DCM)/nm 
232, 265 (E/dm3mor 1 cn7 1 8420, 960), 6H (200M&, CDC13) 2.9 (1H, s, OH), 7.0-7.6 
(1311, m., arom); m/z (FAB) 279 (M+, -OH). 
4,4',4"-Trifluorotriphenylmethyl alcohol I C191115F30 314.311 (29) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry tetrahydrofliran (Sml) was added. A solution of 4-
bromofluorobenrzene (3. imI, 0.03mol) in dry tetrahydrofuran was added dropwise until 5 
ml had eluted, whereupon rapid stirring induced reflux and the solution became 
colourless. The remainder of the 4-bromofluorobenzene solution was added. The 
resulting solution was stirred until no further exotherm was observed (1 hour). A 
solution of 4,4'-difluorobenzophenone (4.5g,0.02mol) in dry tetrahydrofuran was then 
added dropwise to the resultant solution inducing an exotherm and a red colouration. 
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The solution was refluxed for 2 hours, cooled and added to an iced saturated ammonium 
chloride solution and stirred for 12 hours. The organic layer was separated and washed 
thoroughly with water and brine, then dried with anhydrous sodium sulphate. 
Evaporation in vacuo resulted in a yellow oil, crystallisation from diethyl ether / hexane 
yielded the title compound ( 1.9g, 28% ) as a white powder, nip. 92.5-93.5 °C 
(lit.94°C 71 ); ( Found: C, 72.38; H, 4.57. C 19H141720 calculated is C, 72.61; H, 4.17 ); 
t1c. Rf (D) 0.3; Um (CHBr3)Icm' 3473 (OH), 3050 (arom), 1600 (arom), 835, 655 (F 
arom); 4a,, (DCM)/nm 230, 263 (c/dm3mol 1 cm' 8298, 946), 6H (200MIFIz, CDC13) 2.9 
(lB. s, OH), 7.0-7.6 (1311, m, arom); m/z (El) 297 (M+, -OH), 314 (M). 
2-Chiorofripheny1inethyl alcohol [C191115C10 294.78 1 (30) 
A flask containing magnesium turnings (1.9g, 0.08mol) and an iodine crystal was flushed 
with nitrogen and dry diethyl ether (Sml) was added. A solution of bromobenzene 
(1.9ml, 0.Olmol) in dry diethyl ether was added dropwise until 5 ml had eluted, 
whereupon rapid stirring induced reflux and the solution became colourless. The 
remainder of the bromobenzene solution was added. The resulting solution was stirred 
until no further exotherm was observed (1 hour). A solution of 2-chlorobenzophenone 
(2g,0.09mol) in dry diethyl ether was then added dropwise to the resultant solution 
inducing an exotherm and a red colouration. The solution was refluxed for 2 hours, 
cooled and added to an iced saturated ammonium chloride solution and stirred for 12 
hours. The organic layer was separated and washed thoroughly with water and brine, 
then dried with anhydrous sodium sulphate. Evaporation in vacuo resulted in a yellow 
oil, crystallisation from diethyl ether / hexane yielded the title compound ( 0.09g, 32%) 
as a white powder, nip. 90-91 °C ( Found: C, 77.59; H, 5.44. C 19H1500 requires C, 
77.42; H, 5.13 ); t.l.c. R (D) 0.4; Um (CHBr3)/cm' 3390 (OH), 3050 (arom), 1600 
(arom), 688 (Cl arom); X (DCM)/nm 226, 266 (E/dn2moF'cm 1 9833, 1311), SH 
(200M&, CDC13) 4.65 (iF!,, OH), 7.2-7.8 (141-1, m, arom); m/z (FAB) 277 (M+, -OH). 
m/z (El) 294 (MH), FIRMS (El) 294.09486, C 191-1 1500 requires 294.08114. 
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2,2'-Dicblorotriphenytmethyl alcohol I C19H14 0 329.23 1 (31) 
Butyl lithium (3m1, Smmol) was injected dropwise to a sealed reaction flask containing a 
solution of bromobenzene (0. 5m1, 5mmol) in dry diethyl ether under a nitrogen 
atmosphere. The resultant reflux ensued for 40 minutes, thereafter the solution was 
cooled to 0 °C. A solution of the 2,2'-dichlorobenzophenone (ig, 4mmol) in dry diethyl 
ether was added portionwise and the resultant solution was stirred for 2 hours at 0 °C, 
before being added to an iced saturated ammonium chloride solution. The solution was 
stirred rapidly for 30 minutes before being extracted with ethyl acetate, and the 
consequent organic layer was washed copiously with water and dried with anhydrous 
sodium sulphate. Evaporation in vacuo afforded an oil which crystallised from 
petroleum ether 40-60 to yield the title compound (913mg,70%) as colourless crystals, 
nip. 98-100 °C; (Found C, 69.28; H, 4.52; C 19H14020 requires C, 69.32; H, 4.29); t.l.c. 
Rf (D) 0.4; Um (CHBr3)/cm-1 3558 (OH), 3050 (arom), 1600 (arom), (DCM)/nm 
226, 266 (e/dm3mol'cm' 9833, 1311), 6H (200MHz, CDC13) 4.78 (1H, OH), 7.2-7.8 
(13H, in, arom); m/z (El) 328 (M'), HRMS (El) 328.05594, C 19H14C1O requires 
328.04217. 
NaBen1oxycarbonylaspartic acid-a-benzvl-1-tripheny1methy1 ester 
Lc381133NQ6 599.7 1 (32) 
Under a nitrogen atmosphere, ZAspOBzl (300mg, 0.8mmol) was dissolved in dry 
dichloromethane (3m1) and triphenylmethyl bromide (136mg,0.4mmol) was added 
resulting in a yellow colouration. After 5 minutes stirring at room temperature 
diisopropylethylamine (50tl) was added resulting in a colourless solution. A further 5 
minutes stirring before addition of diisopropylethylamine (50.tl) and the resultant 
solution stirred for 2 hours at room temperature. Addition of diethyl ether induced a 
precipitate of the DIEA.HBr salt which was removed by centrifugation, ethyl acetate was 
added and the combined organics copiously washed with water, saturated sodium 
bicarbonate solution and brine. The organic layer was dried with anhydrous sodium 
117 
Chapter 6: Experimental 
sulphate and evaporated in vacuo to an off-white solid. Recrystallisation from diethyl 
ether / hexane yielded the title compound (10 1mg, 40%) as a white solid; nip. 77-81 °C; 
(Found C, 76.00; H 5.50; N, 2.02; C 38H33N06 requires C, 76.11; H, 5.55; N, 2.33); t.l.c. 
decomposition; Umax (CHBr3)/cm' 3340 (NH), 3050 (arom), 1725 (CO urethane), 1664 
(CO ester), 750 (arom); H(2OOMHz, CDC1 3) 3.04, 3.06, 3.18 (21-, ddd, CH2), 4.6-4.7 
(IF!. in, NHCH), 5.09 (4H, in, benzylic H), 5.65-5.68 (1H, d, NH), 7.19-7.36 (25H, in, 
arom); 6c (200MHz, CDC13) 37.57 (CH2), 50.45 (N}IcH),  67.02, 67.37 (benzylic C), 
127.12-127.95 (arom), 134.0, 135.99 (quaternary benzylic), 142.64 (trityl arom. 
quaternary), 146.71 (trityl quaternary), 155.88 (NHçO), 168.76 (CO ester), 170.30 (CO 
ester); m/z (FAB) decompositon, 243 (trityl cation). 
Na1Benzvloxycarbonylaspartic acid-a-benzvl-13-(4-chlorotriphenylmethyl) ester 
L.38ll32NQ6CI 634.13 1 (33) 
Under a nitrogen atmosphere, ZAspOBzl (363mg, 1.02mmol) was dissolved in dry 
dichioromethane (3m1) and 4-chiorotriphenylmethyl bromide (250mg,0.7mmol) was 
added resulting in a yellow colouration. After 5 minutes stirring at room temperature 
diisopropylethylamine (lOOp.l) was added resulting in a colourless solution. A further 5 
minutes stirring before addition of diisopropylethylamine (190p1) and the resultant 
solution stirred for 2 hours at room temperature. Addition of diethyl ether induced a 
precipitate of the DIEA.HBr salt which was removed by centrifugation, ethyl acetate was 
added and the combined organics copiously washed with water, saturated sodium 
bicarbonate solution and brine. The organic layer was dried with anhydrous sodium 
sulphate and evaporated in vacuo to an off-white solid. Recrystaffisation from diethyl 
ether / hexane yielded the title compound (283mg, 66%) as a white solid; nip. 89-91 °C; 
(Found C, 73.04; H, 5.56; N, 2.14; C38H33N06 requires C, 71.98; H, 5.09; N, 2.21); t.l.c. 
decomposition; Umax (CHBr3)/cm 1 3340 (NH), 3050 (arom), 1725 (CO urethane), 1664 
(CO ester), 750 (arom); X 1,, (DCM)/nm 235, 258 (c/dm 3moF'cm 1 2112, 1689); 6H 
(200MHz, CDC13) 2.83-3.12 (2H, ddd, 13CH2), 4.65-4.68 (1H, in, NHCH), 5.10 (41t m, 
benzylic H), 5.84-5.87 (1H, d, NH), 7.20-7.43 (241-  in, arom); & (200MHz, CDC1 3) 
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36.25 (CH2), 50.11 (NHCH), 67.11, 67.48 (benzylic C), 81.54 (CAr 3), 127.30-129.20 
(arom), 132.94, 134.89 (quaternary benzylic), 135.78 (trityl arom. quaternary), 145.18 
(trityl arom.quaternary), 146.25 (!QC), 155.92 (NHcO), 170.29 (CO ester), 175.58 (CO 
ester); m/z (FAB) decompositon. 
Jr-Benzvloxycarbonylaspartic acid -a- benz''1 -f- ( 4.4 1-difluorotriphenylmethyl) 
ester[ C38H31NO6 635.66 1 (34) 
Under a nitrogen atmosphere, ZAspOBzl (905mg, 2.5mmol) was dissolved in dry 
dichioromethane (3m1) and 4,4'-difluorotriphenyhnethyl bromide (590mg,1.7mmol) was 
added resulting in a yellow colouration. After 5 minutes stirring at room temperature 
diisopropylethylamine (200p.1) was added resulting in a colourless solution. A further 5 
minutes stirring before addition of diisopropylethylamine (535pi) and the resultant 
solution stirred for 2 hours at room temperature. Addition of diethyl ether induced a 
precipitate of the DIEA.HBr salt which was removed by centrifugation, ethyl acetate was 
added and the combined organics copiously washed with water, saturated sodium 
bicarbonate solution and brine. The organic layer was dried with anhydrous sodium 
sulphate and evaporated in vacuo to an off-white solid. Recrystallisation from diethyl 
ether / hexane yielded the title compound (634mg, 59%) as a white solid; nip. 124-125 
°C; (Found C, 71.77; H, 4.87-, N, 2.13; C38H31NO6172 requires C, 71.80; H,, 4.92; N, 
2.20); t.l.c. decomposition; Um (CHIBr3)Icm' 3337 (NH), 3050 (arom), 1739 (CO 
urethane), 1730 (CO ester), 737 (arom); 7 (DCM)/nm 235, 260 (c/dm 3moPcm 1 2463, 
1800); H  (200MHz, CDC13) 3.05-3.18 (214, ddd, 13CH2), 4.65-4.68 (1H, in, NHCH), 
5.04-5.17 (411, iii, benzylic H), 5.70 (1H d, NH), 6.90-6.99 (4H, m, ortho arom. H) 
7.02-7.34 (2314, in, arom); 6 c (200411z, CDC13) 37.56 (J3CH2), 50.43 (NHCH), 66.96, 
67.40 (benzylic C), 90.17 (cAr 3), 114.41 (CF), 127.46-130.17 (arom), 134.85, 135.88 
(quaternary benzylic), 138.30 (trityl arom. quaternary), 142.40 (trityl 
arom.quatemary),146.44 (CF), 155.81 (NHCO), 168.68 (CO ester), 170.24 (CO ester); 
m/z (FAB) decompositon. 
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Na9_F1uorenyImethoxycarbonylasparticacid_amethyl_6.(2g2 '-dichiorofriphenyl 
methyl) ester F C394QNO6 680.58 1 (38) 
2,2'-Dichlorotriphenylmethyl alcohol (710mg,2.2mmol) was refluxed in a 1:1 dry 
dichioromethane / acetyl bromide (lOmi) solution for 4 hours, before being evaporated in 
vacuo to yield an off-white solid, 850mg. The solid was dissolved in dry 
dichioromethane under a nitrogen atmosphere, to which a solution of FmocAspOMe 
(800mg, 2.2mmol) in dry dichioromethane was added. The solution was stirred at room 
temperature for 5 minutes before addition of DIEA (200pl) and a further 360p.l was 
added 5 minutes later. The resultant solution was stirred for 2 hours at room 
temperature and the precipitate induced was filtered. The ethereal solution was added to 
ethyl acetate and the organics copiously washed with water before being dried with 
anhydrous sodium sulphate. The solution was evaporated in vacuo resulting in an oil 
which crystallised from diethyl ether / petroleum ether 40-60 to afford the title 
compound (900mg,60%) as a white solid, nip. 7 1-75 °C, (Found C, 68.43; H, 4.38; N, 
2.08; C391131NO 602 requires C, 68.83; H, 4.59; N, 2.06); t.Lc. decomposition; 
?(MeOH)/nm 302 (c/dm3mol 1 cm' 7235); Om (CHBr3)/cm' 3332 (NH), 3045 
(arom), 1728 (CO urethane), 1691 (CO ester); 6H(200MIHz, CDC1 3) 3.12-3.42 (211, ddd, 
13CH2), 3.72 (3H, s, 0C113), 4.24-4.43 ( 311, m, Fmoc Cfl/CH), 4.68-4.72 (1H, in, 
NHCH), 5.84-5.88 (1H, d, NH), 5.70 (111, d, NH), 7.15-7.79 (2111, m, arom); & 
(200MHz, CDC13) 36.89 (f3C112), 46.87 (Fmoc CH), 50.09 (NHCH), 52.59 (OC113), 
67.07 (Fmoc CH2), 90.92 (CAr3), 119.80-133.58 (arom), 138.00 (trityl arom. 
quaternary), 138.98 (trityl arom. quatemary), 141.07, 143.55, 143.56 (quaternary 
arom.Fmoc C), 155.87 (NHçO), 169.35 (çO ester), 170.97 (CO ester); m/z (FAB) 
decompositon. 
2,2,4,4-Tetramethylpentan-3-ol I C9UO 144.26 1 (43) 
A flame dried flask containing lithium aluminium hydride in tetrahydrofuran (20ml, 
35mmol) under a nitrogen atmosphere, was diluted by dry tetrahydrofuiran (50m1) and 
cooled to 0 °C. 2,2,4,4-Tetramethylp entan-3- one (5g, 35mmol) was added dropwise 
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over 20 minutes, and the resultant solution refluxed for 4 hours. The solution was 
cooled and added to an iced sodium potassium tartrate solution and stirred for 15 
minutes. The solution was extracted with diethyl ether and the organic layer washed 
copiously with sodium bicarbonate and water, before being dried with anhydrous sodium 
sulphate. Evaporation in vacuo ( without heating ) yielded the title compound (4.1g, 
90%) as a colourless crystalline solid, nip. 42-43 °C; Um (CHBr3)/cm 1 3473 (OH), 
2956 (aliph.C); 6H  (200MHz, CDC13) 0.95 (18H s, tBu x2), 3.0 (111, s, CII);  8c  
(200mhz, CDC13) 28.5 (tBu), 85.6 (cHOH). 
NaBenzvloxycarbonylaspartic acid-a-benzyl-6-(2.2,4,4-teframethylpent-3-yl) ester 
LN6 483.60 1 (44) 
ZAspOBzl (2g, 5.6mmol) was dissolved in dry tetrahydrofuran (20m1), to which a 
catalytic amount of 4-(N,N'-dimethylamino)-pyridine was added and the solution stirred 
at room temperature for 5 minutes. Dicyclohexylcarbodiimide (1.3g, 6.2mmol) was 
added resulting in a precipitate after several minutes, whereupon 2,2,4,4-
tetramethylpentan-3-ol (88 1mg, 6.2mmol) was added. The resultant solution was stirred 
for 6 hours at room temperature before being filtered and the addition of diethyl ether. 
The solution was copiously washed with saturated sodium bicarbonate solution and then 
water, before being dried with anhydrous sodium sulphate. Evaporation in vacuo 
yielded the title compound (2.75g,93%) as a colourless oil, t.l.c.(A) R 2 0.7; [a] 22D +74.5 
(c.1, DCM); Um (neat)/cm' 3350 (NH), 3039 (arom), 1750 (CO ester), 4ax  
(DCM)/nm 227, 258 (E/ 563, 423 dm3mot'cm 1 ); 5H(200MIH7, CDC13) 0.95 (18H,, s, tBu 
x2), 2.95-3.05 (2H, ddd, f3CH2), 4.58 (111, s, COOCH), 4.67-4.68 (1H, m, NHCH), 5.08 
(4H in, benzylic H), 6.01-.04 (1H, d, NH), 7.25-7.3 1 (1OH, in, arom); Sc  (200MHz, 
CDC13) 28.35 (tBu), 36.01 (quat. ester C), 36.50 (IH2), 50.17 (NHCH), 67.03 
(benzylic C), 86.32 (COOcH),  127.5-128.1 (arom), 134.8-135.9 (quaternary benzylic), 
155.6 (NUCO), 170.20 (!CO ester), 170.20 (CO ester); m/z (FAB) 484 (M), HRMS 
(FAB) found 484.26978, C 281138N06 requires 484.26991. 
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Aspartic acid-13-(2,24,4-tetramethylpent-3-yl)ester I C 13 NO, 258.34 1(45 
ZAsp(OTmp)OBzl (1.9g,3.9mmol) was dissolved in 5% acetic acid / 95% ethanol, to 
which 5% palladium supported on charcoal (500mg) was added. The reaction vessel 
was attached to a hydrogen reservoir and the solution was stirred rapidly at atmospheric 
pressure. Complete hydrogen uptake was achieved in 3 hours, whereupon the solution 
was filtered through celite and evaporated in vacuo to yield a colourless gum. 
Trituration with diethyl ether yielded the title compound (920mg, 91%) as a white solid, 
nip. 205-2 10 °C; t.1.c.(A) R f 0.1 (+ve ninhydrinl+ve Kaiser/+ve Marys tests); [a] 22D +16 
(c.l, MeOH); Umax (CIiBr3)/cm' 3350 (NH), 3042 (arom), 1750 (CO ester), 6H 
(2001V11{z, DMSO) 0.95 (1811, s, tBu x2), 3.03-3.05 (214, ddd, 13CH 2), 4.49 (111, s, 
COOCH), 4.14 (111. in, NHCH); 6 c (200MHz, DMSO) 28.53 (tBu), 36.86 (quat. ester 
C), 36.86 (13CH2),  48.44 (NHCH), 86.26 (COOCH), 169.57 (NHçO), 169.85 (CO 
ester), m/z (FAB) 260 (MH); FIRMS (FAB) 260.18637, C 131426N04 requires 260.18618. 
Na_9_Fluorenyhnethoxycarbonylaspartic acid-13-(2,24,4-teframethylpent-3-yI)ester 
Ic2835N06 481.59 1 (46) 
HAsp(OTmp)OH (260mg, 1.Ommol) was dissolved in dioxan / water (4m1, 1:1), to 
which FmocOSu (320mg, 0.9mmol) in dioxan (lml) was added and the suspension was 
stirred for 5 minutes before the addition of potassium hydrogen carbonate (2 10mg, 
2mmol). The resultant solution was stirred for up to 12 hours before being evaporated 
in vacuo. Diethyl ether was added and the organic phase washed with water, the 
resulting aqueous phase was acidified with potassium hydrogen sulphate (2nimol) and 
extracted with ethyl acetate. Analysis by thin layer chromatography indicated the vast 
majority of the desired product was in the diethyl ether fraction. The diethyl ether 
fraction was acidified with potassium hydrogen sulphate and copiously washed with 
water, whereupon it was dried with anhydrous sodium sulphate. The solution was 
evaporated in vacuo to yield an oil which upon trituration with diethyl ether yielded the 
title compound (400mg,90%) in 90% purity. The purity was enhanced by flash 
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chromatography over silica gel,, eluted with 20% ethyl acetate / 80% hexane, and the 
resultant fraction triturated with diethyl ether to yield the title compound (300mg, 70%) 
as a white foam, m.p. 60-65 °C, (Found C, 69.97; H, 7.56; N, 2.63; C28H35N06 requires 
C, 69.83; H, 7.33; N, 2.91); t.l.c.(A) Rf 0.5 (-ye ninhydrinl+ve Marys test); [a] 22D +21 
(c. 1, CHC13); Umax (CHBr3)Icm' 3431 (NH), 1723 (CO ester); 4,,-, (DCM)/nm 229, 268, 
290, 300 (e/ 5852, 17740, 5365, 6096 dm3mor'cm 1 ); SH (200MHz, CDC13) 0.99 (1811, 
s, tBu x2), 2.96-3.13 (2H, ddd, 13CH2), 4.21-.44 (311, m, Fmoc CflICH), 4.62 (111, s, 
COOCH), 4.68 (1H, m, NHCII),  5.88 (111, d, NH), 7.25-.76 (811, in, arom); & 
(200MHz, CDC13) 28.50 (tBu), 36.40 (quat. ester C), 36.80 (f3CH 2), 46.80 (Fmoc dH), 
50.17 (NHCH), 67.30 (Fmoc CH2), 87.30 (COOCH), 119.8-127.6 (arom), 141.1-143.5 
(quat. arom), 156.0 (NIHcO), 170.80 (CO ester), 175.0 (CO ester); m/z (FAB) 482 
(MEl); ITRMS (FAB) 482.25526, C28H36N06 requires 482.25426; m/z (El) 481 (M+), 
HRMS (El) 48 1.24447, C 28H36NO6 requires 48 1.24644. 
2,2.4,4-Tetramethylpent-3-yl hydrocmnamate F C18ll2802 , 276.2 1 (47) 
Hydrocinnamic acid (161mgg, 1. immol) was dissolved in dry tetrahydrofuran (lOmi), to 
which a catalytic amount of 4-(N,N'-dimethylamino)-pyridine was added and the solution 
stirred at room temperature for 5 minutes. Dicyclohexylcarbodiiniide (23 0mg, 1. immol) 
was added resulting in a precipitate after several minutes, whereupon 2,2,4,4-
tetramethylpentan-3-ol (140mg, 0.97mmol) was added. The resultant solution was 
stirred for 12 hours at room temperature before being filtered and diethyl ether added. 
The solution was copiously washed with saturated sodium bicarbonate solution and then 
water, before being dried with anhydrous sodium sulphate. Evaporation in vacuo 
yielded a colourless oil, purification by flash chromatography with elution by 20% ethyl 
acetate / 80% hexane through silica afforded the title compound (174mg, 65%) as a 
colourless oil, t.l.c.(B) Rf 0.7; Um (neat)/cni' 3039 (arom), 2961 (aliph), 1719 (CO 
ester), 8H (200MHz, CDC13) 0.95 (18H, s, tBu x2), 2.67 (21-1, t, CCH 2), 2.98 (2H, t, 
CjCH2), 4.59 (111, s, COOCH), 7.23-7.25 (5H, m, arom); 6 c (200MHz, CDC13) 27.26 
(tBu), 35.63 (quat. ester C), 34.60 (çH2),  84.48 (COOCH), 124.86-127.12 (arom CH), 
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171.28 (CO ester); mlz (FAB) 277 (ML{); ITRMS : Found 277.21582, C 18H2802 
requires 277.21676. 
Synthesis of MS2 phage incorporatmg Asp' 5(OTmp) I C761[121 028, 1761.87 1 (48) 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-AJa-Pro- Ser-Asn-Phe-OH 
The synthesis was initiated with a functionalised FmocPhe-Resin (0.56mmoIIg; 446mg, 
0.25 nimol). All amino acid side chains were protected as previously described except 
Asp 15  which was protected as the 2,2,4,4-tetramethylpent-3-yl ester. All amino acids 
were single coupled as the HOCt treated activated ester. The N-terminal amine 
protecting group, Fmoc, was removed on completion of the assembly phase while the 
reaction vessel was on the automated synthesiser. The resultant fünctionalised resin was 
copiously washed with DMF, 1,4-dioxan, dichioromethane and diethyl ether. 
The resin bound product (50mg) was suspended in a solution of 95% TFA / 5% water 
(lOmi) and stirred vigorously at room temperature for 3 hours. The suspension was 
evaporated in vacuo and filtered into a flask of diethyl ether (lOOmi). The resultant 
precipitate was separated by centrifugation and washed copiously with diethyl ether. 
The resultant white solid was dissolved in 30% acetic acid / 70% water and applied to 
the top of a G25 Sephadex column. The column was eluted with 30% acetic acid / 70% 
water and the peptide containing fractions pooled, analysed by analytical HPLC (column 
E, A=H20, B=CH3CN, 0.1% TFA; imI/min., 5-60% B over 30 minutes, X=214nm). 
The main peak eluting at R 27 minutes (55%B) was isolated and analysed by ToFMS, 
m/z 1889, indicating the peak to be the Asp 15(OTmp)-protected title compound. 
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Treatment of MS2 phage incorporating Asp' 5(OTmp) (48)1 C76B12100 8, 1761.87] 
with 50% piperidine / DMF 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The resin bound product (50mg) was suspended in a solution of 50% piperidine / DMF 
and stirred vigorously for 5 hours at room temperature. The suspension was filtered and 
the resin copiously washed with DMF before being suspended in a 95% TFA / 5% water 
(lOmi) solution and stirred vigorously at room temperature for 3 hours. The suspension 
was evaporated in vacuo and filtered into a flask of diethyl ether (lOOmI). The resultant 
precipitate was separated by centrifugation and washed copiously with diethyl ether. 
The resultant white solid was dissolved in 30% acetic acid / 70% water and applied to 
the top of a G25 Sephadex column. The column was eluted with 30% acetic acid / 70% 
water and the peptide containing fractions pooled, analysed by analytical HPLC (column 
C, A=H20, B=CH3CN, 0.1% TFA; imI/min., 10-90% B over 30 minutes, X214nm). 
The main peak eluting at R 19 minutes (58%B) was isolated and analysed by ToFMS, 
mlz 1889 Da, indicating the peak to be the Asp' 5(OTmp)-protected title compound. The 
pooled fractions were lyophilised to yield 26mg of white solid. The aforementioned main 
peak was isolated by preperative HPLC (column D, AH 20, B=CH3CN, 0.1% TFA; 
9mllmin., 10-90% B over 30 minutes, X=214nm). m/z (FAB) 1889, HRMS: found 
1889.2213, C 85H139N20028 requires 1889. 1579. 
Treatment of MS2 phage incorporating Asp' 5(OTmp) (48)1 C76H12100 8, 1761.871 
with TFA / TFMSA 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The resin bound product (50mg) was suspended a scavenger cocktail of thioamsole / 
EDT / m-cresol (100.tl,, 100t1 200p.l) and stirred vigorously at -15 °C for 10 minutes 
under a nitrogen atmosphere. TFA (imi) was added and then TFMSA (lOOtl) and the 
resultant solution stirred vigorously for 90 minutes before being filtered into a flask of 
diethyl ether (lOOmi). The resultant precipitate was separated by centrifugation and 
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washed copiously with diethyl ether. The resultant white solid was dissolved in 30% 
acetic acid / 70% water and applied to the top of a G25 Sephadex column. The column 
was eluted with 30% acetic acid / 70% water and the peptide containing fractions 
pooled, analysed by analytical HPLC (column E, A=H 20, B=CH3CN, 0.1% TFA; 
lmllmin., 5-60% B over 30 minutes, X=214nm), The main peak eluting at R 1 20.5 
minutes (42%B) was isolated and analysed by ToFMS, m/z 1763, indicating the peak to 
be the completely deprotected title compound. The pooled fractions were lyophilised to 
yield 23mg of white solid. The aforementioned main peak was isolated by prep erative 
HPLC (column D, A=H20, B=CH3CN, 0.1% TFA; 9m1/min., 10-90% B over 30 
minutes, ?=214nm). m/z (FAB) 1762 (M 4), HRMS: found 1762.87127, C76H121N20028 
requires 1762.86927; amino acid analysis :Asx 4 3.8 1, Thr2 2.06, Ser 1 1.04, Pro 1 1.21, 
G1y3 2.94, Ala 1 1.08, VaL 3.94, Leu 1 1.06, Phe 1 0.88. 
Treatment of MS2 phage incorporating Asp' 5(OTmp) (48I Cfl1210Q 8 , 1761.871 
with TFA / ffBF4 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The resin bound product (30mg) was suspended a scavenger cocktail of thioamsole / 
EDT / m-cresol (1 .6m1, 200 p1, 200g1) and stirred vigorously at 4°C for 10 minutes under 
a nitrogen atmosphere. TFA (2.4m1) was added and then 1.4M HBF 4-diethyl ether 
complex (500tl) and the resultant solution stirred vigorously for 60 minutes before being 
filtered into a flask of diethyl ether (lOOmi). The resultant precipitate was separated by 
centrifugation and washed copiously with diethyl ether. The resultant white solid was 
dissolved in 30% acetic acid / 70% water and applied to the top of a G25 Sephadex 
column. The column was eluted with 30% acetic acid / 70% water and the peptide 
containing fractions pooled, analysed by analytical HPLC (column C, A=H 20, 
BCH3CN, 0.1% TFA; lml/min., 10-90% B over 30 minutes, X=214nni), The main peak 
eluting at R1 15.6 minutes (45%B) was isolated and analysed by ToFMS, m/z 1763, 
indicating the peak to be the completely deprotected title compound. The pooled 
fractions were lyophilised to yield 15mg of white solid. The aforementioned main peak 
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was isolated by preperative HPLC (column D, A=H 20, B=CH3CN, 0.1% TFA; 9m1/min., 
10-90% B over 30 minutes, 2214nm). m/z (FAB) 1763, HRMS: found 1762.9900, 
C76171121N20028 requires 1762.9149; amino acid analysis :Asx 4 3.8 1, Thr2 2.06, Ser i 1. 04, 
Pro 1 1.21, G1y3 2.94, Ala 1 1.08, VaL1 3.94, Leu 1 1.06, Phe 1 0.88. 
Synthesis of MS2 phase incorporating Asp' 5(OtBu) I C76fl12108, 1761.871 
(48.5) 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The synthesis was initiated with a flinctionalised FmocPhe-Resin (0.56mmolIg; 446mg, 
0.25 mmol). All amino acid side chains were protected as previously described. All 
amino acids were single coupled as the HOCt treated activated ester. The N-terminal 
amine protecting group, Fmoc, was removed on completion of the assembly phase while 
the reaction vessel was on the automated synthesiser. The resultant fimctionalised resin 
was copiously washed with DMF, 1,4-dioxan, dichloromethane and diethyl ether. 
The resin bound product (50mg) was suspended a scavenger cocktail of thioanisole / 
EDT / m-cresol (100d, 100il, 200p.l) and stirred vigorously at room temperature for 10 
minutes under a nitrogen atmosphere. TFA (imi) was added and then TFMSA (lOOpl) 
and the resultant solution stirred vigorously for 60 minutes before being filtered into a 
flask of diethyl ether (lOOml). The resultant precipitate was separated by centrifugation 
and washed copiously with diethyl ether. The resultant white solid was dissolved in 30% 
acetic acid I 70% water and applied to the top of a G25 Sephadex column. The column 
was eluted with 30% acetic acid / 70% water and the peptide containing fractions 
pooled, analysed by analytical HPLC (column E, A=H 20, B=CH3CN, 0.1% TFA; 
imI/min., 5-60% B over 30 minutes, ?=214nm), There were two major components; one 
peak eluting at R1 23.1 minutes (47%B) was isolated and analysed by ToFMS, m/z 1763, 
indicating the peak to be the completely deprotected title compound The second peak 
eluted at R1 23.3 minutes (48%B) was isolated and analysed by ToFMS, m/z 1746, 
indicating the peak to be the corresponding aspartiniide derivative of the title compound 
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Synthesis of N-terminal ferrodoxin incorporating Asp 11 ' 13(OTmp) [C76H,210Q 81 
2133.12 1 (49) 
H-Ala- Ser-Tyr-Lys-Val-Thr-Leu-Lys-Thr-Pro-Asp 1 '-Gly-Asp 13-Asn-Val-lle-Thr-Val-
Pro-Asp-NH2 
The synthesis was initiated with a functionalised FmocAsp-dibenzosuberyl amide Resin 
(0.56mmoIIg; 446mg, 0.25 mmol). All amino acid side chains were protected as 
previously described except Asp" and Asp 13  which were protected as the 2,2,4,4-
tetramethylpent-3-yl esters. All amino acids were single coupled as the HOCt preformed 
activated ester. The N-terminal amine protecting group, Fmoc, was removed on 
completion of the assembly phase while the reaction vessel was on the automated 
synthesiser. The resultant functionalised resin was copiously washed with DMF, 1,4-
dioxan, dichioromethane and diethyl ether. 
The resin bound product (50mg) was suspended a scavenger cocktail of thioanisole I 
EDT / m-cresol (0.8m1, 200d, 200tl) and stirred vigorously at 4°C for 10 minutes under 
a nitrogen atmosphere. TFA (2.4m1) was added and then 0.7M HBF 4-diethyl ether 
complex (250.il) and the resultant solution stirred vigorously for 60 minutes before being 
filtered into a flask of diethyl ether (1 OOml). The resultant precipitate was separated by 
centrifugation and washed copiously with diethyl ether. The resultant white solid was 
dissolved in 30% acetic acid / 70% water and applied to the top of a G25 Sephadex 
column. The column was eluted with 30% acetic acid / 70% water and the peptide 
containing fractions pooled, analysed by analytical HPLC (column C, A=H 20, 
B=CH3CN, 0.1% TEA; imI/min., 10-90% B over 30 minutes, ?=214nm), There were 5 
peaks which eluted, these were isolated and analysed by ToEMS, indicating the peaks to 
be the Asp protected and deprotected title compounds. The pooled fractions were 
lyophilised to yield 14mg of white solid. The aforementioned peaks were isolated by 
preperative HPLC (column D, A=1120, B=CH3CN, 0.1% TEA; 9m1/min., 10-90% B 
over 30 minutes, 2=214nm). 
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Peak 1. 3-peptide m/z (FAB) 2134 (MM, HRMS: found 2133.12170, C 94H155N24032 
requires 2133. 12728. 
Peak 2. Aspartimide m/z(FAB) 2115, HRMS: found 2115.11760, C94H153N24031 
requires 2115.11672 
Peak 3. cc-peptide m/z(FAB) 2132 (M+), HRMS: found 2133.1215 1, C 94H155N24032 
requires 2133.12728. 
Peak 4. Asp(OTmp)-peptide mlz (FAB) 2258 (M+), HRMS: found 2259.27604, 
C 103H173N24032 requires 2259.268 13 
Peak 5. BisAsp(OTmp)-peptide m/z (T0F) 2384.85 (M),(FAB): found 2374, 
C 112H191N24032 requires 2384.4055. 
Peak 3 was submitted for amino acid analysis : Asx 4 4.16, Thr3 3.20, Ser i 1.03, Pr02 
2.3 1, G!y i 1. 14, Ala 1 1. 16, Va!3 3.17, 11e 1 0.77, Leu 1 1. 10, Tyr i 0.99, Lys2 2.22. 
All 20 of the amino acid residues were sequenced by Edman degradation and found to be 
in agreement with the required sequence of the a—peptide. 
2-Methyl-2,4-diphenylpentan-3-one I C1800 .252.36 1 (52) 
Under an dry argon atmosphere, potassium tert-butoxide (8.3g, 70mmol) was suspended 
in dry tetrahydrofuran and cooled to -78 T. 'Butyl lithium (37m], 70mmol) was then 
added dropwiseand the solution stirred for 10 minutes at -78 T. Whereupon a solution 
of 1,3-diphenylpropan-2-one (4g, 19mmol) dissolved in iodomethane (12.5m1,0.2mol) 
was added dropwise over 20 minutes, resulting in an evolution of gas, and the solution 
became red before turning to an off-white colour. The solution was allowed to warm to 
room temperature and stirred for 3.5 hours, and then added to iced water solution and 
extracted with pentane x 3. The organic phase was copiously washed with water and 
dried with anhydrous sodium sulphate, and evaporated in vacuo to a yellow oil which 
solidified on scratching. Recrystaffisation from absolute ethanol yielded the title 
compound (4. lg,85%) as a white crystalline solid, nip. 54-56 °C, (Found C, 85.31; H, 
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8.24; C 18H200 requires C, 85.67; H, 7.99); t.1.c.(E) Rf 0.5 ; Umax (CHBr3)1cm 1 3050 
(arom), 2950 (aliph), 1707 (CO); X T (DCM)lnm 229, 260 (El 5156, 586 dm3mor'cm 1 ); 
6H (200MIHZ, CDC13) 1.23 (3H, d, CHC), 1.38 (3H s, CH), 1.50 (3H s, C), 3.80 
(111, q, C113CH), 7.02-7.21 (10H, in, arom); öc (200MHz, CDC1 3) 21.68 (çH3), 24.31 
(CH3), 25.53 (CH3), 47.33 (!CH), 53.11 (C(CH 3)2), 126.40-128.47 (arom CH), 141.57 
(quat. arom Q, 142.92 (quat. aroni ), 213.32 (CO); m/z (El) 252.0; HRMS : Found 
252.15 183 C 18H200 requires 252.15 142. 
2 g4-Dilflethyl-2,4-diphenylpentan-3-one [C 19fl 2O , 266.38 1 (53) 
Sodium hydride (480mg, 12mmol) was suspended in dry tetrahydrofuran in a flame dried 
flask under an argon atmosphere. The 1,3-cliphenylpropan-2-one (500mg, 2.4mmol) was 
dissolved in iodomethane (l.Oml, 16mmol) and added dropwise over 15 minutes at room 
temperature to the sodium hydride suspension. The yellow suspension turned to a milky 
white after 15 minutes and the resulting solution was refluxed (bath T=90 °C) for 12 
hours. After one hour had passed iodomethane (0.5m1, 8mmol) was again added. The 
solution was cooled and added to an iced water solution and extracted with pentane. 
The organic phase was copiously washed with water and dried with anhydrous sodium 
sulphate, evaporation in vacuo to give a crystalline solid within a yellow oil. The 
suspension was washed with petroleum ether 40-60 and recrystallisation from absolute 
ethanol yielded the title compound (64mg, 10%) as a colourless crystalline solid, nip. 
110-111 °C, (Found C, 85.77; II, 8.22; C 19II220 requires C, 85.67; H, 8.32); t.l.c.(E) R f 
0.4 ; Umax (CHBr3)/cm' 3050 (arom), 2950 (aliph), 1682 (CO); max  (DCM)/nm 229, 260 
(l 5789, 430 cIm3mor'cm'); 6H  (200MIIIz, CDC13) 1.27 (12H s, CH3 x 4), 7.16-7.27 
(1011, in, arom); 8c (200Mhz, CDC1 3) 27.74 (CH3), 52.85 (C(CH3)2), 125.68 (arom 
CH), 126.29 (arom CH), 128.23 (arom CH), 144.23 (quat. arom ), 213.21 (CO); 
GCMS 266 (M) 
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2-Methyl-2.4-diphenylpentan-3-ol I C18ff20 , 254.361 
Lithium aluminium hydride (1.2g, 32mmol) was suspended in dry tetrahyrofuran (30m1) 
in a flame dried flask under an argon atmosphere. A solution of 2-methyl-2,4-
diphenylpentan-3-one (2g, 8mmol) dissolved in thy tetrahydrofuran was added dropwise 
over a period of 10 minutes with rapid stirring. On total addition of the ketone, the 
solution was heated to reflux for 4 hours, before being cooled. The grey suspension was 
added to an iced aqueous solution of sodium potassium tartrate and stirred for 30 
minutes, whereupon it was extracted with pentane. The organic phase was copiously 
washed with water and dried with anhydrous sodium sulphate, evaporation yielded the 
title compound (1.4g, 70%) as a colourless oil t.l.c.(E) R f 0.3 ; Um (neat) /cm' 3485 
(OH), 3056 (arom), 2971 (aliph), 1598 (arom); Am (DCM)/nm 230, 263 (s/dm 3mor 1 cm 
1 4876,  580); 6(200MHz, CDC13) 1.07 (3H, d, CHCII),  1.27 (3H, s, Cfl),  1.29 (3H s, 
CH3), 2.82 (1H in, OH), 3.76 (1H, q, CH3CH), 3.91 (1H, d, CHOH),  7.18-7.45 (1OH, 
m, arom); 6c (200MHz, CDC13) 21.85 (çH3),  22.08 (CH3), 27.26 (çH3),  42.25 
(CH3CH), 67.82 (C(CH3)2), 82.86 (CHOH), 125.80-128.57 (arom CH), 144.17 (quat. 
arom C), 144.97 (quat. arom C), 213.32 (CO); m/z (FAB) 237 (M, -OH); HRMS 
Found 237.16463 C 18H21 requires 237.16433 (M, -OH). 
13-Bis(4 1-methoxyphenyl)propan-2-one I C1 H 803 , 270.33 1 (54) 
4-Methoxyphenylacetic acid (5g. 30mmol) was dissolved in an aqueous solution of 
sodium carbonate (3.2g, 30mmol), whereupon a solution of manganese chloride 
tetrahydrate (6g, 30.6mmol) in water (20m1) was added dropwise. The solution was 
stirred at room temperature for 30 minutes before the resulting precipitate was filtered 
and copiously washed with water. The off-white solid was dried in vacuo at 80 °C and 
was placed in a 50 ml flask attached to a Claisen still head and vaccuum adapter 
incorporating a collecting flask which was submerged in liquid nitrogen. The flask was 
heated to 200-250 °C at Ca. 0.5 Ton for 4 hours which resulted in a yellow crystalline 
solid distilling into the collection flask. Recrystaffisation from absolute ethanol yielded 
131 
Chapter 6: Experimental 
the title compound (2.4g, 60%) as a white crystalline solid, nip. 84-85 °C (lit.86-
8700 100 ; (Found C, 75.49; H, 6.51; C 17H1803 calculated for C, 75.53; H, 6.71); t.l.c.(C) 
Rf 0.25 Umax (CHBr3)1cm 1 3050 (arom), 1715 (CO); ? (DCM)/nm 234, 278 (El 
14820, 3360 dm3mor 1 cm 1 ); 8H  (200MEIz, CDC13) 3.65 (411, s, a CH2  x2), 3.79 (6H, s, 
OC x 2), 6.84-7.10 (811, dd, arom); c  (200MiHz, CDC13) 46.65 (CH2), 53.88 
(OCH3), 112.84 (arom CH), 124.83 (quat. arom Q, 129.22 (arom CH), 157.40 (quat. 
arom COCH3), 205.25 (CO); m/z (El) 270 (M) HRMS (El) Found 270.12488; C 17H1803 
calculated for 270. 12559. 
2-Methyl-2.4-bis(4 1-methoxyuhenyl)pentan-3-one I C2oll03, 312.411 (55) 
Under an dry argon atmosphere, potassium tert-butoxide (8.3g, 0.07mol) was suspended 
in dry tetrahydrofuran and cooled to -78 °C. 'Butyl lithium (37m1, 0.07mol) was then 
added dropwise and the solution stirred for 10 minutes at -78 T. Whereupon a solution 
of 1, 3 -bis(4 '-methoxyphenyl)propan-2-one (4g, 1 Smmol) dissolved in iodomethane 
(10mI,0. lSmol) was added dropwise over 20 minutes, resulting in an evolution of gas 
and a red colouration, before turning to an off-white colour. The solution was allowed 
to warm to room temperature and stirred for 3.5 hours, and then added to iced water 
solution and extracted with pentane x 3. The organic phase was copiously washed with 
water and dried with anhydrous sodium sulphate, and evaporated in vacuo to a yellow oil 
which solidified on scratching. Recrystaffisation from absolute ethanol yielded the title 
compound (4g,85%) as a white crystalline solid, nip. 67-68 °C, (Found C, 76.66; H, 
7.78; C20H2403 requires C, 76.89; H, 7.74); t.l.c.(C) R f 0.6 ; Umax (CHBr3)/cm' 3050 
(arom), 2950 (aliph), 1705 (CO); X,ax (DCM)lnm 235, 278 (cl 16380, 3380 dm3mor'cm 
) H (200MHz, CDC13) 1.23 (311, d, CHC), 1.34 (311, s, Cj), 1.45 (311, s, Crn), 
3.75 (311, s, OCfl),  3.80 (311, s, OC), 6.65-7.21 (811, m, arom); c (200MHz, CDC1 3) 
2 1.5 9 (CH3),24.48 (çH3),  25.53 (CH3), 46.10 (CH), 52.23 (c(CH3)2), 55.04 (OC143), 
55.13 (Oc113), 113.48 (aromçH), 113.74 (aromCH), 127.57 (aromCH), 128.43 (arom 
CH), 133.76 (quat. arom Q, 135.00 (quat. arom C), 158.05 (arom COCH 3), 158.32 
132 
Chapter 6: Experimental 
(arom COCH3), 213.87 (CO); GCMS 312 (M), m/z (El) 312 (M), HRMS : Found 
3 12.17279, C20H2403 requires 312.17254. 
2,4-Diniethyl-2,4-bis(4 1-methoxy phenyl)pentan-3-one I C21603 , 326.44 1 (56 
Sodium hydride (400mg, l6mmol) was suspended in dry tetrahydrofitran in a flame dried 
flask under an argon atmosphere. The 1, 3-bis(4'-methoxyphenyl)propan-2- one (900mg, 
3.3mmol) was dissolved in iodomethane (imi, l6mmol) and added dropwise over 15 
minutes at room temperature to the sodium hydride suspension. The yellow suspension 
turned to a milky white after 15 minutes and the resulting solution was refluxed (bath 
T=90 °C) for 12 hours. After one hour had passed iodomethane (Ind, l6mmol) was 
again added. The solution was cooled and added to an iced water solution and extracted 
with pentane. The organic phase was copiously washed with water and dried with 
anhydrous sodium sulphate, evaporation in vacuo to give a crystalline solid within a 
yellow oil. The suspension was washed with petroleum ether 40-60 and recrystallisation 
from absolute ethanol yielded the title compound (120mg, 11%) as a colourless 
crystalline solid, nip. 142-145 °C, (Found C, 77.33; H, 8.15; C21H2603 requires C, 
77.27; H, 8.03); t.l.c.(C) R f 0.6 ; Dm (CHBr3)/cm' 3050 (arom), 2950 (aliph), 1682 
(CO); 4 a., (DCM)/nm 235, 278 (El 17052, 3176 dm3mor 1 cm'); 6H  (200Mhz, CDC13) 
1.23 (12H, s, C x 4), 3.78 (6H, s, OCII  x 2), 6.77-7.11 (8H, d, arom); Sc  (200Mhz, 
CDC13) 27.85 (H3), 51.99 (ç(CH3)2), 55.04 (OCH3), 113.43 (arom CH), 126.80 (arom 
CH), 136.33 (quat. arom C), 157.89 (arom COCH 3), 213.55 (CO); m/z (GCMS) 326 
(M), (El) 326 (M), FIRMS: Found 326.18745, C 21H2603 requires 326.18819. 
Attempted Synthesis of 2,4.-Dimethyl-2,4-diphenylpentan-3-one 
Method A 
Potassium hydride (8mmol) was suspended in dry tetrahydrofuran in a flame dried flask 
under an argon atmosphere. The 2-methyl-2,4-diphenylpentan-3-one (0.5g, 2mmol) was 
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added dropwise over 15 minutes at room temperature to the potassium hydride 
suspension. Then a solution of 18-crown-6 (529mg,2mmo1) dissolved in dry THF was 
added to the yellow suspension and the resulting solution stirred for 10 minutes before 
the addition of iodomethane (0.6m1, lOmmol). The resultant solutuion was refluxed 
(bath T90 °C) for 10 hours. After one hour had passed iodomethane (0.6m1, lOmmol) 
was again added. After the 10 hours the solution was cooled and added to an iced water 
solution and extracted with pentane. The organic phase was copiously washed with 
water and dried with anhydrous sodium sulphate, evaporation in vacuo to give a 
crystalline solid. Reciystaffisation from absolute ethanol yielded the title compound 
(480mg), 90% yield. 
Method B 
The 1,3 -diphenylpropan- 3- one (500mg, 2.4mmol) was dissolved in iodomethane (1.5m1, 
24mmol) and added to a suspension of potassium hydroxide (2.7g, 48mmol) in DMSO 
(30m1). The solution was vigorously stirred at 50-60 °C until an exotherm ensued, which 
resulted in the reaction mixture being maintained within this temperature range without 
external heating. The solution was stirred for 1 hour after the addition before being 
added to lOOmI of ice water. The product was extracted with pentane and washed 
copiously with water befor being dried with anhydrous sodium sulphate. Evaporation of 
the solvent in vacuo yielded the title compound as an oil. 
GCMS 2-Methyl-2,4-diphenylpentan-3-one 88% 
Method C: 
The crude product from procedure B was treated once again utilising the potassium 
hydroxide / DMSO protocol outlined above to investigate if permethylation ensued after 
repeated applications. 
GQMS: 2-Methyl-2,4-diphenylpentan-3-one 88% 
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Method D: 
Potassium tert-butoxide (2.7g, 24mmol) was suspended in dry benzene in a flame dried 
flask under an argon atmosphere. The 1,3-diphenylpropan-2-one (0.5g,2.4mmol) was 
dissolved in iodomethane (1. 5m1, 24mmo1) and added dropwise over 15 minutes at room 
temperature to the suspension. the resulting solution was refluxed (bath T=90 °C) for 12 
hours. After one hour had passed iodomethane (0. 15ml, 2.4mmol) was again added. On 
completion of the 12 hours the solution was cooled and added to an iced water solution 
and extracted with pentane. The organic phase was copiously washed with water and 
dried with anhydrous sodium sulphate, evaporation in vacuo to give an oil. 
GCMS: 	2-Methyl-2,4-diphenylp entan- 3- one 90% 
2,4-Dimethyl-2,4- diphenylp entan- 3 -one 8.5% 
Method E: 
Sodium hydride (480mg, 12mmol) was suspended in dry tetrahydrofliran in a flame dried 
flask under an argon atmosphere. The 1,3-thphenylpropan-2-one (500mg, 2.4nimol) was 
dissolved in iodomethane (1.0m1, 16mmol) and added dropwise over 15 minutes at room 
temperature to the sodium hydride suspension. The yellow suspension turned to a milky 
white after 15 minutes and the resulting solution was refluxed (bath T=50 °C) for 12 
hours. After one hour had passed iodomethane (0.5m1, 8mmol) was again added. The 
solution was cooled and added to an iced water solution and extracted with pentane. 
The organic phase was copiously washed with water and dried with anhydrous sodium 
sulphate, evaporation in vacuo yielded a yellow oil. 
GCMS: 	2-Methyl-2,4-cliphenylpentan-3-one 70% 
2,4-Diphenylpentan-3-one 30% 
2g4Dimethyl2g4bis(4 1-methoxyphenyl)penthn-3ol [C218O3, 328.451 (57) 
Lithium aluminium hydride (83 5mg, 22mmol) was suspended in dry tetrahyrofuran 
(30ml) in a flame dried flask under an argon atmosphere. A solution of 2,4-dimethyl-2,4-
bis(4 '-methoxyphenyl)pentan-3-one (1.8g, 5. 5mmol) dissolved in dry tetrahydrofitran 
was added dropwise over a period of 10 minutes with rapid stirring. On total addition of 
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the ketone, the solution was heated to reflux for 4 hours, before being cooled. The grey 
suspension was added to an iced aqueous solution of sodium potassium tartrate and 
stirred for 30 minutes, whereupon it was extracted with pentane. The organic phase was 
copiously washed with water and dried with anhydrous sodium sulphate, evaporation in 
vacuo yielded an off-white solid. Recrystallisation from absolute ethanol afforded the 
title compound (1.6mg, 88%) as a white crystalline solid, nip. 78 °C, (Found C, 76.59; 
H, 8.39; C21 H2803 requires C, 76.79; H, 8.59); t.l.c.(E) R1 0.3; Um (neat) /cm' 3582 
(OH), 3021 (arom), 2971 (aliph), 1608 (arom); 4. (DCM)/um 233, 276 (s / 13138, 
3102 dm3mor'cm'); H  (200MiHz, CDC13) 1.12 (6H, s, Cflx2), 1.23 (6H, s, CH x2), 
3.80 (6H s, OC), 3.83 (1H, s, CHOH),  6.83 (4H d, arom), 7.28 (4H, d, arom); & 
(200MHz, CDC13) 21.85 (CH3), 22.08 (CH3 ), 27.26 (CH3), 42.25 (CH3CH), 67.82 
(C(CH3)2), 82.86 (CHOH), 125.80-128.57 (arom CH), 144.17 (quat. arom C), 144.97 
(quat. arom C), 213.32 (CO); m/z (FAB) 328 (M); HRMS Found 328.20525C21112303 
requires 328.20385. 
2-Methyl-34-bis(4'-methoxyphenyl)pent-l-ene F C2ofl0 , 296.4 1 (59) 
Under an argon atmosphere, 2-methyl-2,4-bis(4 '-methoxyphenyl)pentan-3-ol (520mg, 
1.7mmol) was dissolved in HMPT and the solution heated to reflux (240 °C) for 10 
minutes. The solution was then cooled to 210 °C and stirred for 30 minutes, whereupon 
it was cooled to 0°C and pentane added. The solution was copiously washed with brine 
and water before being dried with anhydrous sodium sulphate and evaporated in vacuo 
to yield an orange oil. Scratching induced solidification and reciystaffisation from 
absolute ethanol yielded the title compound (443mg, 90%yield) as white crystalline 
needles, nip. 95-96 °C, (Found C, 80.86; H, 8.12; C 20H2402 requires C, 81.04; H, 8.16); 
t.l.c.(E) R1 0.4; Um (neat) /cm' 3021 (arom), 2971 (aliph), 1644 (olefin); 5H (200MHz, 
CDC13) 1.00 (3H, d, CHCII),  1.49 (311, s, CflCCH2), 3.20 (II-T, m, CHCH3), 3.37 (IH, 
d, CJJA.r), 3.79 (314, s, 0C113),  3.80 (311, s, OCfl),  4.57 (lIT, s, CCH), 4.73 (lIT, s, 
CCII), 6.81-7.25 (8H, m, arom); 6c (200MiHz, CDC1 3) 20.95 (cH3),  22.32 (CH3), 41.18 
(CH3CH), 55.08 (OCH3), 59.24 (ArCH), 111.43 (CCH2),113.44 (arom), 128.03-129.08 
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(aromCH), 134.62 (quat. aromC), 138.63 (quat. aromC), 146.99 (quat. CCH 2), 157.44 
(quat. arom cOCH3) 157.94 (quat. arom cOCH 3); m/z (El) 296.2 (M); FIRMS : Found 
297.18620, C201-12502 requires 297.18546. 
NaBenzvloxycarbonyIaspartic acid-a-benzvl-13-(24-dimethyl-2,4-bis 
(4'-methoxyphenyl)pent-3-0) ester I C40HNO8 665 1 (60) 
ZAspOBzl (2g, 5.6mmol) was dissolved in dry tetrahydrofliran (30m1), to which a 
catalytic amount of 4-(N,N'-dimethylamino)-pyridine was added and the solution stirred 
at room temperature for 5 minutes. Diisopropylcarbodiimide (970tl, 6.2mmol) was 
added followed by 2,4-dimethyl-2,4-bis(4 '-methoxyphenyl)pentan-3-ol (2g, 6. 2mmol). 
The resultant solution was stirred for 6 hours at room temperature before being filtered 
and the addition of diethyl ether. The solution was copiously washed with saturated 
sodium bicarbonate solution and then water, before being dried with anhydrous sodium 
sulphate. Evaporation in vacuo yielded the title compound (3.5g. 93%) as a colourless 
oil,, t.l.c.(A) Rf 0.7; Um (neat)/cm' 3364 (NH), 3054 (arom), 1728 (CO ester); 6H 
(200MHz, CDC13) 1.06 (6H, s, CH x2), 1.09(311, s, Cfl3), 1.11 (3H, s, Crn),  2.93-3.22 
(2H, ddd, f3CH2), 3.75 (3H, s, OCj), 3.79 (3H, s, 0C113), 4.73 (lH, m, NHCH), 5.24 
(411, m, benzylic H), 5.52 (1H, s, COOCII),  5.90 (1H, d, NH), 6.77-7.41 (8H, m, arom); 
c (200MHz, CDC13) 25.04 (çH3), 25.42 (CH3), 28.29 (CH3), 29.11 (CH3), 36.03 
(3CH2), 42.08 (quat. CH3)2), 50.13 (NHCH), 66.64 (benzylic CH2), 67.11 (benzylic 
CH2), 86.52 (COOCH), 112.76 (aryl !CH), 127.43-128.20 (benzylic arom. CH), 134.89 
(quat. benzylic arom.), 135.93 (quat. benzylic arom.), 138.40 (quat. aryl c), 138.65 
(quat. aryl Q, 155.72 (quat. arom. COCH 3), 157.40 (NHCO), 170.22 (CO ester); rnlz 
(FAB) 668 (MH); FIRMS (FAB) 668.32529, C 40H46N08 requires 668.32234. 
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Aspartic acid -1- (2,4-dimethyl-2,4- bis (4'-methoxyphenyl) pent-3-0) ester 
Lc.25ll33NQ6 443.54 1 (61) 
ZAsp(O-2,4-dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl)OBzl (1. 9g,3 . 9mmol) was 
dissolved in 5% acetic acid / 95% ethanol, to which 5% palladium supported on charcoal 
(500mg) was added. The reaction vessel was attached to a hydrogen reservoir and the 
solution was stirred rapidly at atmospheric pressure. Complete hydrogen uptake was 
achieved in 3 hours, whereupon the solution was filtered through celite and evaporated 
in vacuo to yield a colourless gum. Trituration with diethyl ether yielded the title 
compound (920mg, 91%) as a white solid, nip. 219-221 °C; t.Lc.(A) R f 0.1 (+ve 
ninhydrinl+ve Kaiser/+ve Marys tests); Om (CHBr3)/cm' 3350 (NH), 3042 (arom), 
1724 (CO ester), A,, (DCM)/nm 231, 276 (c/ 9863, 1897 dm 3mor 1 cm 1 ); 6H  (200MHz, 
CDC13) 0.95 (12H, s, CH3 x4), 3.24 (2H, s, CH2), 3.68 (6H, s, OC1J  x2), 4.08 (11L 
m, NHCH); 5.42 (1H,, s, COOCH), 6.80 (411, d, arom. CH), 7.03 (41-, d, arom. CH); 6 c  
(200MIHz, CDC13) 25.53 (CH3), 29.66 (CH3), 34.42 (f3çH2),  42.18 (quat. ester C), 
50.95 (NHCH), 54.89 (OC143), 87.04 (COOCH), 112.91 (arom. CH), 127.79 (arom 
CE), 138.20 (quat. arom. Q, 157.43 (quat. arom. ), 172.50 (NHCO), 203.19 (cOOR), 
m/z (FAB) 444 (MH); HRMS (FAB) 444.23982, C 251134NO6 requires 444.23861. 
Na9fluorenyhnethoxycarbonyl aspartic acid -13-(2,4-dimethyl-2.4-bis(4'- 
methoxyphenyl)pent-3-yl)ester FC40ll43NQ8 665.79 1 (62) 
HAsp(O-2,4-dimethyl-2,4-bis[4'-methoxyphenyl]pent-3-yl)OH (500mg, 1. immol) was 
dissolved in dioxan / water (4m1,, 1:1), to which FmocOSu (320mg, 0.9mmol) in dioxan 
(imi) was added and the suspension was stirred for 5 minutes before the addition of 
potassium hydrogen carbonate (210mg, 2mmol). The resultant solution was stirred for 
up to 12 hours before being evaporated in vacuo. Diethyl ether was added and the 
organic phase washed with water, the resulting aqueous phase was acidified with 
potassium hydrogen sulphate (2mmol) and extracted with ethyl acetate. Analysis by thin 
layer chromatography indicated the vast majority of the desired product was in the 
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diethyl ether fraction. The diethyl ether fraction was acidified with potassium hydrogen 
sulphate and copiously washed with water, whereupon it was dried with anhydrous 
sodium sulphate. The solution was evaporated in vacuo to yield an oil which upon 
trituration with diethyl ether yielded the title compound (540mg,90%) in 90% purity. 
The purity was enhanced by flash chromatography over silica gel, eluted with 20% ethyl 
acetate / 80% hexane, and the resultant fraction triturated with diethyl ether to yield the 
title compound (4 19mg, 70%) as a white foam, nip. 79-81 °C, (Found C, 69.24; H, 
6.50; N, 1.41; C40H43N08 requires C, 72.16; H, 6.51; N, 2.10); t.l.c.(A) Rf 0.4 (-ye 
ninhydrinl+ve Marys test); [a] 22D ±29.4 (c.1, CHC13); Om (CHBr3)/cm 1 3418 (NE'), 
1721 (CO ester); X,,, (DCM)/nm 229, 267, 300 (E/dm 3mor'cm 1 10056, 11465, 6145); 
6H(200MHZ, CDC13) 1.07 (12H, s, C x4), 3.00 (2H, ddd, 13CH 2), 3.75 (6H, s, OC), 
4.24 (3H, m, Fmoc Cl/CH), 4.62 (11-1, m, NHCH), 5.48 (111, s, COOCH), 5.88 (111, d, 
NH), 6.74-7.76 (1611, in, arom. CH); 6c  (200MiHz, CDC13) 25.51 (CH3), 28.75 (CH3), 
36.21 (13CH2),  42.38 (C(CH3)2), 46.86 (Fmoc CH), 49.96 (NHCH), 55.04 (OCH3), 
67.43 (Fmoc C112), 87.27 (COOCH), 113.03 (ester arom. CH), 119.86 (ester arom. 
CH), 124.98-127.64 (Fmoc arom. CH), 138.85 (Fmoc quat. arom C), 141.13 (Fmoc 
quat. arom C), 143.50 (ester quat. aroni. C), 156.15 (quat. arom. OCH 3), 157.53 
(NIICO), 170.77 (CO ester), 175.19 (CO ester); ni/z (FAB) 666 (MH); FIRMS (FAB) 
666.30358, C4oH44NO8requires 666.30669. 
2,4-Dimethyl-2,4-bis(4'-methoxyphenyl)pent-3-yl hydrocinnamate 
J_cisll2sb 276.2 1 (63) 
Hydrocinnamic acid (200mg, 1.3mmol) was dissolved in dry tetrahydrofliran (lOmi), to 
which a catalytic amount of 4-(N,N-dimethylamino)-pyridine was added and the solution 
stirred at room temperature for 5 minutes. Diisopropylcarbodiiniide (197pI, 1.3mmol) 
was added followed by 2,4-dimethyl-2,4-bis(4 '-methoxyphenyl)pentan-3-ol (394mg, 
1.2mmol). The resultant solution was stirred for 12 hours at room temperature before 
being filtered and diethyl ether added. The solution was copiously washed with saturated 
sodium bicarbonate solution and then water, before being dried with anhydrous sodium 
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sulphate. Evaporation in vacuo yielded a colourless oil,, purification by flash 
chromatography with elution by 20% ethyl acetate / 80% hexane through silica afforded 
the title compound (232mg, 70%) as a colourless oil, t.l.c.(C) Rf 0.7; Um,, (neat)/cm' 
3039 (arom), 2961 (aliph), 1719 (CO ester), 6H(200MHZ, CDC1 3) 0.95 (18H, s, tBu x2), 
2.67 (21L t, CjCH2), 2.98 (21-L t, CflCH2), 4.59 (lH, s, COOCH), 7.23-7.25 (511, m, 
arom); & (200M11z, CDC1 3 ) 27.26 (tBu), 35.63 (quat. ester C), 34.60 (CH2), 84.48 
(COOCH), 124.86-127.12 (arom CH), 171.28 (CO ester); m/z (FAB) 277 (MW); 
HRMS : Found 277.21582, C,H2802 requires 277.21676. 
Synthesis of MS2 phage incorporating Asp' 5(ODmbp) I C76H1210 , 1761.87 1 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The synthesis was initiated with a functionalised FmocPhe-Resin (0.56mmoI/g; 446g, 
0.25 mm 1). All amino acid side chains were protected as previously described except 
Asp' 5 which was protected as the 2,4-dimethyl-2,4-bis(4 '-methoxyphenyl)pent-3-yl ester. 
All amino acids were single coupled as the HOCt treated activated ester. The N-terminal 
amine protecting group, Fmoc, was removed on completion of the assembly phase while 
the reaction vessel was on the automated synthesiser. The resultant fImctionalised resin 
was copiously washed with DMF, 1,4-dioxan, dichioromethane and diethyl ether. 
The resin bound product (3 0mg) was suspended in a solution of 20% piperidine / 80% 
DIVIF and sonicated for 5 hours, the resin was filtered and then suspended in a TFA 
(lOmi) solution which consisted of a scavenger cocktail of thioanisole / EDT / m-cresol 
(100p], lOOp], 200d) and stirred vigorously at room temperature for 4.5 hours. The 
suspension was evaporated in vacuo and filtered into a flask of diethyl ether (lOOmi). 
The resultant precipitate was separated by centrifugation and washed copiously with 
diethyl ether. The resultant white solid was dissolved in 30% acetic acid / 70% water 
and applied to the top of a G25 Sephadex column. The column was eluted with 30% 
acetic acid / 70% water and the peptide containing fractions pooled and lyophilised to 
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yield a white solid (14mg). Analysis by analytical HPLC indicated one main product 
(column C, A=H20, B=CH3CN, 0.1% TFA; imI/min., 10-90% B over 30 minutes, 
X=214nm), R= 19 minutes (57%B) which was isolated and analysed by mass 
spectrometry, mlz (FAB) 2073, indicating the Asp(ODmbp)-protected peptide. The 
aforementioned peak was isolated by preperative HPLC (column D, A=H 20, B=CH3CN, 
0.1% TFA; 9m1/min., 10-90% B over 30 minutes, X=214nm) m/z (FAB) 2073, FIRMS 
(FAB) found 2073.07679, C 97H147N20030 requires 2073.06256 (Asp protected peptide). 
Treatment of MS2 phage incorporating Asp' 5(ODmbp) (64)1 C76H12j008 
1761.871 with TFA / HBF4 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The resin bound product (20mg) was suspended a scavenger cocktail of thioanisole / 
EDT / m-cresol (420pJ, 200.i1, 200pl) and stirred vigorously at 4°C for 10 minutes under 
a nitrogen atmosphere. TFA (2.4m1) was added and then 1.4M H1317 4-diethyl ether 
complex (544d) and the resultant solution stirred vigorously for 30 mins. before being 
filtered into a flask of diethyl ether (lOOmi). The resultant precipitate was separated by 
centrifugation and washed copiously with diethyl ether. The resultant white solid was 
dissolved in 30% acetic acid / 70% water and eluted through a G25 Sephadex column. 
The column was eluted with 30% acetic acid / 70% water and the peptide containing 
fractions pooled, analysed by analytical HPLC (column C, A=H 20, B=CH3CN, 0.1% 
TFA; imI/min., 10-90% B over 30 minutes, ?=214nm), the products were analysed, the 
main constituent eluted at R,= 14.0 min.,(45 1/oB); m/z (FAB) 1762 (M); FIRMS: found 
1761.87936, C76Hi21N2oO28 requires 1761.86592. 
Treatment of MS2 phage incorporating Asp 15(ODmbp) I C76H12100, 1761.87] 
with TFA I TFMSA (64) 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
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The resin bound product (20mg) was suspended a scavenger cocktail of thioanisole / 
EDT / m-cresol (0.lmII 0.lmlI 0.2m1) and stirred vigorously at -15°C for 10 minutes 
under a nitrogen atmosphere. TFA (lml) was added and then TFMSA (100tl) and the 
resultant solution stirred vigorously for 15-90 mins. before being filtered into a flask of 
diethyl ether (lOOmi). The resultant precipitate was separated by centrifugation and 
washed copiously with diethyl ether. The resultant white solid was dissolved in 30% 
acetic acid / 70% water and eluted through a G25 Sephadex column. The column was 
eluted with 30% acetic acid / 70% water and the peptide containing fractions pooled, 
analysed by analytical HPLC (column C, A=11 20, B=CH3CN, 0.1% TFA; imI/min., 10-
90% B over 30 minutes, X=:214nm), indicating one main product R= 14 min.,(45%B); 
m/z (FAB) 1763, HRMS: found 176 1.87936, C 76H121N20028 requires 176 1.86592. 
Treatment of MS2 phage incorporating Asp' 5(ODmbp) (64)1 C76H1210Q 81 
1761.871 with TFA / TMSBr 
H-Val-Leu-Val-Asp-Asn-Gly-Gly-Thr-Gly-Asp-Val-Thr-Val-Ala-Pro- Ser-Asn-Phe-OH 
The resin bound product (20mg) was suspended a cooled scavenger cocktail of 
thioanisole / EDT / m-cresol (1.2m11 0.6m1/ 0.2m1) and stirred vigorously at 0°C for 2 
minutes under a nitrogen atmosphere. TFA (7.5m1) incorporating TMSBr (1.35m1) was 
added and the resultant solution stirred vigorously for up to 90 mins. before being 
filtered into a flask of diethyl ether (lOOml). The resultant precipitate was separated by 
centrifugation and washed copiously with diethyl ether. The resultant white solid was 
dissolved in 30% acetic acid / 70% water and eluted through a G25 Sephadex column. 
The column was eluted with 30% acetic acid / 70% water and the peptide containing 
fractions pooled, analysed by analytical HPLC (column C, AH 20, B=CH3CN, 0.1% 
TFA; lmllmin., 10-90% B over 30 minutes, X=214nm), one main product R= 14.0 
min.,(45%B); m/z (FAB)176 (MH), H.RMS: found 1762.87677, C 76171 122N20028 requires 
1762.87374. 
142 
Chapter 6: Experimental 
5.3 STABILITY STUDIES 
FEPLC stability studies of model protecting group esters 
An investigation into the stability of the aforementiomed protecting groups to hydrolysis 
was undertaken, a C 4 RP Aquapore butyl 7 micron (4.6 x 100mm) column was utilised, 
with a gradient of 90%A, 10%B to 10 1/oA, 90%B over 30 minutes. 
Stability of hydrocinnamate esters to acidolysis 
The corresponding hydrocinnamate esters (20mg) were added to a solution of 95% TFA 
/ 5% water and vigorously stirred at room temperature for 4 days. Aliquotes of the 
solution were removed at regular intervals, evaporated in vacuo and dissolved in lml 
acetonitrile. The resultant solution was analysed by h.p.l.c. (A=214nm) until acidolysis 
was complete indicated by the emergence of the hydrocinnamic acid and complete 
disappearance of the hyctrocinnamate ester peak. 
Stability of hydrocinnamate esters to base hydrolysis 
The corresponding hydrocinnamate ester (2mmol) was dissolved in dioxane (5m!) to 
which aqueous sodium hydroxide (4mmol, 5m!) was added and the resultant solution 
stirred vigorously for 7 days. Aliquotes of 0.5m1 were removed at regular intervals and 
quenched using pH 7 phosphate buffer (25m1). The resultant solution was analysed by 
HPLC as before. 
Stability studies on FmocAsp(OTmp)OH 
FmocAsp(OTmp)OH was dissolved in a TFA solution (lOml) incorporating a scavenger 
mix containing thioanisole / EDT / in-cresol (0.2m1/ 0.2m1/ 0.2m1) and was stirred 
vigorously at room temperature. Aliquotes of the solution were extracted at regular 
intervals, diluted with acetonitrile and injected for IHIPLC analysis (X=302nm). 
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Stability studies on FmocAsp(ODmbp)OB 
FmocAsp(ODmbp)OH was dissolved in a TFA solution (lOmi) incorporating a 
scavenger mix containing thioarnsole / EDT / m-cresol (0.2m1/ 0.2m1/ 0.2m1) and was 
stirred vigorously at room temperature. Aliquotes of the solution were extracted at 
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U1 
Empirical formula C20 H24 03 
Formula weight 312.39 
Wavelength 1.54 184 A 
Crystal system Orthorhombic 
Space group Pca2(1) 
Unit cell dimensions a = 18.374(2) A 	alpha = 90 deg. 
b = 6.2933(7) A 	beta = 90 deg. 
c = 15.044(2) A gamma = 90 deg. 
Volume 1739.6(4) A"3 
Z 4 
Density (calculated) 1.193 Mg/m/",3 
Crystallographic Data of 2-Methyl-2,4-bis(4 '-melhoxyphenyl)pentan-3-one 
r.I 
Empirical formula C21H2603 
Formula weight 326.42 
Wavelength 1.54184 A 
Crystal system Orthorhombic 
Space group P2(1)2(1)2 
Unit cell dimensions a = 8.175(2) A 	alpha = 90 deg. 
b = 17.336(2) A 	beta = 90 deg. 
c = 6.3439(9) A gamma = 90 deg. 
Volume 899. 0(2) AA3 
Z 2 
Density (calculated) 	 1.206 Mg/m-3 
Crystallographic Data of 2,4-Dimethyl-2,4-bis(4 '-methoxyphenyl)pentan-3-one 
Empirical formula C 19H220 
Formula weight 266.37 
Wavelength 1.54184 A 
Crystal system Orthorhombic 
Space group Pbca 
Unit cell dimensions a = 12.455(5) A 	alpha = 90 deg. 
b = 12.890(5) A 	beta = 90 deg. 
c= 19.106(5)A gamma 	9Odeg. 
Volume 3067.4(19) AA3 
Z 8 
Density (calculated) 1.154 Mg/m"3 
Crystallographic Data of 2,4-Dimethyl-2,4-diphenylpentan-3-one 
Empirical formula C 18H200 
Formula weight 252.36 
Wavelength 1.54180 A 
Crystal system Triclinic 
Space group P-i 
Unit cell dimensions a = 6.233(4) A 	alpha = 89.780 deg. 
b= 11.150(6)A 	beta83.330deg. 
c = 21.23(1) A gamma = 78.650 deg. 
Volume 1436.25 A'3 
Z 4.00 
Crystallographic Data of2-Methyl-2,4-diphenylpentan-3-one 
Empirical formula C20H2402 
Formula weight 296.39 
Wavelength 1.54184 A 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 7.2835(6) A 	alpha = 90 deg. 
b = 7.4206(10) A 	beta = 91.635(7) deg. 
c = 16.0786(12) A gamma = 90 deg. 
Volume 868. 7(2) A"3 
Z 2 
Density (calculated) 1.133 Mg/m-3 
Crystallographic Data of 2-Methyl-3,4-bis(4 '-methoxyphenyl)pent-l-ene 
Empirical formula C21H2803 
Formula weight 328.43 
Wavelength 0.71073 A 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 18.185(2) A 	alpha = 90 deg. 
b = 7.8003(11) A 	beta = 106.080(7) deg. 
c = 13.316(2) A gamma = 90 deg. 
Volume 1815.0(4)A"3 
Z 4 
Density (calculated) 1.202 Mg/m''3 
Crystallographic Data of2,4-Dimethyl-2,4-bis(4'-methoxyphenyl)pentan-3-ol 
